data_2mfp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mfp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.403 -2.792 0 N-CA-C 113.183 0.809 . . . . 73.099999999999994 113.183 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -136.95 -166.03 1.84 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 105.277 -2.12 . . . . 73.040000000000006 105.277 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -71.12 -22.33 62.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.594 0.634 . . . . 73.430000000000007 110.289 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -76.01 -10.57 59.52 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.095 0.474 . . . . 64.519999999999996 110.044 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 t -87.39 -19.14 28.53 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 119.663 -0.815 . . . . 72.230000000000004 109.816 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 12.85 81.22 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.146 -1.181 . . . . 62.100000000000001 110.146 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -101.43 -179.08 3.92 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 114.586 -0.807 . . . . 73.0 109.166 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.67 157.8 37.34 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.837 -0.801 . . . . 70.010000000000005 108.837 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -135.25 106.36 10.23 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 110.18 -0.304 . . . . 72.120000000000005 110.18 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.04 159.35 97.77 Favored 'Cis proline' 0 C--O 1.248 1.015 0 C-N-CA 123.704 -1.373 . . . . 73.430000000000007 110.401 -0.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.5 t -89.23 126.36 58.96 Favored Pre-proline 0 N--CA 1.408 -2.551 0 C-N-CA 119.435 -0.906 . . . . 72.340000000000003 109.56 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -84.41 13.81 2.63 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.114 2.543 . . . . 74.129999999999995 114.221 -172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.85 -42.82 2.09 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.383 0.913 . . . . 61.340000000000003 115.383 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.25 -99.95 2.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.962 -0.637 . . . . 62.329999999999998 114.124 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 m -59.19 -38.31 79.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.886 0.874 . . . . 72.299999999999997 112.279 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.6 4.46 81.93 Favored Glycine 0 C--O 1.253 1.338 0 C-N-CA 120.043 -1.075 . . . . 74.430000000000007 112.298 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.8 t -97.34 81.1 2.96 Favored 'General case' 0 N--CA 1.399 -3.008 0 O-C-N 121.427 -1.043 . . . . 71.329999999999998 111.46 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.68 72.93 10.51 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 122.564 1.174 . . . . 72.239999999999995 109.075 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.115 0 CA-C-N 113.218 -1.81 . . . . 74.219999999999999 107.235 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.361 -0.607 . . . . 74.549999999999997 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 16.4 t70 -138.66 -168.36 2.38 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 107.433 -1.321 . . . . 64.340000000000003 107.433 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 10.9 t70 -57.27 -36.1 70.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.101 1.361 . . . . 73.439999999999998 112.033 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -73.6 -1.77 20.17 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.167 -0.924 . . . . 73.430000000000007 111.872 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -99.26 -19.07 17.28 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.332 0.587 . . . . 75.219999999999999 109.959 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.538 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . 88.29 -3.65 85.43 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 110.574 -1.011 . . . . 61.119999999999997 110.574 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.14 178.78 8.19 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.767 -0.717 . . . . 73.200000000000003 109.522 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.96 155.99 34.9 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 109.021 -0.733 . . . . 74.219999999999999 109.021 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.79 109.01 11.92 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 122.926 0.141 . . . . 72.140000000000001 110.75 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.96 159.4 98.05 Favored 'Cis proline' 0 C--O 1.241 0.642 0 C-N-CA 123.322 -1.533 . . . . 71.340000000000003 109.318 -0.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 t -83.61 125.0 74.72 Favored Pre-proline 0 N--CA 1.416 -2.171 0 C-N-CA 119.024 -1.071 . . . . 73.439999999999998 109.522 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.04 0.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.21 2.606 . . . . 62.229999999999997 114.413 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.04 -27.31 5.03 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 121.335 -0.46 . . . . 63.140000000000001 114.152 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.25 -121.18 1.95 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.909 -0.663 . . . . 74.409999999999997 113.433 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.9 m -62.98 -30.11 71.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.388 1.075 . . . . 71.409999999999997 110.875 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.8 -6.15 71.59 Favored Glycine 0 C--O 1.257 1.556 0 CA-C-N 115.79 -0.641 . . . . 73.450000000000003 112.12 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 16.3 t -90.81 84.37 5.82 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 118.834 -1.146 . . . . 73.0 110.573 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 8' ' ' GLY . 5.1 ptm180 -78.64 68.61 4.66 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.744 1.259 . . . . 75.209999999999994 109.775 172.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.1 m . . . . . 0 C--N 1.299 -1.605 0 CA-C-N 112.024 -2.353 . . . . 73.019999999999996 108.116 171.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 N--CA 1.434 -1.26 0 CA-C-O 121.005 0.431 . . . . 74.129999999999995 111.262 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.549 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 10.4 t70 -153.19 -168.82 3.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.749 -2.315 . . . . 60.229999999999997 104.749 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.53 -22.52 58.99 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.942 0.792 . . . . 75.230000000000004 109.291 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -77.09 -8.81 58.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.874 -1.057 . . . . 71.230000000000004 109.948 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.549 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 1.6 t -87.23 -23.04 24.87 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.041 -0.527 . . . . 64.329999999999998 109.592 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.04 -4.86 71.69 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.379 -1.488 . . . . 64.450000000000003 109.379 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 m -86.75 167.56 14.32 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 114.769 -0.716 . . . . 74.540000000000006 110.594 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 153.57 43.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.867 -1.16 . . . . 75.310000000000002 107.867 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 t -131.59 111.25 14.96 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.082 -1.081 . . . . 75.540000000000006 108.082 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.69 150.26 95.35 Favored 'Cis proline' 0 C--O 1.243 0.743 0 C-N-CA 124.175 -1.177 . . . . 74.349999999999994 111.847 0.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.5 134.34 42.73 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 109.285 -0.635 . . . . 73.5 109.285 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.87 -11.01 16.79 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.845 2.363 . . . . 73.450000000000003 113.649 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.9 -40.55 3.08 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.341 -0.457 . . . . 73.099999999999994 113.154 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.43 -117.3 2.13 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.336 -0.705 . . . . 72.319999999999993 111.336 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.6 m -72.18 115.31 11.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.962 -0.755 . . . . 74.510000000000005 108.962 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.64 -9.34 7.69 Favored Glycine 0 C--N 1.288 -2.089 0 N-CA-C 107.662 -2.175 . . . . 74.319999999999993 107.662 -172.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 t -87.95 82.25 7.29 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.709 -0.746 . . . . 74.409999999999997 109.822 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -79.57 70.64 6.09 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 123.251 1.5 . . . . 74.310000000000002 110.645 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.288 -2.07 0 CA-C-N 111.08 -2.782 . . . . 74.450000000000003 106.828 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.0 m . . . . . 0 N--CA 1.414 -2.229 0 N-CA-C 109.35 -0.611 . . . . 71.450000000000003 109.35 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.18 -173.39 2.66 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.076 -0.713 . . . . 71.5 109.076 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.71 -23.37 42.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 121.757 0.789 . . . . 71.010000000000005 109.113 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -74.47 -12.12 60.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.616 -1.174 . . . . 74.150000000000006 109.056 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.02 -17.47 35.13 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.396 -0.82 . . . . 74.150000000000006 109.603 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 87.54 -3.82 86.19 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.744 -1.342 . . . . 62.229999999999997 109.744 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.4 m -87.58 172.06 10.03 Favored 'General case' 0 N--CA 1.404 -2.732 0 CA-C-N 113.906 -1.147 . . . . 71.420000000000002 110.364 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.61 155.65 40.46 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 124.316 1.01 . . . . 73.430000000000007 108.517 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.64 108.79 10.09 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 108.159 -1.052 . . . . 71.510000000000005 108.159 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.36 150.52 95.06 Favored 'Cis proline' 0 C--O 1.242 0.691 0 C-N-CA 124.055 -1.227 . . . . 74.109999999999999 111.387 0.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -84.7 127.84 63.56 Favored Pre-proline 0 N--CA 1.413 -2.283 0 N-CA-C 108.242 -1.021 . . . . 72.25 108.242 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.72 -24.26 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.583 2.189 . . . . 73.209999999999994 113.404 -172.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -36.74 4.08 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.55 -0.833 . . . . 61.119999999999997 112.6 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.36 -118.56 0.54 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.857 -0.687 . . . . 73.430000000000007 113.37 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -65.1 -24.59 67.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.466 0.65 . . . . 74.109999999999999 111.906 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.06 -9.13 75.78 Favored Glycine 0 C--O 1.257 1.535 0 CA-C-N 115.613 -0.721 . . . . 51.020000000000003 111.36 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 11.4 t -90.73 92.41 8.8 Favored 'General case' 0 N--CA 1.395 -3.191 0 C-N-CA 118.991 -1.084 . . . . 73.129999999999995 110.712 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 92.8 mtt180 -83.1 66.2 8.56 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.438 1.114 . . . . 73.400000000000006 108.192 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.5 m . . . . . 0 C--N 1.299 -1.617 0 CA-C-N 112.037 -2.347 . . . . 72.120000000000005 106.541 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 N--CA 1.416 -2.164 0 N-CA-C 109.899 -0.408 . . . . 75.299999999999997 109.899 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.71 -159.07 0.96 Allowed 'General case' 0 C--O 1.267 2.008 0 N-CA-C 105.9 -1.889 . . . . 64.230000000000004 105.9 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.594 1.088 . . . . 54.25 111.203 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -65.92 -21.75 66.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.566 0.58 . . . . 72.439999999999998 112.566 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.2 t -81.97 -35.65 28.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.043 0.449 . . . . 74.310000000000002 110.114 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.21 4.54 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 108.56 -1.816 . . . . 75.340000000000003 108.56 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.33 179.32 5.98 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.099 -1.074 . . . . 65.540000000000006 108.099 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.39 154.36 40.31 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.994 -0.743 . . . . 72.099999999999994 108.994 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.35 106.56 24.25 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 73.019999999999996 108.632 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.68 161.25 86.75 Favored 'Cis proline' 0 C--O 1.249 1.061 0 C-N-CA 123.607 -1.414 . . . . 75.120000000000005 109.969 0.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 16.7 t -85.4 118.6 71.06 Favored Pre-proline 0 N--CA 1.422 -1.846 0 C-N-CA 118.832 -1.147 . . . . 74.219999999999999 110.111 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -92.17 -18.15 0.84 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.034 2.49 . . . . 74.420000000000002 114.181 -173.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.05 -171.57 16.23 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.194 -1.562 . . . . 64.239999999999995 109.194 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.35 -130.3 49.49 Favored Glycine 0 C--O 1.245 0.791 0 CA-C-N 117.212 0.506 . . . . 74.109999999999999 113.015 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.2 m -67.96 -29.43 68.47 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.552 0.741 . . . . 73.040000000000006 110.721 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.07 -19.16 73.58 Favored Glycine 0 C--O 1.259 1.682 0 N-CA-C 110.991 -0.844 . . . . 61.340000000000003 110.991 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.5 t -88.58 88.41 7.6 Favored 'General case' 0 N--CA 1.392 -3.331 0 C-N-CA 119.153 -1.019 . . . . 73.129999999999995 110.199 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -71.41 57.17 0.25 Allowed 'General case' 0 C--O 1.208 -1.116 0 CA-C-O 121.846 0.832 . . . . 72.129999999999995 109.997 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.2 m . . . . . 0 C--N 1.298 -1.67 0 C-N-CA 125.417 1.487 . . . . 61.219999999999999 108.02 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 N--CA 1.432 -1.349 0 N-CA-C 112.335 0.495 . . . . 73.140000000000001 112.335 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 20.4 t70 -127.33 -172.7 2.72 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 107.05 -1.463 . . . . 74.430000000000007 107.05 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.418 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 8.7 t70 -73.06 -19.47 61.17 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.843 0.857 . . . . 73.420000000000002 109.038 -177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HG2' ' OD2' ' A' ' 4' ' ' ASP . 42.9 mmtm -53.23 -35.59 60.1 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.081 1.352 . . . . 75.219999999999999 110.013 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 m -71.16 -45.52 63.31 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.286 -1.325 . . . . 63.140000000000001 112.594 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.39 17.93 40.72 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 107.68 -2.168 . . . . 75.349999999999994 107.68 -163.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.69 173.13 7.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.957 -1.127 . . . . 75.230000000000004 107.957 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -67.53 149.12 50.57 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 123.964 0.79 . . . . 72.340000000000003 109.083 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 t -132.84 106.08 12.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.072 -0.714 . . . . 74.340000000000003 109.072 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.22 159.6 97.55 Favored 'Cis proline' 0 C--O 1.248 0.983 0 C-N-CA 123.915 -1.286 . . . . 65.329999999999998 111.0 -0.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 46.6 t -98.15 141.72 23.41 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 109.094 -0.706 . . . . 54.140000000000001 109.094 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 21.1 Cg_endo -64.09 -23.54 67.05 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.76 2.307 . . . . 75.299999999999997 113.045 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.13 -47.46 2.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 114.962 0.745 . . . . 51.520000000000003 114.962 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.23 -116.22 0.94 Allowed Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.712 -0.756 . . . . 73.25 114.192 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.7 m -62.04 -30.08 70.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.253 0.621 . . . . 73.420000000000002 111.189 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.46 14.52 40.26 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 116.058 -0.519 . . . . 33.219999999999999 112.34 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 41.9 t -102.44 130.61 49.27 Favored 'General case' 0 N--CA 1.404 -2.73 0 O-C-N 121.623 -0.928 . . . . 65.219999999999999 110.445 175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.32 27.38 0.59 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.395 -0.82 . . . . 74.329999999999998 111.056 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.1 m . . . . . 0 C--N 1.323 -0.581 0 C-N-CA 124.672 1.189 . . . . 63.219999999999999 109.131 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 112.497 0.554 . . . . 43.32 112.497 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 31.0 t70 -169.13 -173.43 1.76 Allowed 'General case' 0 C--O 1.253 1.248 0 N-CA-C 104.896 -2.261 . . . . 75.230000000000004 104.896 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.443 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 19.8 t70 -71.05 -26.55 63.13 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.683 -1.229 . . . . 63.009999999999998 107.683 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -66.28 -14.89 62.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.251 -1.341 . . . . 70.430000000000007 111.082 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 t -88.31 -31.0 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.281 -0.636 . . . . 72.409999999999997 109.281 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.66 3.67 59.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.326 -1.11 . . . . 73.049999999999997 110.326 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.5 174.33 8.16 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.011 -0.594 . . . . 74.329999999999998 109.862 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 153.14 42.3 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.004 -0.739 . . . . 72.450000000000003 109.004 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.46 109.91 11.36 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 118.533 0.606 . . . . 74.349999999999994 109.85 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 149.5 94.26 Favored 'Cis proline' 0 C--O 1.241 0.648 0 C-N-CA 124.045 -1.231 . . . . 74.430000000000007 111.349 0.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.1 t -81.62 128.46 69.29 Favored Pre-proline 0 N--CA 1.424 -1.751 0 N-CA-C 109.674 -0.491 . . . . 45.439999999999998 109.674 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.68 -2.4 7.45 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.047 2.498 . . . . 63.520000000000003 114.557 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.43 5.66 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.796 0.678 . . . . 64.140000000000001 114.796 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 -113.42 2.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.256 -0.973 . . . . 60.210000000000001 111.939 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -57.91 -37.75 74.62 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.408 0.683 . . . . 75.129999999999995 111.235 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.22 -2.7 73.96 Favored Glycine 0 C--O 1.256 1.488 0 C-N-CA 120.977 -0.63 . . . . 72.200000000000003 112.974 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.738 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 18.9 t -95.11 96.62 9.35 Favored 'General case' 0 N--CA 1.402 -2.854 0 C-N-CA 118.658 -1.217 . . . . 74.030000000000001 110.844 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -79.23 57.16 2.22 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.347 1.07 . . . . 75.400000000000006 108.681 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.738 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.4 m . . . . . 0 C--N 1.309 -1.18 0 C-N-CA 126.774 2.029 . . . . 74.340000000000003 107.793 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.8 m . . . . . 0 N--CA 1.415 -2.183 0 N-CA-C 109.92 -0.4 . . . . 75.420000000000002 109.92 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -146.25 -168.58 3.04 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 108.373 -0.973 . . . . 72.129999999999995 108.373 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.33 -29.76 61.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.132 0.573 . . . . 53.240000000000002 111.857 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -90.75 -5.34 55.82 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 120.922 0.391 . . . . 63.520000000000003 109.949 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 t -67.71 -31.83 72.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.637 -0.875 . . . . 63.25 108.637 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 0.95 55.15 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 109.512 -1.435 . . . . 53.049999999999997 109.512 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -95.1 173.81 7.38 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.791 -0.704 . . . . 74.040000000000006 110.712 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 157.61 36.73 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.221 0.95 . . . . 64.120000000000005 108.944 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.88 110.79 11.07 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.944 -0.761 . . . . 73.209999999999994 108.944 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.39 144.36 74.88 Favored 'Cis proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.416 -1.493 . . . . 72.129999999999995 110.756 -0.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -76.55 130.9 75.49 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.509 -0.923 . . . . 75.430000000000007 108.509 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.75 -40.23 47.05 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.659 2.239 . . . . 73.209999999999994 112.069 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.34 -46.2 1.12 Allowed Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.177 -1.011 . . . . 62.549999999999997 113.443 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.27 -84.32 1.62 Allowed Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.132 -1.187 . . . . 62.32 110.132 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -67.34 131.42 45.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.73 -1.581 . . . . 75.25 106.73 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.77 -9.21 77.37 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.25 -0.976 . . . . 74.329999999999998 111.26 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 45.1 t -85.09 90.4 7.85 Favored 'General case' 0 N--CA 1.412 -2.335 0 C-N-CA 118.71 -1.196 . . . . 65.510000000000005 110.72 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -77.15 70.34 3.53 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-O 123.401 1.572 . . . . 73.540000000000006 111.035 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.292 -1.927 0 CA-C-N 110.645 -2.98 . . . . 73.239999999999995 105.661 170.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.6 m . . . . . 0 N--CA 1.435 -1.186 0 N-CA-C 106.377 -1.712 . . . . 72.25 106.377 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -124.7 -171.38 2.34 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.654 -0.498 . . . . 72.049999999999997 109.654 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.74 -40.49 88.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.329 1.052 . . . . 64.439999999999998 111.376 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.07 0.37 36.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.821 -0.627 . . . . 75.409999999999997 111.127 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -89.14 -14.66 35.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.915 -0.772 . . . . 74.310000000000002 108.915 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.562 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 76.44 30.52 56.54 Favored Glycine 0 C--O 1.204 -1.767 0 N-CA-C 109.502 -1.439 . . . . 63.200000000000003 109.502 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.8 176.65 6.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.926 -0.768 . . . . 73.409999999999997 108.926 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 157.08 34.09 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.034 0.833 . . . . 73.409999999999997 108.828 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.37 102.44 10.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.767 -0.457 . . . . 74.439999999999998 109.767 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.99 163.22 90.6 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.796 -1.335 . . . . 73.310000000000002 110.721 0.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.9 t -92.43 129.85 39.45 Favored Pre-proline 0 N--CA 1.41 -2.458 0 C-N-CA 120.074 -0.651 . . . . 71.25 110.187 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.29 -25.93 6.63 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.003 2.468 . . . . 72.040000000000006 113.714 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.67 -33.6 5.56 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.268 -0.968 . . . . 73.430000000000007 113.916 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.57 -118.0 1.07 Allowed Glycine 0 C--O 1.229 -0.205 0 C-N-CA 120.493 -0.861 . . . . 44.439999999999998 113.738 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -62.77 -31.89 72.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.313 0.578 . . . . 74.530000000000001 110.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.34 -12.61 66.46 Favored Glycine 0 C--O 1.254 1.398 0 CA-C-N 115.696 -0.684 . . . . 74.299999999999997 111.789 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.7 t -88.91 75.21 8.09 Favored 'General case' 0 N--CA 1.4 -2.939 0 C-N-CA 118.928 -1.109 . . . . 75.140000000000001 109.955 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 11.5 ptm180 -77.97 68.14 3.96 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-O 123.531 1.634 . . . . 72.540000000000006 110.274 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.501 0 CA-C-N 111.156 -2.747 . . . . 75.409999999999997 106.728 172.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.8 m . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 109.027 -0.731 . . . . 75.450000000000003 109.027 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -144.03 -165.89 2.23 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.133 -1.062 . . . . 74.120000000000005 108.133 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -75.43 -17.0 60.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.622 0.769 . . . . 74.329999999999998 109.875 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HZ3' ' HB3' ' A' ' 6' ' ' LYS . 3.1 mmmp? -65.32 -23.81 67.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.367 -0.833 . . . . 54.409999999999997 110.148 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m -76.23 -50.47 14.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.075 -0.966 . . . . 63.450000000000003 111.079 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.78 2.6 39.92 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 107.822 -2.111 . . . . 73.450000000000003 107.822 -165.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.58 170.5 16.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 109.021 -0.733 . . . . 65.209999999999994 109.021 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -68.26 155.11 40.39 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.152 -1.055 . . . . 62.350000000000001 108.152 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.61 110.45 8.8 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.95 -1.13 . . . . 75.340000000000003 107.95 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.77 142.24 74.16 Favored 'Cis proline' 0 C--O 1.24 0.584 0 C-N-CA 124.065 -1.223 . . . . 62.420000000000002 111.186 0.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 41.9 t -78.33 125.46 84.81 Favored Pre-proline 0 N--CA 1.424 -1.76 0 N-CA-C 109.382 -0.599 . . . . 72.329999999999998 109.382 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.23 -16.5 22.28 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.628 2.219 . . . . 75.319999999999993 113.244 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.71 -36.99 3.63 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.858 -0.687 . . . . 72.329999999999998 113.59 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.74 -110.14 0.99 Allowed Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.422 -0.894 . . . . 75.450000000000003 113.139 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -56.87 -39.96 75.28 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.57 1.148 . . . . 73.340000000000003 111.059 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.24 0.99 72.13 Favored Glycine 0 C--O 1.258 1.626 0 CA-C-N 115.763 -0.653 . . . . 74.040000000000006 113.043 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 29.8 t -89.41 96.61 10.78 Favored 'General case' 0 N--CA 1.396 -3.125 0 C-N-CA 118.219 -1.392 . . . . 73.129999999999995 110.953 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -78.02 63.0 2.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.317 -0.856 . . . . 72.129999999999995 108.997 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.3 m . . . . . 0 C--N 1.3 -1.556 0 C-N-CA 126.629 1.972 . . . . 75.439999999999998 107.034 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 N--CA 1.435 -1.197 0 CA-C-O 120.643 0.258 . . . . 71.420000000000002 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -136.61 -170.17 2.62 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 116.07 -0.513 . . . . 74.420000000000002 109.985 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.6 -29.21 69.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.462 1.105 . . . . 63.229999999999997 112.219 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -80.31 -7.96 59.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.394 -0.522 . . . . 74.400000000000006 111.717 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.82 -25.94 29.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.235 -0.986 . . . . 63.340000000000003 111.427 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.8 8.89 69.11 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 109.396 -1.481 . . . . 73.329999999999998 109.396 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -100.68 173.31 6.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.333 -0.988 . . . . 71.319999999999993 108.333 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 158.1 31.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 123.724 0.64 . . . . 73.430000000000007 109.735 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 t -132.83 104.64 12.85 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.22 -0.659 . . . . 71.439999999999998 109.22 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.69 159.91 95.66 Favored 'Cis proline' 0 C--O 1.236 0.377 0 C-N-CA 124.031 -1.237 . . . . 63.420000000000002 109.817 -0.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.97 128.45 58.1 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 108.571 -0.9 . . . . 64.120000000000005 108.571 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.49 -10.63 3.12 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.023 2.482 . . . . 73.519999999999996 114.389 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.96 -175.77 35.51 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.173 -1.171 . . . . 52.219999999999999 110.173 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -123.07 29.33 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 116.853 0.326 . . . . 75.200000000000003 113.493 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 m -72.27 -21.7 61.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.432 0.634 . . . . 61.439999999999998 110.173 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.05 -14.65 78.93 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.286 -0.725 . . . . 71.519999999999996 111.286 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 30.0 t -90.44 91.06 8.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 118.119 -1.432 . . . . 64.219999999999999 110.81 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 71.05 3.13 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.605 1.193 . . . . 74.239999999999995 108.754 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.0 m . . . . . 0 C--N 1.291 -1.942 0 CA-C-N 111.23 -2.713 . . . . 74.140000000000001 108.632 172.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 N--CA 1.426 -1.628 0 N-CA-C 108.997 -0.742 . . . . 73.420000000000002 108.997 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 20.6 t70 -140.76 -169.09 2.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.419 -1.697 . . . . 74.150000000000006 106.419 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.402 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 30.9 t70 -70.38 -18.23 63.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 122.281 1.038 . . . . 71.430000000000007 110.197 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -81.18 2.49 27.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.478 -1.237 . . . . 72.099999999999994 110.603 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.41 -21.97 12.93 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.795 -0.762 . . . . 65.430000000000007 112.574 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.53 16.59 68.22 Favored Glycine 0 C--O 1.212 -1.259 0 N-CA-C 109.685 -1.366 . . . . 73.219999999999999 109.685 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -106.41 179.87 4.14 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 123.283 0.633 . . . . 75.219999999999999 109.932 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.06 42.12 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.967 -1.123 . . . . 71.409999999999997 107.967 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.25 107.07 11.21 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.29 -0.633 . . . . 75.430000000000007 109.29 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.25 157.62 99.29 Favored 'Cis proline' 0 C--O 1.246 0.908 0 C-N-CA 123.79 -1.338 . . . . 71.200000000000003 110.644 0.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.9 t -89.31 132.71 36.65 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 109.192 -0.669 . . . . 54.399999999999999 109.192 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.38 4.43 6.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.816 2.344 . . . . 70.109999999999999 113.065 -175.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.07 -40.21 3.09 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 115.498 0.959 . . . . 53.32 115.498 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.91 -77.11 0.66 Allowed Glycine 0 C--N 1.311 -0.855 0 C-N-CA 119.95 -1.119 . . . . 70.319999999999993 113.042 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.4 m -47.01 -41.65 16.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.626 1.57 . . . . 75.230000000000004 113.708 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.03 27.36 8.25 Favored Glycine 0 C--O 1.256 1.492 0 C-N-CA 120.917 -0.659 . . . . 75.5 111.674 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.1 t -92.74 84.43 5.0 Favored 'General case' 0 N--CA 1.403 -2.81 0 C-N-CA 118.38 -1.328 . . . . 72.219999999999999 109.774 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -77.91 65.41 3.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 122.338 1.066 . . . . 75.219999999999999 108.825 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.481 0 CA-C-N 112.235 -2.257 . . . . 72.409999999999997 105.518 172.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 109.33 -0.619 . . . . 74.349999999999994 109.33 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -140.22 -159.7 0.99 Allowed 'General case' 0 C--O 1.261 1.661 0 N-CA-C 107.019 -1.474 . . . . 75.510000000000005 107.019 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.03 -10.05 59.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 74.040000000000006 110.765 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.75 -27.44 60.35 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.306 -0.627 . . . . 74.120000000000005 109.306 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -82.77 -37.78 24.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.699 0.629 . . . . 74.010000000000005 112.699 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.04 27.22 9.59 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 119.164 -1.493 . . . . 75.099999999999994 109.546 -170.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.5 -178.44 3.38 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.2 -1.407 . . . . 72.239999999999995 107.2 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.81 154.87 39.74 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.948 0.78 . . . . 70.209999999999994 109.695 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.1 t -131.04 107.18 15.04 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.644 -0.873 . . . . 71.340000000000003 108.644 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.5 155.55 89.55 Favored 'Cis proline' 0 C--O 1.247 0.938 0 C-N-CA 124.313 -1.119 . . . . 73.209999999999994 109.582 0.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.4 t -83.36 123.46 76.91 Favored Pre-proline 0 N--CA 1.412 -2.374 0 C-N-CA 119.666 -0.814 . . . . 73.049999999999997 109.668 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.7 4.5 6.57 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 123.895 3.063 . . . . 71.219999999999999 115.451 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.67 -34.13 3.97 Favored Glycine 0 C--N 1.315 -0.586 0 N-CA-C 116.196 1.238 . . . . 75.349999999999994 116.196 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.71 -101.62 2.62 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 119.678 -1.248 . . . . 75.400000000000006 113.337 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 m -61.17 -36.74 80.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.261 1.025 . . . . 73.25 110.22 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.22 -1.44 88.11 Favored Glycine 0 C--O 1.254 1.375 0 C-N-CA 120.468 -0.873 . . . . 75.540000000000006 112.247 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 21.5 t -96.88 97.24 9.12 Favored 'General case' 0 N--CA 1.401 -2.903 0 C-N-CA 118.518 -1.273 . . . . 74.120000000000005 110.411 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -77.46 57.55 1.56 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 109.456 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.641 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.1 m . . . . . 0 C--N 1.315 -0.927 0 C-N-CA 127.074 2.149 . . . . 71.140000000000001 107.444 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.434 -1.261 0 N-CA-C 108.34 -0.985 . . . . 73.230000000000004 108.34 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -133.93 -170.16 2.45 Favored 'General case' 0 C--O 1.258 1.508 0 N-CA-C 108.747 -0.834 . . . . 71.329999999999998 108.747 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.36 -45.35 84.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.03 1.122 . . . . 71.329999999999998 114.03 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.4 -5.61 40.95 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.359 0.503 . . . . 75.120000000000005 112.359 -172.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.42 -28.02 34.45 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.461 -0.57 . . . . 64.510000000000005 109.461 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.74 12.15 59.67 Favored Glycine 0 CA--C 1.498 -0.98 0 N-CA-C 109.501 -1.44 . . . . 74.329999999999998 109.501 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.51 -178.33 3.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.505 -0.848 . . . . 73.120000000000005 108.861 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.75 161.78 25.54 Favored 'General case' 0 C--O 1.259 1.559 0 N-CA-C 108.261 -1.015 . . . . 74.319999999999993 108.261 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 t -137.12 107.54 8.79 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.488 -0.56 . . . . 71.019999999999996 109.488 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.88 157.12 99.07 Favored 'Cis proline' 0 C--O 1.24 0.596 0 C-N-CA 124.282 -1.133 . . . . 71.200000000000003 111.153 -0.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.8 t -86.89 129.07 53.71 Favored Pre-proline 0 N--CA 1.411 -2.385 0 N-CA-C 109.557 -0.534 . . . . 71.209999999999994 109.557 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 22.7 Cg_exo -64.38 -35.63 49.08 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.958 2.439 . . . . 75.25 113.313 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.17 -46.8 1.11 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.011 -1.09 . . . . 71.120000000000005 112.967 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.56 -95.31 2.24 Favored Glycine 0 C--O 1.25 1.153 0 N-CA-C 110.131 -1.188 . . . . 74.219999999999999 110.131 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 m -69.38 123.57 21.57 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.913 -1.514 . . . . 63.039999999999999 106.913 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.66 -22.58 21.61 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 109.54 -1.424 . . . . 60.109999999999999 109.54 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.8 t -96.65 91.86 5.93 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.945 -1.102 . . . . 71.120000000000005 109.677 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -54.52 -24.83 22.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.504 -0.771 . . . . 73.209999999999994 111.578 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 37.1 m . . . . . 0 C--O 1.215 -0.729 0 CA-C-N 115.478 -0.783 . . . . 74.219999999999999 112.01 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.7 m . . . . . 0 N--CA 1.428 -1.553 0 CA-C-O 120.562 0.22 . . . . 71.310000000000002 111.334 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 22.4 t70 -139.32 -171.4 3.11 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 107.129 -1.434 . . . . 74.230000000000004 107.129 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.444 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 1.3 p30 -77.99 -28.04 49.22 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.766 -0.828 . . . . 74.099999999999994 108.766 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -74.52 -10.38 59.5 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.962 -1.472 . . . . 71.340000000000003 110.198 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -34.13 49.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.94 -1.027 . . . . 75.439999999999998 108.434 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.56 56.18 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.08 -1.608 . . . . 64.530000000000001 109.08 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.1 m -97.39 173.6 7.11 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 113.773 -1.213 . . . . 62.219999999999999 109.183 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.01 163.8 27.64 Favored 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.987 0.804 . . . . 62.5 109.796 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 t -137.2 108.42 8.82 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.003 -0.74 . . . . 75.310000000000002 109.003 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.17 150.17 93.13 Favored 'Cis proline' 0 CA--C 1.514 -0.476 0 C-N-CA 123.989 -1.255 . . . . 73.409999999999997 110.476 0.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.7 t -79.86 119.04 75.43 Favored Pre-proline 0 N--CA 1.416 -2.148 0 C-N-CA 120.212 -0.595 . . . . 72.049999999999997 109.68 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -86.22 0.78 8.05 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.137 2.558 . . . . 74.209999999999994 114.296 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.45 -156.45 30.56 Favored Glycine 0 C--N 1.302 -1.33 0 N-CA-C 110.113 -1.195 . . . . 72.150000000000006 110.113 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -136.42 47.44 Favored Glycine 0 C--O 1.254 1.381 0 O-C-N 123.801 0.353 . . . . 65.239999999999995 113.724 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -79.94 -23.62 41.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.238 -0.653 . . . . 73.540000000000006 109.238 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.3 -20.32 71.26 Favored Glycine 0 C--O 1.251 1.186 0 CA-C-N 115.322 -0.854 . . . . 75.420000000000002 111.187 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.87 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.3 t -86.91 99.8 12.11 Favored 'General case' 0 N--CA 1.4 -2.949 0 O-C-N 121.687 -0.89 . . . . 64.129999999999995 109.895 176.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -73.45 64.42 0.84 Allowed 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.925 0.869 . . . . 73.310000000000002 109.094 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.87 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.6 m . . . . . 0 C--N 1.285 -2.2 0 CA-C-N 113.252 -1.795 . . . . 71.430000000000007 110.876 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 93.7 m . . . . . 0 N--CA 1.425 -1.72 0 N-CA-C 110.164 -0.31 . . . . 74.340000000000003 110.164 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -131.24 -174.68 3.46 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.435 -0.95 . . . . 74.329999999999998 108.435 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.34 -32.89 70.8 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 112.279 0.474 . . . . 64.329999999999998 112.279 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -76.48 -1.66 28.33 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.788 0.804 . . . . 74.109999999999999 110.523 -177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.9 t -80.8 -28.57 36.26 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 114.903 -1.044 . . . . 64.420000000000002 108.404 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 8.63 58.92 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 108.875 -1.69 . . . . 63.219999999999999 108.875 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.1 m -106.87 166.18 10.78 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-N 114.347 -0.926 . . . . 75.129999999999995 110.591 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -65.42 154.58 38.04 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.629 1.205 . . . . 72.150000000000006 108.926 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.9 t -134.1 105.34 11.39 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.606 -0.887 . . . . 73.329999999999998 108.606 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.26 157.36 99.37 Favored 'Cis proline' 0 C--O 1.246 0.891 0 C-N-CA 124.066 -1.222 . . . . 64.329999999999998 112.096 -0.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 43.8 t -99.96 141.06 22.06 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 108.463 -0.94 . . . . 73.239999999999995 108.463 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.58 -41.01 34.3 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.523 2.149 . . . . 73.329999999999998 113.052 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.38 -44.41 1.31 Allowed Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.002 -1.094 . . . . 70.019999999999996 113.959 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.99 -69.73 0.26 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.774 -1.203 . . . . 64.019999999999996 113.39 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 m -50.43 -57.24 8.48 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.543 1.137 . . . . 64.329999999999998 112.267 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 49.97 0.83 Allowed Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.347 -1.101 . . . . 74.409999999999997 110.347 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.8 t -110.25 109.03 19.35 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-O 121.893 0.854 . . . . 54.240000000000002 111.574 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.71 68.59 4.72 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 123.078 1.418 . . . . 75.530000000000001 109.275 172.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 6.6 m . . . . . 0 C--N 1.285 -2.209 0 CA-C-N 111.264 -2.698 . . . . 64.329999999999998 107.376 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 N--CA 1.429 -1.501 0 CA-C-O 121.701 0.763 . . . . 71.230000000000004 112.785 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 18.3 t70 -139.91 -171.79 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 75.5 105.821 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.416 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 29.3 t70 -82.74 -25.37 32.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.767 -1.197 . . . . 74.219999999999999 107.767 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.14 -7.81 53.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.689 -1.141 . . . . 65.150000000000006 109.449 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 5.9 t -85.82 -24.54 26.72 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.861 -1.163 . . . . 71.329999999999998 107.861 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.9 6.42 60.5 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.652 -1.379 . . . . 73.310000000000002 109.652 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 m -99.54 -178.97 4.06 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 114.18 -1.01 . . . . 64.450000000000003 109.879 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.4 159.32 21.83 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.393 -0.965 . . . . 73.340000000000003 108.393 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -137.5 109.44 8.74 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 108.925 -0.769 . . . . 73.219999999999999 108.925 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.75 149.56 94.06 Favored 'Cis proline' 0 C--O 1.25 1.106 0 C-N-CA 123.756 -1.352 . . . . 75.420000000000002 111.792 0.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.41 131.9 46.57 Favored Pre-proline 0 N--CA 1.427 -1.599 0 N-CA-C 108.228 -1.026 . . . . 74.310000000000002 108.228 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.09 -19.74 6.7 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.264 1.976 . . . . 74.319999999999993 115.07 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.04 -44.74 1.42 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.329 -0.939 . . . . 41.310000000000002 113.451 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.06 -117.56 1.8 Allowed Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.32 -0.943 . . . . 74.209999999999994 110.961 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 m -70.11 112.98 6.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.847 -1.168 . . . . 65.319999999999993 107.847 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.43 -21.5 4.81 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 108.274 -1.93 . . . . 62.409999999999997 108.274 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.1 t -92.66 93.92 8.75 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.879 -0.728 . . . . 65.239999999999995 110.721 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -77.5 64.11 2.77 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.035 0.922 . . . . 73.519999999999996 109.186 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 20.1 m . . . . . 0 C--N 1.31 -1.125 0 C-N-CA 126.765 2.026 . . . . 63.530000000000001 109.92 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.419 -2.013 0 N-CA-C 112.956 0.724 . . . . 73.310000000000002 112.956 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.4 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 4.5 p-10 -132.42 -170.13 2.37 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.01 -1.478 . . . . 64.519999999999996 107.01 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.52 -33.01 74.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 75.540000000000006 111.535 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -82.1 -0.15 43.35 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.396 0.617 . . . . 72.439999999999998 111.291 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.1 t -87.86 -16.14 34.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.034 -1.098 . . . . 73.230000000000004 108.034 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.92 -4.9 81.96 Favored Glycine 0 CA--C 1.496 -1.141 0 N-CA-C 109.503 -1.439 . . . . 72.040000000000006 109.503 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 m -90.43 171.75 9.22 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.077 -1.061 . . . . 75.219999999999999 110.616 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.2 158.98 35.48 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.908 -1.042 . . . . 75.010000000000005 108.352 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 t -135.77 107.96 9.91 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 109.566 -0.531 . . . . 73.549999999999997 109.566 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.3 152.1 97.31 Favored 'Cis proline' 0 C--O 1.245 0.849 0 C-N-CA 123.633 -1.403 . . . . 75.129999999999995 110.489 -0.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.3 t -77.22 131.54 72.11 Favored Pre-proline 0 N--CA 1.419 -2.024 0 N-CA-C 109.812 -0.44 . . . . 74.430000000000007 109.812 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.73 -9.62 13.25 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.863 2.375 . . . . 75.510000000000005 113.774 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.61 -32.95 4.55 Favored Glycine 0 C--N 1.31 -0.88 0 C-N-CA 120.847 -0.692 . . . . 74.329999999999998 114.217 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.34 -127.52 0.57 Allowed Glycine 0 C--N 1.32 -0.321 0 C-N-CA 120.94 -0.648 . . . . 64.319999999999993 113.673 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -60.08 -29.26 68.46 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.889 0.875 . . . . 74.120000000000005 110.339 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.72 -3.49 63.44 Favored Glycine 0 C--O 1.256 1.507 0 CA-C-N 115.103 -0.953 . . . . 55.25 112.334 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 35.5 t -89.03 93.59 9.65 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 118.563 -1.255 . . . . 75.129999999999995 109.605 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -77.88 64.34 3.09 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.912 -1.04 . . . . 75.209999999999994 109.084 174.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 7.3 m . . . . . 0 C--N 1.299 -1.598 0 C-N-CA 126.682 1.993 . . . . 75.299999999999997 107.794 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.42 -1.947 0 CA-C-O 121.195 0.521 . . . . 74.420000000000002 112.382 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.7 t70 -140.18 -177.68 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.108 -1.812 . . . . 72.129999999999995 106.108 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.67 -35.35 72.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.382 -0.97 . . . . 72.140000000000001 108.382 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -74.12 -7.17 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.928 -1.033 . . . . 74.439999999999998 111.068 178.211 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.461 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.5 t -83.32 -16.85 44.56 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.313 -0.995 . . . . 73.340000000000003 108.313 176.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.82 10.52 78.84 Favored Glycine 0 CA--C 1.485 -1.799 0 N-CA-C 109.715 -1.354 . . . . 72.049999999999997 109.715 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -104.26 172.17 6.94 Favored 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 113.911 -1.144 . . . . 64.109999999999999 109.625 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -70.64 159.61 34.1 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.194 -0.912 . . . . 74.510000000000005 108.856 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.13 112.8 6.77 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.347 -0.612 . . . . 72.549999999999997 109.347 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.24 140.82 69.45 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.54 -1.442 . . . . 72.540000000000006 110.505 -0.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 35.5 t -76.64 130.24 77.13 Favored Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 120.376 -0.53 . . . . 53.450000000000003 110.192 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.18 -29.45 39.34 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.505 2.137 . . . . 75.439999999999998 112.839 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.25 -29.54 12.19 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 119.858 -1.163 . . . . 73.010000000000005 115.691 171.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.39 -115.84 2.24 Favored Glycine 0 C--N 1.314 -0.653 0 C-N-CA 119.791 -1.195 . . . . 71.129999999999995 112.486 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.0 p -70.19 -16.8 63.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.696 0.76 . . . . 73.109999999999999 110.814 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.5 22.26 36.34 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.903 -0.879 . . . . 70.349999999999994 110.903 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.5 t -115.44 115.28 26.27 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-O 121.596 0.712 . . . . 71.129999999999995 111.057 174.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -80.94 61.22 4.46 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.327 -0.99 . . . . 73.219999999999999 108.327 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.713 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 m . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 124.639 1.175 . . . . 74.099999999999994 111.011 173.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.431 -1.4 0 N-CA-C 113.623 0.971 . . . . 64.319999999999993 113.623 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -143.37 -168.94 2.94 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 104.488 -2.412 . . . . 64.409999999999997 104.488 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.85 -29.28 62.03 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.205 -1.405 . . . . 71.450000000000003 107.205 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.71 -11.72 39.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.265 -1.334 . . . . 74.299999999999997 110.856 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -92.85 -19.3 21.84 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.548 -0.538 . . . . 71.120000000000005 109.548 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.03 52.71 Favored Glycine 0 C--O 1.209 -1.465 0 N-CA-C 109.665 -1.374 . . . . 72.129999999999995 109.665 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -113.95 176.51 5.01 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 122.862 0.465 . . . . 74.209999999999994 109.863 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.93 154.55 37.13 Favored 'General case' 0 C--O 1.25 1.097 0 O-C-N 124.204 0.94 . . . . 72.450000000000003 108.599 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.26 108.86 10.4 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.542 -0.54 . . . . 74.409999999999997 109.542 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.78 152.06 97.73 Favored 'Cis proline' 0 C--O 1.24 0.62 0 C-N-CA 123.549 -1.438 . . . . 73.109999999999999 110.934 -0.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.4 t -87.75 134.69 35.06 Favored Pre-proline 0 C--N 1.292 -1.896 0 N-CA-C 108.177 -1.046 . . . . 72.299999999999997 108.177 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -70.79 -37.55 6.57 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 121.83 1.687 . . . . 75.019999999999996 112.259 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.63 124.94 5.33 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.65 -0.98 . . . . 72.209999999999994 110.65 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 -75.8 1.39 Allowed Glycine 0 C--N 1.314 -0.665 0 N-CA-C 109.858 -1.297 . . . . 74.420000000000002 109.858 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.5 m -81.51 134.64 35.55 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.682 -1.599 . . . . 74.430000000000007 106.682 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.08 6.82 80.65 Favored Glycine 0 C--O 1.243 0.701 0 CA-C-O 122.411 1.006 . . . . 74.319999999999993 110.654 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.73 81.76 3.21 Favored 'General case' 0 N--CA 1.384 -3.737 0 O-C-N 121.694 -0.886 . . . . 61.219999999999999 110.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -79.12 68.17 5.01 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 123.124 1.44 . . . . 75.439999999999998 110.152 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.101 0 CA-C-N 112.447 -2.16 . . . . 63.310000000000002 105.423 170.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.663 0 N-CA-C 108.052 -1.092 . . . . 75.400000000000006 108.052 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.7 125.38 7.52 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 106.26 -2.736 . . . . 64.329999999999998 106.26 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 39.5 m -118.46 124.07 46.72 Favored 'General case' 0 N--CA 1.403 -2.792 0 C-N-CA 119.351 -0.94 . . . . 73.099999999999994 113.183 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -136.95 -166.03 1.84 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 105.277 -2.12 . . . . 73.040000000000006 105.277 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -71.12 -22.33 62.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.594 0.634 . . . . 73.430000000000007 110.289 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -76.01 -10.57 59.52 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.095 0.474 . . . . 64.519999999999996 110.044 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.569 ' SG ' ' HA3' ' A' ' 31' ' ' GLY . 8.0 t -87.39 -19.14 28.53 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 119.663 -0.815 . . . . 72.230000000000004 109.816 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 12.85 81.22 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.146 -1.181 . . . . 62.100000000000001 110.146 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -101.43 -179.08 3.92 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 114.586 -0.807 . . . . 73.0 109.166 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.67 157.8 37.34 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.837 -0.801 . . . . 70.010000000000005 108.837 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -135.25 106.36 10.23 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 110.18 -0.304 . . . . 72.120000000000005 110.18 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.04 159.35 97.77 Favored 'Cis proline' 0 C--O 1.248 1.015 0 C-N-CA 123.704 -1.373 . . . . 73.430000000000007 110.401 -0.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.5 t -89.23 126.36 58.96 Favored Pre-proline 0 N--CA 1.408 -2.551 0 C-N-CA 119.435 -0.906 . . . . 72.340000000000003 109.56 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -84.41 13.81 2.63 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.114 2.543 . . . . 74.129999999999995 114.221 -172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.85 -42.82 2.09 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.383 0.913 . . . . 61.340000000000003 115.383 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.25 -99.95 2.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.962 -0.637 . . . . 62.329999999999998 114.124 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 m -59.19 -38.31 79.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.886 0.874 . . . . 72.299999999999997 112.279 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.6 4.46 81.93 Favored Glycine 0 C--O 1.253 1.338 0 C-N-CA 120.043 -1.075 . . . . 74.430000000000007 112.298 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.8 t -97.34 81.1 2.96 Favored 'General case' 0 N--CA 1.399 -3.008 0 O-C-N 121.427 -1.043 . . . . 71.329999999999998 111.46 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.68 72.93 10.51 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 122.564 1.174 . . . . 72.239999999999995 109.075 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 -0.37 17.51 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.218 -1.81 . . . . 74.219999999999999 107.235 170.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -131.07 138.45 49.58 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 106.833 -1.543 . . . . 75.400000000000006 106.833 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.2 m 58.9 28.81 18.04 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.327 -0.99 . . . . 73.140000000000001 108.327 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.11 129.47 35.71 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.076 -0.966 . . . . 54.020000000000003 112.649 -170.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -99.94 -25.61 14.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.911 -1.144 . . . . 72.049999999999997 107.911 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.9 m -72.99 -56.11 5.6 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.421 -0.809 . . . . 72.140000000000001 111.0 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.97 138.66 2.65 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.536 -0.84 . . . . 72.209999999999994 111.836 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.09 -34.03 0.04 OUTLIER Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.857 -0.687 . . . . 64.319999999999993 111.866 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.3 111.57 0.9 Allowed 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.487 0.715 . . . . 74.219999999999999 111.278 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 64.02 20.7 12.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.637 1.175 . . . . 71.340000000000003 111.304 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.569 ' HA3' ' SG ' ' A' ' 7' ' ' CYS . . . . . . . . 1 C--O 1.31 4.868 0 CA-C-N 116.142 -0.481 . . . . 74.439999999999998 113.798 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.432 0.634 . . . . 64.030000000000001 109.853 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.85 151.66 20.19 Favored Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 110.111 -1.196 . . . . 70.129999999999995 110.111 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.0 m -108.92 163.61 13.14 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.361 -0.607 . . . . 74.549999999999997 109.361 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 16.4 t70 -138.66 -168.36 2.38 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 107.433 -1.321 . . . . 64.340000000000003 107.433 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 10.9 t70 -57.27 -36.1 70.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.101 1.361 . . . . 73.439999999999998 112.033 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -73.6 -1.77 20.17 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.167 -0.924 . . . . 73.430000000000007 111.872 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -99.26 -19.07 17.28 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.332 0.587 . . . . 75.219999999999999 109.959 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.538 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . 88.29 -3.65 85.43 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 110.574 -1.011 . . . . 61.119999999999997 110.574 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.14 178.78 8.19 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.767 -0.717 . . . . 73.200000000000003 109.522 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.96 155.99 34.9 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 109.021 -0.733 . . . . 74.219999999999999 109.021 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.79 109.01 11.92 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 122.926 0.141 . . . . 72.140000000000001 110.75 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.96 159.4 98.05 Favored 'Cis proline' 0 C--O 1.241 0.642 0 C-N-CA 123.322 -1.533 . . . . 71.340000000000003 109.318 -0.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 t -83.61 125.0 74.72 Favored Pre-proline 0 N--CA 1.416 -2.171 0 C-N-CA 119.024 -1.071 . . . . 73.439999999999998 109.522 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.04 0.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.21 2.606 . . . . 62.229999999999997 114.413 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.04 -27.31 5.03 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 121.335 -0.46 . . . . 63.140000000000001 114.152 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.25 -121.18 1.95 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.909 -0.663 . . . . 74.409999999999997 113.433 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.9 m -62.98 -30.11 71.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.388 1.075 . . . . 71.409999999999997 110.875 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.8 -6.15 71.59 Favored Glycine 0 C--O 1.257 1.556 0 CA-C-N 115.79 -0.641 . . . . 73.450000000000003 112.12 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 16.3 t -90.81 84.37 5.82 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 118.834 -1.146 . . . . 73.0 110.573 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 8' ' ' GLY . 5.1 ptm180 -78.64 68.61 4.66 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.744 1.259 . . . . 75.209999999999994 109.775 172.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.1 m -136.04 12.83 3.35 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.024 -2.353 . . . . 73.019999999999996 108.116 171.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -75.85 -33.53 60.02 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.378 -0.828 . . . . 75.239999999999995 109.737 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 t -145.08 11.65 1.37 Allowed 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.402 -0.817 . . . . 64.129999999999995 108.923 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . -128.46 88.76 2.79 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.275 -0.639 . . . . 61.420000000000002 109.275 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -79.96 115.19 19.4 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.754 0.787 . . . . 75.409999999999997 112.368 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.4 m -156.02 142.33 18.41 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.54 -1.282 . . . . 73.219999999999999 107.54 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.19 -64.42 1.53 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.65 -0.98 . . . . 74.420000000000002 110.65 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.71 -65.83 2.46 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.685 -0.566 . . . . 73.319999999999993 111.685 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -114.64 139.12 49.9 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.909 -1.145 . . . . 73.140000000000001 107.909 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.24 96.4 8.45 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.89 0.376 . . . . 72.420000000000002 110.628 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.022 0 N-CA-C 109.775 -1.33 . . . . 61.340000000000003 109.775 178.119 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 108.91 -0.774 . . . . 74.019999999999996 108.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.32 49.27 5.3 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 108.111 -1.996 . . . . 72.040000000000006 108.111 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 57.1 m -63.0 147.31 51.03 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.14 -1.03 . . . . 74.129999999999995 111.262 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.549 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 10.4 t70 -153.19 -168.82 3.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.749 -2.315 . . . . 60.229999999999997 104.749 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.53 -22.52 58.99 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.942 0.792 . . . . 75.230000000000004 109.291 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -77.09 -8.81 58.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.874 -1.057 . . . . 71.230000000000004 109.948 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.549 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 1.6 t -87.23 -23.04 24.87 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.041 -0.527 . . . . 64.329999999999998 109.592 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.04 -4.86 71.69 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.379 -1.488 . . . . 64.450000000000003 109.379 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 m -86.75 167.56 14.32 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 114.769 -0.716 . . . . 74.540000000000006 110.594 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 153.57 43.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.867 -1.16 . . . . 75.310000000000002 107.867 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 t -131.59 111.25 14.96 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.082 -1.081 . . . . 75.540000000000006 108.082 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.69 150.26 95.35 Favored 'Cis proline' 0 C--O 1.243 0.743 0 C-N-CA 124.175 -1.177 . . . . 74.349999999999994 111.847 0.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.5 134.34 42.73 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 109.285 -0.635 . . . . 73.5 109.285 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.87 -11.01 16.79 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.845 2.363 . . . . 73.450000000000003 113.649 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.9 -40.55 3.08 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.341 -0.457 . . . . 73.099999999999994 113.154 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.43 -117.3 2.13 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.336 -0.705 . . . . 72.319999999999993 111.336 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.6 m -72.18 115.31 11.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.962 -0.755 . . . . 74.510000000000005 108.962 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.64 -9.34 7.69 Favored Glycine 0 C--N 1.288 -2.089 0 N-CA-C 107.662 -2.175 . . . . 74.319999999999993 107.662 -172.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 t -87.95 82.25 7.29 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.709 -0.746 . . . . 74.409999999999997 109.822 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -79.57 70.64 6.09 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 123.251 1.5 . . . . 74.310000000000002 110.645 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' ' HA3' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -119.82 -37.65 3.08 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 111.08 -2.782 . . . . 74.450000000000003 106.828 169.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 t -60.29 104.73 0.35 Allowed 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.91 -1.041 . . . . 53.25 109.488 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.9 t 71.14 35.01 1.69 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.545 1.138 . . . . 73.430000000000007 109.909 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.34 -14.31 53.16 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.351 0.596 . . . . 54.530000000000001 109.72 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -178.61 -41.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.121 -1.807 . . . . 74.409999999999997 106.121 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 t -131.41 -175.77 3.81 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.38 -1.711 . . . . 72.209999999999994 106.38 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.31 -177.16 14.86 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 110.939 -0.864 . . . . 72.329999999999998 110.939 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.03 -98.51 2.45 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.665 -0.974 . . . . 71.340000000000003 110.665 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.99 114.16 8.57 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.109 -0.7 . . . . 72.450000000000003 109.109 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.13 164.82 25.15 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.767 -1.568 . . . . 74.230000000000004 106.767 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 21' ' ' CYS . . . . . . . . 0 C--O 1.266 2.117 0 O-C-N 124.159 0.912 . . . . 74.439999999999998 113.965 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.593 0 N-CA-C 108.367 -0.975 . . . . 72.230000000000004 108.367 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.55 -165.22 12.04 Favored Glycine 0 N--CA 1.411 -3.018 0 CA-C-N 115.012 -0.994 . . . . 65.219999999999999 112.066 175.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.0 m -134.85 155.37 50.78 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 109.35 -0.611 . . . . 71.450000000000003 109.35 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.18 -173.39 2.66 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.076 -0.713 . . . . 71.5 109.076 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.71 -23.37 42.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 121.757 0.789 . . . . 71.010000000000005 109.113 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -74.47 -12.12 60.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.616 -1.174 . . . . 74.150000000000006 109.056 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.02 -17.47 35.13 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.396 -0.82 . . . . 74.150000000000006 109.603 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 87.54 -3.82 86.19 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.744 -1.342 . . . . 62.229999999999997 109.744 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.4 m -87.58 172.06 10.03 Favored 'General case' 0 N--CA 1.404 -2.732 0 CA-C-N 113.906 -1.147 . . . . 71.420000000000002 110.364 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.61 155.65 40.46 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 124.316 1.01 . . . . 73.430000000000007 108.517 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.64 108.79 10.09 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 108.159 -1.052 . . . . 71.510000000000005 108.159 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.36 150.52 95.06 Favored 'Cis proline' 0 C--O 1.242 0.691 0 C-N-CA 124.055 -1.227 . . . . 74.109999999999999 111.387 0.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -84.7 127.84 63.56 Favored Pre-proline 0 N--CA 1.413 -2.283 0 N-CA-C 108.242 -1.021 . . . . 72.25 108.242 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.72 -24.26 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.583 2.189 . . . . 73.209999999999994 113.404 -172.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -36.74 4.08 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.55 -0.833 . . . . 61.119999999999997 112.6 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.36 -118.56 0.54 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.857 -0.687 . . . . 73.430000000000007 113.37 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -65.1 -24.59 67.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.466 0.65 . . . . 74.109999999999999 111.906 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.06 -9.13 75.78 Favored Glycine 0 C--O 1.257 1.535 0 CA-C-N 115.613 -0.721 . . . . 51.020000000000003 111.36 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 11.4 t -90.73 92.41 8.8 Favored 'General case' 0 N--CA 1.395 -3.191 0 C-N-CA 118.991 -1.084 . . . . 73.129999999999995 110.712 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.44 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 92.8 mtt180 -83.1 66.2 8.56 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.438 1.114 . . . . 73.400000000000006 108.192 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.5 m -147.36 23.33 1.16 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 112.037 -2.347 . . . . 72.120000000000005 106.541 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 p -116.66 -56.44 2.28 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.005 -0.998 . . . . 74.209999999999994 111.95 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m -78.79 -30.33 45.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.079 -0.509 . . . . 72.430000000000007 111.026 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.14 165.9 11.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.446 -0.576 . . . . 72.400000000000006 109.446 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.59 92.27 5.92 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.089 0.471 . . . . 73.329999999999998 109.819 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -154.09 142.1 20.25 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.728 -1.212 . . . . 74.319999999999993 107.728 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.4 -60.02 0.09 OUTLIER Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.205 -0.998 . . . . 72.129999999999995 111.409 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.37 -109.29 3.05 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.502 -1.039 . . . . 74.239999999999995 110.502 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.69 92.47 1.92 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.09 0.471 . . . . 75.420000000000002 111.025 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.22 112.91 6.9 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.801 -0.636 . . . . 73.299999999999997 109.639 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.636 0 N-CA-C 109.541 -1.424 . . . . 63.450000000000003 109.541 -177.507 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.665 0 CA-C-O 121.563 0.697 . . . . 64.310000000000002 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.33 127.17 8.56 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 108.811 -1.715 . . . . 73.319999999999993 108.811 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.8 m -126.88 144.6 50.94 Favored 'General case' 0 N--CA 1.416 -2.164 0 O-C-N 122.467 -0.431 . . . . 75.299999999999997 109.899 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.71 -159.07 0.96 Allowed 'General case' 0 C--O 1.267 2.008 0 N-CA-C 105.9 -1.889 . . . . 64.230000000000004 105.9 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.594 1.088 . . . . 54.25 111.203 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -65.92 -21.75 66.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.566 0.58 . . . . 72.439999999999998 112.566 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.2 t -81.97 -35.65 28.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.043 0.449 . . . . 74.310000000000002 110.114 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.21 4.54 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 108.56 -1.816 . . . . 75.340000000000003 108.56 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.33 179.32 5.98 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.099 -1.074 . . . . 65.540000000000006 108.099 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.39 154.36 40.31 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.994 -0.743 . . . . 72.099999999999994 108.994 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.35 106.56 24.25 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 73.019999999999996 108.632 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.68 161.25 86.75 Favored 'Cis proline' 0 C--O 1.249 1.061 0 C-N-CA 123.607 -1.414 . . . . 75.120000000000005 109.969 0.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 16.7 t -85.4 118.6 71.06 Favored Pre-proline 0 N--CA 1.422 -1.846 0 C-N-CA 118.832 -1.147 . . . . 74.219999999999999 110.111 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -92.17 -18.15 0.84 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.034 2.49 . . . . 74.420000000000002 114.181 -173.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.05 -171.57 16.23 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.194 -1.562 . . . . 64.239999999999995 109.194 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.35 -130.3 49.49 Favored Glycine 0 C--O 1.245 0.791 0 CA-C-N 117.212 0.506 . . . . 74.109999999999999 113.015 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.2 m -67.96 -29.43 68.47 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.552 0.741 . . . . 73.040000000000006 110.721 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.07 -19.16 73.58 Favored Glycine 0 C--O 1.259 1.682 0 N-CA-C 110.991 -0.844 . . . . 61.340000000000003 110.991 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.5 t -88.58 88.41 7.6 Favored 'General case' 0 N--CA 1.392 -3.331 0 C-N-CA 119.153 -1.019 . . . . 73.129999999999995 110.199 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -71.41 57.17 0.25 Allowed 'General case' 0 C--O 1.208 -1.116 0 CA-C-O 121.846 0.832 . . . . 72.129999999999995 109.997 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.2 m -129.54 -5.35 4.72 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 125.417 1.487 . . . . 61.219999999999999 108.02 173.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -108.71 -9.73 15.23 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.419 -0.956 . . . . 72.230000000000004 108.419 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 m -117.44 16.26 14.69 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.215 -0.902 . . . . 54.210000000000001 109.453 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.77 -18.19 24.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.733 -0.667 . . . . 74.019999999999996 111.265 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 64.21 20.65 12.27 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.541 0.736 . . . . 74.540000000000006 111.776 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 t -165.73 178.33 6.66 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.498 -1.297 . . . . 70.329999999999998 107.498 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.72 -88.89 0.83 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 121.274 -0.488 . . . . 70.319999999999993 111.907 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.18 67.9 1.5 Allowed Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 109.736 -1.346 . . . . 71.329999999999998 109.736 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 70.66 84.52 0.14 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 125.02 1.328 . . . . 73.510000000000005 110.384 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.63 119.45 16.24 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.997 -1.001 . . . . 72.109999999999999 110.255 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 CA-C-N 116.282 -0.417 . . . . 73.439999999999998 113.254 175.115 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 N-CA-C 112.012 0.375 . . . . 73.400000000000006 112.012 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.77 96.64 0.45 Allowed Glycine 0 N--CA 1.465 0.588 0 O-C-N 124.092 0.87 . . . . 73.340000000000003 111.195 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.7 m -114.87 157.42 23.33 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 112.335 0.495 . . . . 73.140000000000001 112.335 -172.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 20.4 t70 -127.33 -172.7 2.72 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 107.05 -1.463 . . . . 74.430000000000007 107.05 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.418 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 8.7 t70 -73.06 -19.47 61.17 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.843 0.857 . . . . 73.420000000000002 109.038 -177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HG2' ' OD2' ' A' ' 4' ' ' ASP . 42.9 mmtm -53.23 -35.59 60.1 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.081 1.352 . . . . 75.219999999999999 110.013 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 m -71.16 -45.52 63.31 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.286 -1.325 . . . . 63.140000000000001 112.594 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.39 17.93 40.72 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 107.68 -2.168 . . . . 75.349999999999994 107.68 -163.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.69 173.13 7.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.957 -1.127 . . . . 75.230000000000004 107.957 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -67.53 149.12 50.57 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 123.964 0.79 . . . . 72.340000000000003 109.083 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 t -132.84 106.08 12.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.072 -0.714 . . . . 74.340000000000003 109.072 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.22 159.6 97.55 Favored 'Cis proline' 0 C--O 1.248 0.983 0 C-N-CA 123.915 -1.286 . . . . 65.329999999999998 111.0 -0.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 46.6 t -98.15 141.72 23.41 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 109.094 -0.706 . . . . 54.140000000000001 109.094 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 21.1 Cg_endo -64.09 -23.54 67.05 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.76 2.307 . . . . 75.299999999999997 113.045 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.13 -47.46 2.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 114.962 0.745 . . . . 51.520000000000003 114.962 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.23 -116.22 0.94 Allowed Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.712 -0.756 . . . . 73.25 114.192 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.7 m -62.04 -30.08 70.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.253 0.621 . . . . 73.420000000000002 111.189 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.46 14.52 40.26 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 116.058 -0.519 . . . . 33.219999999999999 112.34 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 41.9 t -102.44 130.61 49.27 Favored 'General case' 0 N--CA 1.404 -2.73 0 O-C-N 121.623 -0.928 . . . . 65.219999999999999 110.445 175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.32 27.38 0.59 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.395 -0.82 . . . . 74.329999999999998 111.056 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.1 m -134.63 19.64 3.58 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.672 1.189 . . . . 63.219999999999999 109.131 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 17.5 m -103.38 -34.61 8.68 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.814 -0.63 . . . . 72.430000000000007 110.629 -175.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -107.18 19.18 20.74 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.657 0.741 . . . . 62.530000000000001 109.103 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.68 151.85 46.24 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.155 -1.054 . . . . 72.140000000000001 108.155 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -119.47 95.84 4.96 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.36 -0.608 . . . . 75.140000000000001 109.36 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.9 m -87.72 -0.7 57.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.472 -0.786 . . . . 73.420000000000002 111.224 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.28 -175.64 16.4 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.814 -0.707 . . . . 73.310000000000002 111.867 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.24 -35.76 70.31 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.074 -0.81 . . . . 62.149999999999999 111.074 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.51 83.5 7.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.324 -0.621 . . . . 73.420000000000002 109.324 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.79 172.5 2.07 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 106.333 -1.728 . . . . 72.140000000000001 106.333 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.78 0 C-N-CA 119.12 -1.514 . . . . 45.219999999999999 114.198 177.816 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 112.661 0.615 . . . . 71.329999999999998 112.661 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.5 73.38 2.68 Favored Glycine 0 C--N 1.307 -1.061 0 N-CA-C 108.764 -1.734 . . . . 73.310000000000002 108.764 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 m -119.11 167.29 11.94 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 112.497 0.554 . . . . 43.32 112.497 -170.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 31.0 t70 -169.13 -173.43 1.76 Allowed 'General case' 0 C--O 1.253 1.248 0 N-CA-C 104.896 -2.261 . . . . 75.230000000000004 104.896 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.443 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 19.8 t70 -71.05 -26.55 63.13 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.683 -1.229 . . . . 63.009999999999998 107.683 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -66.28 -14.89 62.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.251 -1.341 . . . . 70.430000000000007 111.082 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 t -88.31 -31.0 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.281 -0.636 . . . . 72.409999999999997 109.281 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.66 3.67 59.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.326 -1.11 . . . . 73.049999999999997 110.326 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.5 174.33 8.16 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.011 -0.594 . . . . 74.329999999999998 109.862 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 153.14 42.3 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.004 -0.739 . . . . 72.450000000000003 109.004 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.46 109.91 11.36 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 118.533 0.606 . . . . 74.349999999999994 109.85 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 149.5 94.26 Favored 'Cis proline' 0 C--O 1.241 0.648 0 C-N-CA 124.045 -1.231 . . . . 74.430000000000007 111.349 0.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.1 t -81.62 128.46 69.29 Favored Pre-proline 0 N--CA 1.424 -1.751 0 N-CA-C 109.674 -0.491 . . . . 45.439999999999998 109.674 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.68 -2.4 7.45 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.047 2.498 . . . . 63.520000000000003 114.557 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.43 5.66 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.796 0.678 . . . . 64.140000000000001 114.796 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 -113.42 2.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.256 -0.973 . . . . 60.210000000000001 111.939 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -57.91 -37.75 74.62 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.408 0.683 . . . . 75.129999999999995 111.235 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.22 -2.7 73.96 Favored Glycine 0 C--O 1.256 1.488 0 C-N-CA 120.977 -0.63 . . . . 72.200000000000003 112.974 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.738 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 18.9 t -95.11 96.62 9.35 Favored 'General case' 0 N--CA 1.402 -2.854 0 C-N-CA 118.658 -1.217 . . . . 74.030000000000001 110.844 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -79.23 57.16 2.22 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.347 1.07 . . . . 75.400000000000006 108.681 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.738 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.4 m -145.17 -35.44 0.32 Allowed 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 126.774 2.029 . . . . 74.340000000000003 107.793 176.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 m -63.0 109.26 1.41 Allowed 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.51 -0.922 . . . . 73.209999999999994 108.51 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.9 m 72.3 17.67 4.82 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.433 1.093 . . . . 74.140000000000001 111.258 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.1 133.76 37.81 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.259 -0.645 . . . . 61.350000000000001 109.259 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -74.86 -63.76 1.19 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.824 -0.625 . . . . 75.319999999999993 111.377 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 m -110.15 98.09 7.43 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.055 0.455 . . . . 74.430000000000007 110.69 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -145.84 9.2 1.57 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.243 -0.979 . . . . 73.230000000000004 112.601 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.34 -114.02 6.17 Favored Glycine 0 C--O 1.241 0.577 0 N-CA-C 110.696 -0.962 . . . . 64.439999999999998 110.696 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.1 97.55 8.85 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.441 -0.948 . . . . 73.310000000000002 108.441 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.94 95.97 10.11 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.116 -0.493 . . . . 63.119999999999997 110.865 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.277 2.804 0 C-N-CA 120.996 -0.621 . . . . 75.420000000000002 112.538 179.713 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.896 0 N-CA-C 108.56 -0.904 . . . . 74.519999999999996 108.56 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.61 147.9 39.2 Favored Glycine 0 C--O 1.25 1.138 0 O-C-N 124.417 1.073 . . . . 73.319999999999993 112.425 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.8 m -136.51 167.43 21.38 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 109.92 -0.4 . . . . 75.420000000000002 109.92 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -146.25 -168.58 3.04 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 108.373 -0.973 . . . . 72.129999999999995 108.373 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.33 -29.76 61.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.132 0.573 . . . . 53.240000000000002 111.857 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -90.75 -5.34 55.82 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 120.922 0.391 . . . . 63.520000000000003 109.949 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 t -67.71 -31.83 72.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.637 -0.875 . . . . 63.25 108.637 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 0.95 55.15 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 109.512 -1.435 . . . . 53.049999999999997 109.512 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -95.1 173.81 7.38 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.791 -0.704 . . . . 74.040000000000006 110.712 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 157.61 36.73 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.221 0.95 . . . . 64.120000000000005 108.944 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.88 110.79 11.07 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.944 -0.761 . . . . 73.209999999999994 108.944 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.39 144.36 74.88 Favored 'Cis proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.416 -1.493 . . . . 72.129999999999995 110.756 -0.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -76.55 130.9 75.49 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.509 -0.923 . . . . 75.430000000000007 108.509 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.75 -40.23 47.05 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.659 2.239 . . . . 73.209999999999994 112.069 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.34 -46.2 1.12 Allowed Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.177 -1.011 . . . . 62.549999999999997 113.443 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.27 -84.32 1.62 Allowed Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.132 -1.187 . . . . 62.32 110.132 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -67.34 131.42 45.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.73 -1.581 . . . . 75.25 106.73 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.77 -9.21 77.37 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.25 -0.976 . . . . 74.329999999999998 111.26 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 45.1 t -85.09 90.4 7.85 Favored 'General case' 0 N--CA 1.412 -2.335 0 C-N-CA 118.71 -1.196 . . . . 65.510000000000005 110.72 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -77.15 70.34 3.53 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-O 123.401 1.572 . . . . 73.540000000000006 111.035 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -145.01 -51.82 0.27 Allowed 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 110.645 -2.98 . . . . 73.239999999999995 105.661 170.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 m -59.04 99.22 0.05 OUTLIER 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 113.911 -1.495 . . . . 73.340000000000003 109.92 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m 67.65 23.36 8.77 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.174 0.99 . . . . 73.299999999999997 111.008 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.34 -41.82 84.58 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.922 -0.769 . . . . 71.329999999999998 108.922 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -142.91 -40.93 0.32 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.435 -1.257 . . . . 75.400000000000006 107.825 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.4 t -138.69 -172.98 3.43 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.554 -1.647 . . . . 75.030000000000001 106.554 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.07 -86.25 1.71 Allowed Glycine 0 C--N 1.303 -1.273 0 C-N-CA 120.477 -0.868 . . . . 63.299999999999997 111.306 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.75 -118.72 7.21 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 121.445 -0.407 . . . . 71.129999999999995 112.818 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.52 68.63 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.073 0.549 . . . . 74.329999999999998 111.901 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 67.45 -67.29 0.18 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.053 1.341 . . . . 73.310000000000002 111.933 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.542 0 N-CA-C 111.389 -0.684 . . . . 73.200000000000003 111.389 179.348 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 N-CA-C 106.076 -1.824 . . . . 75.430000000000007 106.076 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.36 -88.12 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 105.32 -3.112 . . . . 73.239999999999995 105.32 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.6 m -128.27 143.8 51.06 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.377 -1.712 . . . . 72.25 106.377 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -124.7 -171.38 2.34 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.654 -0.498 . . . . 72.049999999999997 109.654 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.74 -40.49 88.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.329 1.052 . . . . 64.439999999999998 111.376 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.07 0.37 36.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.821 -0.627 . . . . 75.409999999999997 111.127 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -89.14 -14.66 35.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.915 -0.772 . . . . 74.310000000000002 108.915 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.562 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 76.44 30.52 56.54 Favored Glycine 0 C--O 1.204 -1.767 0 N-CA-C 109.502 -1.439 . . . . 63.200000000000003 109.502 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.8 176.65 6.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.926 -0.768 . . . . 73.409999999999997 108.926 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 157.08 34.09 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.034 0.833 . . . . 73.409999999999997 108.828 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.37 102.44 10.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.767 -0.457 . . . . 74.439999999999998 109.767 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.99 163.22 90.6 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.796 -1.335 . . . . 73.310000000000002 110.721 0.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.9 t -92.43 129.85 39.45 Favored Pre-proline 0 N--CA 1.41 -2.458 0 C-N-CA 120.074 -0.651 . . . . 71.25 110.187 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.29 -25.93 6.63 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.003 2.468 . . . . 72.040000000000006 113.714 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.67 -33.6 5.56 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.268 -0.968 . . . . 73.430000000000007 113.916 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.57 -118.0 1.07 Allowed Glycine 0 C--O 1.229 -0.205 0 C-N-CA 120.493 -0.861 . . . . 44.439999999999998 113.738 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -62.77 -31.89 72.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.313 0.578 . . . . 74.530000000000001 110.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.34 -12.61 66.46 Favored Glycine 0 C--O 1.254 1.398 0 CA-C-N 115.696 -0.684 . . . . 74.299999999999997 111.789 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.7 t -88.91 75.21 8.09 Favored 'General case' 0 N--CA 1.4 -2.939 0 C-N-CA 118.928 -1.109 . . . . 75.140000000000001 109.955 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 11.5 ptm180 -77.97 68.14 3.96 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-O 123.531 1.634 . . . . 72.540000000000006 110.274 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -120.66 -28.7 4.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 111.156 -2.747 . . . . 75.409999999999997 106.728 172.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t -95.99 -8.17 34.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.409 -0.814 . . . . 63.409999999999997 110.847 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -126.08 17.97 7.79 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.814 -0.809 . . . . 74.5 108.814 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.25 154.47 27.28 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.057 -1.09 . . . . 72.329999999999998 108.057 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -121.51 10.55 10.47 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.374 0.607 . . . . 74.219999999999999 110.37 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.9 m -104.66 154.29 20.15 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.916 -0.583 . . . . 65.109999999999999 109.506 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.77 142.37 5.35 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.467 -0.873 . . . . 40.149999999999999 112.077 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.84 50.04 3.24 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 114.125 0.41 . . . . 74.349999999999994 114.125 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.84 -84.14 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.026 1.331 . . . . 65.209999999999994 114.002 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.53 168.12 23.56 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.977 0.417 . . . . 71.010000000000005 111.376 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.31 0 N-CA-C 107.685 -2.166 . . . . 75.319999999999993 107.685 175.8 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 109.727 -0.472 . . . . 71.209999999999994 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.0 142.64 16.14 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.821 -0.627 . . . . 72.319999999999993 111.941 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.8 m -140.28 167.48 22.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 123.999 0.92 . . . . 75.450000000000003 109.027 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -144.03 -165.89 2.23 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.133 -1.062 . . . . 74.120000000000005 108.133 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -75.43 -17.0 60.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.622 0.769 . . . . 74.329999999999998 109.875 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HZ3' ' HB3' ' A' ' 6' ' ' LYS . 3.1 mmmp? -65.32 -23.81 67.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.367 -0.833 . . . . 54.409999999999997 110.148 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m -76.23 -50.47 14.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.075 -0.966 . . . . 63.450000000000003 111.079 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.78 2.6 39.92 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 107.822 -2.111 . . . . 73.450000000000003 107.822 -165.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.58 170.5 16.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 109.021 -0.733 . . . . 65.209999999999994 109.021 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -68.26 155.11 40.39 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.152 -1.055 . . . . 62.350000000000001 108.152 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.61 110.45 8.8 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.95 -1.13 . . . . 75.340000000000003 107.95 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.77 142.24 74.16 Favored 'Cis proline' 0 C--O 1.24 0.584 0 C-N-CA 124.065 -1.223 . . . . 62.420000000000002 111.186 0.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 41.9 t -78.33 125.46 84.81 Favored Pre-proline 0 N--CA 1.424 -1.76 0 N-CA-C 109.382 -0.599 . . . . 72.329999999999998 109.382 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.23 -16.5 22.28 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.628 2.219 . . . . 75.319999999999993 113.244 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.71 -36.99 3.63 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.858 -0.687 . . . . 72.329999999999998 113.59 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.74 -110.14 0.99 Allowed Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.422 -0.894 . . . . 75.450000000000003 113.139 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -56.87 -39.96 75.28 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.57 1.148 . . . . 73.340000000000003 111.059 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.24 0.99 72.13 Favored Glycine 0 C--O 1.258 1.626 0 CA-C-N 115.763 -0.653 . . . . 74.040000000000006 113.043 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 29.8 t -89.41 96.61 10.78 Favored 'General case' 0 N--CA 1.396 -3.125 0 C-N-CA 118.219 -1.392 . . . . 73.129999999999995 110.953 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -78.02 63.0 2.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.317 -0.856 . . . . 72.129999999999995 108.997 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.3 m -150.92 25.3 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 126.629 1.972 . . . . 75.439999999999998 107.034 172.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -93.23 -9.93 37.44 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.694 -1.139 . . . . 52.100000000000001 108.781 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -130.15 22.66 5.26 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.313 -1.366 . . . . 74.329999999999998 107.313 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.38 154.26 48.93 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.727 -0.669 . . . . 41.450000000000003 109.937 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -80.83 72.1 7.79 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.414 0.626 . . . . 72.239999999999995 110.657 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.58 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 49.4 m -157.62 26.0 0.28 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.046 -1.465 . . . . 72.129999999999995 107.046 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.03 144.36 10.61 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.414 -1.474 . . . . 50.039999999999999 109.414 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.39 -61.9 1.77 Allowed Glycine 0 C--N 1.3 -1.442 0 C-N-CA 120.576 -0.821 . . . . 72.239999999999995 112.066 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.11 -13.08 31.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.96 0.409 . . . . 74.019999999999996 110.966 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.53 -174.42 0.99 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.555 -1.646 . . . . 73.129999999999995 106.555 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.32 0 C-N-CA 120.579 -0.82 . . . . 71.430000000000007 112.73 174.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 121.154 0.502 . . . . 74.219999999999999 109.65 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.92 76.17 0.04 OUTLIER Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 110.156 -1.178 . . . . 72.109999999999999 110.156 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.6 m -73.78 152.23 40.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.26 -0.47 . . . . 71.420000000000002 110.354 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -136.61 -170.17 2.62 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 116.07 -0.513 . . . . 74.420000000000002 109.985 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.6 -29.21 69.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.462 1.105 . . . . 63.229999999999997 112.219 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -80.31 -7.96 59.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.394 -0.522 . . . . 74.400000000000006 111.717 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.82 -25.94 29.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.235 -0.986 . . . . 63.340000000000003 111.427 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.8 8.89 69.11 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 109.396 -1.481 . . . . 73.329999999999998 109.396 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -100.68 173.31 6.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.333 -0.988 . . . . 71.319999999999993 108.333 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 158.1 31.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 123.724 0.64 . . . . 73.430000000000007 109.735 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 t -132.83 104.64 12.85 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.22 -0.659 . . . . 71.439999999999998 109.22 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.69 159.91 95.66 Favored 'Cis proline' 0 C--O 1.236 0.377 0 C-N-CA 124.031 -1.237 . . . . 63.420000000000002 109.817 -0.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.3 t -85.97 128.45 58.1 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 108.571 -0.9 . . . . 64.120000000000005 108.571 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.49 -10.63 3.12 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.023 2.482 . . . . 73.519999999999996 114.389 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.96 -175.77 35.51 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.173 -1.171 . . . . 52.219999999999999 110.173 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -123.07 29.33 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 116.853 0.326 . . . . 75.200000000000003 113.493 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 m -72.27 -21.7 61.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.432 0.634 . . . . 61.439999999999998 110.173 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.05 -14.65 78.93 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.286 -0.725 . . . . 71.519999999999996 111.286 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 30.0 t -90.44 91.06 8.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 118.119 -1.432 . . . . 64.219999999999999 110.81 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 71.05 3.13 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.605 1.193 . . . . 74.239999999999995 108.754 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.0 m -157.07 15.6 0.27 Allowed 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 111.23 -2.713 . . . . 74.140000000000001 108.632 172.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -119.86 -42.6 2.6 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.848 -0.741 . . . . 73.409999999999997 112.495 -169.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 m -88.38 -18.87 27.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.165 0.507 . . . . 74.230000000000004 111.251 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.18 162.51 21.22 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.323 -0.621 . . . . 65.439999999999998 109.323 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -79.4 90.15 5.02 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.826 0.822 . . . . 72.209999999999994 111.158 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.4 m -97.05 17.26 17.43 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.4 -1.273 . . . . 72.340000000000003 109.809 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.69 -91.58 0.98 Allowed Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.669 -0.696 . . . . 75.540000000000006 112.03 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.15 123.42 1.03 Allowed Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 109.345 -1.502 . . . . 73.140000000000001 109.345 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.67 101.55 9.32 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.532 -0.544 . . . . 74.400000000000006 109.532 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.03 104.38 6.53 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.49 -0.777 . . . . 62.329999999999998 109.344 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.356 0 C-N-CA 120.549 -0.834 . . . . 75.319999999999993 111.017 -177.436 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.369 0.604 . . . . 74.319999999999993 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.83 81.0 0.46 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 111.282 -0.727 . . . . 65.510000000000005 111.282 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 76.1 m -108.55 147.84 31.16 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.997 -0.742 . . . . 73.420000000000002 108.997 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 20.6 t70 -140.76 -169.09 2.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.419 -1.697 . . . . 74.150000000000006 106.419 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.402 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 30.9 t70 -70.38 -18.23 63.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 122.281 1.038 . . . . 71.430000000000007 110.197 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -81.18 2.49 27.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.478 -1.237 . . . . 72.099999999999994 110.603 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.41 -21.97 12.93 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.795 -0.762 . . . . 65.430000000000007 112.574 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.53 16.59 68.22 Favored Glycine 0 C--O 1.212 -1.259 0 N-CA-C 109.685 -1.366 . . . . 73.219999999999999 109.685 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -106.41 179.87 4.14 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 123.283 0.633 . . . . 75.219999999999999 109.932 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.06 42.12 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.967 -1.123 . . . . 71.409999999999997 107.967 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.25 107.07 11.21 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.29 -0.633 . . . . 75.430000000000007 109.29 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.25 157.62 99.29 Favored 'Cis proline' 0 C--O 1.246 0.908 0 C-N-CA 123.79 -1.338 . . . . 71.200000000000003 110.644 0.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.9 t -89.31 132.71 36.65 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 109.192 -0.669 . . . . 54.399999999999999 109.192 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.38 4.43 6.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.816 2.344 . . . . 70.109999999999999 113.065 -175.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.07 -40.21 3.09 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 115.498 0.959 . . . . 53.32 115.498 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.91 -77.11 0.66 Allowed Glycine 0 C--N 1.311 -0.855 0 C-N-CA 119.95 -1.119 . . . . 70.319999999999993 113.042 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.4 m -47.01 -41.65 16.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.626 1.57 . . . . 75.230000000000004 113.708 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.03 27.36 8.25 Favored Glycine 0 C--O 1.256 1.492 0 C-N-CA 120.917 -0.659 . . . . 75.5 111.674 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.1 t -92.74 84.43 5.0 Favored 'General case' 0 N--CA 1.403 -2.81 0 C-N-CA 118.38 -1.328 . . . . 72.219999999999999 109.774 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -77.91 65.41 3.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 122.338 1.066 . . . . 75.219999999999999 108.825 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -134.31 15.35 3.79 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 112.235 -2.257 . . . . 72.409999999999997 105.518 172.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.2 t -81.0 -15.29 56.62 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.717 -1.129 . . . . 75.530000000000001 110.897 -172.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.0 m -106.96 -22.94 12.51 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.596 -0.89 . . . . 73.530000000000001 108.596 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.34 99.03 7.71 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.267 -0.879 . . . . 63.32 110.314 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -87.38 96.32 10.32 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.284 -1.006 . . . . 72.450000000000003 108.284 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.4 t -125.15 104.63 8.62 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.341 -0.985 . . . . 64.099999999999994 108.341 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.45 1.43 76.12 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.637 -0.711 . . . . 73.530000000000001 112.099 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.59 -90.88 1.99 Allowed Glycine 0 N--CA 1.425 -2.036 0 N-CA-C 111.23 -0.748 . . . . 74.010000000000005 111.23 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.35 95.53 10.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.455 -0.202 . . . . 65.0 110.455 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.7 145.16 0.52 Allowed 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.968 1.307 . . . . 73.219999999999999 107.802 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.696 0 C-N-CA 120.478 -0.868 . . . . 74.409999999999997 111.314 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 112.371 0.508 . . . . 64.010000000000005 112.371 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.87 122.93 30.26 Favored Glycine 0 C--O 1.242 0.613 0 O-C-N 123.583 0.552 . . . . 64.109999999999999 112.771 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m -142.06 156.91 45.42 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.33 -0.619 . . . . 74.349999999999994 109.33 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -140.22 -159.7 0.99 Allowed 'General case' 0 C--O 1.261 1.661 0 N-CA-C 107.019 -1.474 . . . . 75.510000000000005 107.019 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.03 -10.05 59.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 74.040000000000006 110.765 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.75 -27.44 60.35 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.306 -0.627 . . . . 74.120000000000005 109.306 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -82.77 -37.78 24.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.699 0.629 . . . . 74.010000000000005 112.699 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.04 27.22 9.59 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 119.164 -1.493 . . . . 75.099999999999994 109.546 -170.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.5 -178.44 3.38 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.2 -1.407 . . . . 72.239999999999995 107.2 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.81 154.87 39.74 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.948 0.78 . . . . 70.209999999999994 109.695 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.1 t -131.04 107.18 15.04 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.644 -0.873 . . . . 71.340000000000003 108.644 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.5 155.55 89.55 Favored 'Cis proline' 0 C--O 1.247 0.938 0 C-N-CA 124.313 -1.119 . . . . 73.209999999999994 109.582 0.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.4 t -83.36 123.46 76.91 Favored Pre-proline 0 N--CA 1.412 -2.374 0 C-N-CA 119.666 -0.814 . . . . 73.049999999999997 109.668 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.7 4.5 6.57 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 123.895 3.063 . . . . 71.219999999999999 115.451 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.67 -34.13 3.97 Favored Glycine 0 C--N 1.315 -0.586 0 N-CA-C 116.196 1.238 . . . . 75.349999999999994 116.196 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.71 -101.62 2.62 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 119.678 -1.248 . . . . 75.400000000000006 113.337 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 m -61.17 -36.74 80.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.261 1.025 . . . . 73.25 110.22 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.22 -1.44 88.11 Favored Glycine 0 C--O 1.254 1.375 0 C-N-CA 120.468 -0.873 . . . . 75.540000000000006 112.247 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 21.5 t -96.88 97.24 9.12 Favored 'General case' 0 N--CA 1.401 -2.903 0 C-N-CA 118.518 -1.273 . . . . 74.120000000000005 110.411 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -77.46 57.55 1.56 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 109.456 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.641 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.1 m -153.94 36.24 0.44 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 127.074 2.149 . . . . 71.140000000000001 107.444 175.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -81.15 -17.81 48.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.487 -0.931 . . . . 74.5 108.487 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -115.49 -40.21 3.44 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.377 -0.971 . . . . 71.349999999999994 108.377 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.58 138.29 41.36 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.458 -0.792 . . . . 60.43 109.469 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -102.16 -1.27 31.74 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.367 -0.533 . . . . 74.319999999999993 112.372 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.8 m -80.1 84.87 5.74 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.29 -1.004 . . . . 71.040000000000006 108.29 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 31' ' ' GLY . . . 88.31 43.65 5.52 Favored Glycine 0 C--O 1.277 2.834 0 N-CA-C 110.539 -1.024 . . . . 42.43 110.539 -176.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 21' ' ' CYS . . . -176.96 44.21 0.1 Allowed Glycine 0 C--O 1.243 0.683 0 CA-C-N 114.841 -0.679 . . . . 75.329999999999998 111.692 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.53 -59.26 0.68 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.608 -0.886 . . . . 63.299999999999997 108.608 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.66 -63.04 1.1 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.013 -1.106 . . . . 73.319999999999993 108.013 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' O ' ' HA2' ' A' ' 27' ' ' GLY . . . . . . . . 0 N--CA 1.436 -1.347 0 N-CA-C 109.493 -1.443 . . . . 64.010000000000005 109.493 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.284 2.9 0 CA-C-O 120.581 0.229 . . . . 75.120000000000005 111.191 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.56 134.49 41.64 Favored Glycine 0 CA--C 1.501 -0.784 0 O-C-N 124.676 1.235 . . . . 72.120000000000005 112.598 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 73.0 m -152.02 178.34 9.54 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.243 1.017 . . . . 73.230000000000004 108.34 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -133.93 -170.16 2.45 Favored 'General case' 0 C--O 1.258 1.508 0 N-CA-C 108.747 -0.834 . . . . 71.329999999999998 108.747 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.36 -45.35 84.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.03 1.122 . . . . 71.329999999999998 114.03 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.4 -5.61 40.95 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.359 0.503 . . . . 75.120000000000005 112.359 -172.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.42 -28.02 34.45 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.461 -0.57 . . . . 64.510000000000005 109.461 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.74 12.15 59.67 Favored Glycine 0 CA--C 1.498 -0.98 0 N-CA-C 109.501 -1.44 . . . . 74.329999999999998 109.501 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.51 -178.33 3.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.505 -0.848 . . . . 73.120000000000005 108.861 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.75 161.78 25.54 Favored 'General case' 0 C--O 1.259 1.559 0 N-CA-C 108.261 -1.015 . . . . 74.319999999999993 108.261 177.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 t -137.12 107.54 8.79 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.488 -0.56 . . . . 71.019999999999996 109.488 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.88 157.12 99.07 Favored 'Cis proline' 0 C--O 1.24 0.596 0 C-N-CA 124.282 -1.133 . . . . 71.200000000000003 111.153 -0.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.8 t -86.89 129.07 53.71 Favored Pre-proline 0 N--CA 1.411 -2.385 0 N-CA-C 109.557 -0.534 . . . . 71.209999999999994 109.557 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 22.7 Cg_exo -64.38 -35.63 49.08 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.958 2.439 . . . . 75.25 113.313 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.17 -46.8 1.11 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.011 -1.09 . . . . 71.120000000000005 112.967 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.56 -95.31 2.24 Favored Glycine 0 C--O 1.25 1.153 0 N-CA-C 110.131 -1.188 . . . . 74.219999999999999 110.131 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 m -69.38 123.57 21.57 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.913 -1.514 . . . . 63.039999999999999 106.913 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.66 -22.58 21.61 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 109.54 -1.424 . . . . 60.109999999999999 109.54 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.8 t -96.65 91.86 5.93 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.945 -1.102 . . . . 71.120000000000005 109.677 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -54.52 -24.83 22.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.504 -0.771 . . . . 73.209999999999994 111.578 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 37.1 m -64.0 -27.88 69.42 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.478 -0.783 . . . . 74.219999999999999 112.01 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 t -72.15 -8.61 55.63 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.146 0.498 . . . . 74.25 111.763 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -110.76 11.45 22.57 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 120.898 0.38 . . . . 71.409999999999997 110.79 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.0 -56.97 0.42 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.299 0.571 . . . . 64.299999999999997 111.168 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -163.7 108.06 1.02 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.283 -1.377 . . . . 74.530000000000001 107.283 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 m -57.99 -52.82 63.91 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.501 0.5 . . . . 75.409999999999997 110.384 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.85 -44.5 0.75 Allowed Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.191 -0.764 . . . . 75.310000000000002 111.191 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.1 -113.59 0.72 Allowed Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.237 -1.145 . . . . 74.319999999999993 110.237 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.4 -43.99 79.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.784 0.802 . . . . 73.310000000000002 108.893 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.45 140.11 47.46 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.424 -1.324 . . . . 73.319999999999993 107.424 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.306 0 C-N-CA 119.433 -1.365 . . . . 71.319999999999993 113.08 -179.555 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 108.891 -0.781 . . . . 63.539999999999999 108.891 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.47 68.46 1.4 Allowed Glycine 0 C--N 1.301 -1.362 0 N-CA-C 109.479 -1.448 . . . . 65.099999999999994 109.479 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.7 m -117.12 169.98 9.01 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.706 -0.247 . . . . 71.310000000000002 111.334 -173.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 22.4 t70 -139.32 -171.4 3.11 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 107.129 -1.434 . . . . 74.230000000000004 107.129 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.444 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 1.3 p30 -77.99 -28.04 49.22 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.766 -0.828 . . . . 74.099999999999994 108.766 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -74.52 -10.38 59.5 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.962 -1.472 . . . . 71.340000000000003 110.198 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -34.13 49.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.94 -1.027 . . . . 75.439999999999998 108.434 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.56 56.18 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.08 -1.608 . . . . 64.530000000000001 109.08 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.1 m -97.39 173.6 7.11 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 113.773 -1.213 . . . . 62.219999999999999 109.183 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.01 163.8 27.64 Favored 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.987 0.804 . . . . 62.5 109.796 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 t -137.2 108.42 8.82 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.003 -0.74 . . . . 75.310000000000002 109.003 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.17 150.17 93.13 Favored 'Cis proline' 0 CA--C 1.514 -0.476 0 C-N-CA 123.989 -1.255 . . . . 73.409999999999997 110.476 0.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.7 t -79.86 119.04 75.43 Favored Pre-proline 0 N--CA 1.416 -2.148 0 C-N-CA 120.212 -0.595 . . . . 72.049999999999997 109.68 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -86.22 0.78 8.05 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.137 2.558 . . . . 74.209999999999994 114.296 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.45 -156.45 30.56 Favored Glycine 0 C--N 1.302 -1.33 0 N-CA-C 110.113 -1.195 . . . . 72.150000000000006 110.113 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -136.42 47.44 Favored Glycine 0 C--O 1.254 1.381 0 O-C-N 123.801 0.353 . . . . 65.239999999999995 113.724 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -79.94 -23.62 41.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.238 -0.653 . . . . 73.540000000000006 109.238 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.3 -20.32 71.26 Favored Glycine 0 C--O 1.251 1.186 0 CA-C-N 115.322 -0.854 . . . . 75.420000000000002 111.187 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.87 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.3 t -86.91 99.8 12.11 Favored 'General case' 0 N--CA 1.4 -2.949 0 O-C-N 121.687 -0.89 . . . . 64.129999999999995 109.895 176.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -73.45 64.42 0.84 Allowed 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.925 0.869 . . . . 73.310000000000002 109.094 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.87 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.6 m -154.56 -24.39 0.12 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.252 -1.795 . . . . 71.430000000000007 110.876 176.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -68.71 -50.05 53.96 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.265 0.555 . . . . 74.030000000000001 111.792 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -89.78 -25.78 20.93 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.951 -0.759 . . . . 75.209999999999994 108.951 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . . . -65.6 -42.85 91.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.625 -0.716 . . . . 73.209999999999994 111.108 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -90.83 103.71 16.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 108.61 -0.885 . . . . 75.319999999999993 108.61 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -88.69 120.37 30.02 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 116.301 -0.409 . . . . 73.019999999999996 110.049 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.5 45.61 0.15 Allowed Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.54 -0.838 . . . . 62.520000000000003 112.526 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.68 48.73 64.71 Favored Glycine 0 C--O 1.236 0.277 0 O-C-N 123.586 0.227 . . . . 72.510000000000005 113.503 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.29 146.59 52.09 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.628 -0.508 . . . . 74.049999999999997 109.628 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.88 -44.27 4.04 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.797 0.332 . . . . 65.420000000000002 110.937 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.273 2.558 0 CA-C-N 116.198 -0.455 . . . . 71.319999999999993 113.174 178.28 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 120.87 0.367 . . . . 72.510000000000005 110.505 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.03 132.04 7.24 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 111.217 -0.753 . . . . 64.0 111.217 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 93.7 m -120.42 162.65 19.16 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 110.164 -0.31 . . . . 74.340000000000003 110.164 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -131.24 -174.68 3.46 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.435 -0.95 . . . . 74.329999999999998 108.435 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.34 -32.89 70.8 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 112.279 0.474 . . . . 64.329999999999998 112.279 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -76.48 -1.66 28.33 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.788 0.804 . . . . 74.109999999999999 110.523 -177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 29' ' ' ALA . 2.9 t -80.8 -28.57 36.26 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 114.903 -1.044 . . . . 64.420000000000002 108.404 175.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 8.63 58.92 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 108.875 -1.69 . . . . 63.219999999999999 108.875 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.1 m -106.87 166.18 10.78 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-N 114.347 -0.926 . . . . 75.129999999999995 110.591 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -65.42 154.58 38.04 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.629 1.205 . . . . 72.150000000000006 108.926 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.9 t -134.1 105.34 11.39 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.606 -0.887 . . . . 73.329999999999998 108.606 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.26 157.36 99.37 Favored 'Cis proline' 0 C--O 1.246 0.891 0 C-N-CA 124.066 -1.222 . . . . 64.329999999999998 112.096 -0.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 43.8 t -99.96 141.06 22.06 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 108.463 -0.94 . . . . 73.239999999999995 108.463 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.58 -41.01 34.3 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.523 2.149 . . . . 73.329999999999998 113.052 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.38 -44.41 1.31 Allowed Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.002 -1.094 . . . . 70.019999999999996 113.959 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.99 -69.73 0.26 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.774 -1.203 . . . . 64.019999999999996 113.39 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 m -50.43 -57.24 8.48 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.543 1.137 . . . . 64.329999999999998 112.267 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 49.97 0.83 Allowed Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.347 -1.101 . . . . 74.409999999999997 110.347 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.8 t -110.25 109.03 19.35 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-O 121.893 0.854 . . . . 54.240000000000002 111.574 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.71 68.59 4.72 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 123.078 1.418 . . . . 75.530000000000001 109.275 172.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 6.6 m -158.88 -36.53 0.06 Allowed 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 111.264 -2.698 . . . . 64.329999999999998 107.376 172.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 p -94.22 -37.86 11.34 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.589 0.709 . . . . 74.299999999999997 109.219 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.9 m -101.75 18.11 21.27 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.629 -0.714 . . . . 74.219999999999999 111.168 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.97 148.92 22.75 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.897 -1.149 . . . . 70.239999999999995 107.897 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -93.53 75.62 4.42 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.592 0.96 . . . . 73.340000000000003 113.592 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.1 m -97.02 136.84 37.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.899 -1.148 . . . . 71.340000000000003 107.899 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.55 -92.29 0.68 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.52 -0.847 . . . . 74.099999999999994 112.075 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.21 69.76 3.28 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 110.66 -0.976 . . . . 71.230000000000004 110.66 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.654 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . . . -147.97 14.92 1.05 Allowed 'General case' 0 C--O 1.251 1.148 0 CA-C-O 121.935 0.874 . . . . 74.409999999999997 109.711 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.02 160.87 14.13 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.473 -0.785 . . . . 73.010000000000005 109.911 -177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.656 0 N-CA-C 110.321 -1.112 . . . . 63.030000000000001 110.321 -177.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.846 0 N-CA-C 107.922 -1.14 . . . . 55.299999999999997 107.922 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.41 93.24 2.21 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 108.1 -2.0 . . . . 61.420000000000002 108.1 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.1 m -79.33 153.65 29.66 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.701 0.763 . . . . 71.230000000000004 112.785 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 18.3 t70 -139.91 -171.79 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 75.5 105.821 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.416 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 29.3 t70 -82.74 -25.37 32.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.767 -1.197 . . . . 74.219999999999999 107.767 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.14 -7.81 53.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.689 -1.141 . . . . 65.150000000000006 109.449 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 5.9 t -85.82 -24.54 26.72 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.861 -1.163 . . . . 71.329999999999998 107.861 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.9 6.42 60.5 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.652 -1.379 . . . . 73.310000000000002 109.652 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 m -99.54 -178.97 4.06 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 114.18 -1.01 . . . . 64.450000000000003 109.879 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.4 159.32 21.83 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.393 -0.965 . . . . 73.340000000000003 108.393 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -137.5 109.44 8.74 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 108.925 -0.769 . . . . 73.219999999999999 108.925 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.75 149.56 94.06 Favored 'Cis proline' 0 C--O 1.25 1.106 0 C-N-CA 123.756 -1.352 . . . . 75.420000000000002 111.792 0.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.41 131.9 46.57 Favored Pre-proline 0 N--CA 1.427 -1.599 0 N-CA-C 108.228 -1.026 . . . . 74.310000000000002 108.228 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.09 -19.74 6.7 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.264 1.976 . . . . 74.319999999999993 115.07 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.04 -44.74 1.42 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.329 -0.939 . . . . 41.310000000000002 113.451 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.06 -117.56 1.8 Allowed Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.32 -0.943 . . . . 74.209999999999994 110.961 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 m -70.11 112.98 6.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.847 -1.168 . . . . 65.319999999999993 107.847 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.43 -21.5 4.81 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 108.274 -1.93 . . . . 62.409999999999997 108.274 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.1 t -92.66 93.92 8.75 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.879 -0.728 . . . . 65.239999999999995 110.721 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -77.5 64.11 2.77 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.035 0.922 . . . . 73.519999999999996 109.186 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 20.1 m -156.68 -24.97 0.1 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 126.765 2.026 . . . . 63.530000000000001 109.92 175.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 p -85.65 -56.88 3.28 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.689 -0.404 . . . . 73.329999999999998 110.694 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.0 m -104.24 22.79 14.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.609 0.718 . . . . 73.439999999999998 110.006 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.4 157.17 47.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.751 -0.833 . . . . 74.010000000000005 108.751 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -88.81 122.46 32.23 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 123.437 0.46 . . . . 73.150000000000006 111.179 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.2 t -136.01 127.56 28.77 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.92 -1.511 . . . . 74.400000000000006 106.92 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.97 142.79 7.45 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 110.076 -1.21 . . . . 74.329999999999998 110.076 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.45 -43.45 1.15 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 110.678 -0.969 . . . . 74.010000000000005 110.678 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.3 154.25 49.02 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.906 -1.146 . . . . 62.350000000000001 107.906 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.16 101.65 12.01 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.905 -0.776 . . . . 75.340000000000003 108.905 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.693 0 C-N-CA 120.7 -0.762 . . . . 71.109999999999999 112.829 -177.559 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.604 0 N-CA-C 107.405 -1.332 . . . . 75.140000000000001 107.405 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.21 42.49 57.79 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 107.283 -2.327 . . . . 60.229999999999997 107.283 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.2 m -61.13 132.14 52.79 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 113.016 -1.592 . . . . 73.310000000000002 112.956 -173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.4 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 4.5 p-10 -132.42 -170.13 2.37 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.01 -1.478 . . . . 64.519999999999996 107.01 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.52 -33.01 74.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 75.540000000000006 111.535 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -82.1 -0.15 43.35 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.396 0.617 . . . . 72.439999999999998 111.291 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.1 t -87.86 -16.14 34.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.034 -1.098 . . . . 73.230000000000004 108.034 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.92 -4.9 81.96 Favored Glycine 0 CA--C 1.496 -1.141 0 N-CA-C 109.503 -1.439 . . . . 72.040000000000006 109.503 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 m -90.43 171.75 9.22 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.077 -1.061 . . . . 75.219999999999999 110.616 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.2 158.98 35.48 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.908 -1.042 . . . . 75.010000000000005 108.352 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 t -135.77 107.96 9.91 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 109.566 -0.531 . . . . 73.549999999999997 109.566 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.3 152.1 97.31 Favored 'Cis proline' 0 C--O 1.245 0.849 0 C-N-CA 123.633 -1.403 . . . . 75.129999999999995 110.489 -0.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.3 t -77.22 131.54 72.11 Favored Pre-proline 0 N--CA 1.419 -2.024 0 N-CA-C 109.812 -0.44 . . . . 74.430000000000007 109.812 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.73 -9.62 13.25 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.863 2.375 . . . . 75.510000000000005 113.774 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.61 -32.95 4.55 Favored Glycine 0 C--N 1.31 -0.88 0 C-N-CA 120.847 -0.692 . . . . 74.329999999999998 114.217 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.34 -127.52 0.57 Allowed Glycine 0 C--N 1.32 -0.321 0 C-N-CA 120.94 -0.648 . . . . 64.319999999999993 113.673 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -60.08 -29.26 68.46 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.889 0.875 . . . . 74.120000000000005 110.339 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.72 -3.49 63.44 Favored Glycine 0 C--O 1.256 1.507 0 CA-C-N 115.103 -0.953 . . . . 55.25 112.334 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 35.5 t -89.03 93.59 9.65 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 118.563 -1.255 . . . . 75.129999999999995 109.605 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 72.3 mtt180 -77.88 64.34 3.09 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.912 -1.04 . . . . 75.209999999999994 109.084 174.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 7.3 m -154.64 21.54 0.46 Allowed 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 126.682 1.993 . . . . 75.299999999999997 107.794 173.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 19' ' ' CYS . 11.1 t -148.5 171.77 15.56 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.18 -1.415 . . . . 63.200000000000003 107.18 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 m -81.43 66.79 7.12 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.026 0.917 . . . . 72.5 111.754 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.94 -54.47 2.61 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.62 -1.993 . . . . 73.109999999999999 105.62 173.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -140.34 -73.31 0.35 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.732 -1.122 . . . . 73.340000000000003 108.429 168.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 5.3 m -79.27 99.54 7.12 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.621 -0.718 . . . . 71.530000000000001 110.385 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.41 -12.48 78.38 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.918 -0.873 . . . . 65.049999999999997 110.918 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.42 101.84 1.11 Allowed Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 110.217 -1.153 . . . . 71.209999999999994 110.217 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.2 100.26 7.39 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 120.925 0.393 . . . . 71.230000000000004 111.09 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.39 -31.76 69.12 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.687 -0.857 . . . . 73.439999999999998 108.687 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.289 3.537 0 C-N-CA 119.613 -1.28 . . . . 65.140000000000001 114.763 176.865 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 108.926 -0.768 . . . . 72.349999999999994 108.926 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.9 32.75 83.68 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 124.496 1.122 . . . . 73.310000000000002 112.156 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.0 m -144.27 161.0 40.03 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 121.195 0.521 . . . . 74.420000000000002 112.382 -172.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.7 t70 -140.18 -177.68 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.108 -1.812 . . . . 72.129999999999995 106.108 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.67 -35.35 72.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.382 -0.97 . . . . 72.140000000000001 108.382 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -74.12 -7.17 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.928 -1.033 . . . . 74.439999999999998 111.068 178.211 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.461 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.5 t -83.32 -16.85 44.56 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.313 -0.995 . . . . 73.340000000000003 108.313 176.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.82 10.52 78.84 Favored Glycine 0 CA--C 1.485 -1.799 0 N-CA-C 109.715 -1.354 . . . . 72.049999999999997 109.715 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -104.26 172.17 6.94 Favored 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 113.911 -1.144 . . . . 64.109999999999999 109.625 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -70.64 159.61 34.1 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.194 -0.912 . . . . 74.510000000000005 108.856 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.13 112.8 6.77 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.347 -0.612 . . . . 72.549999999999997 109.347 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.24 140.82 69.45 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.54 -1.442 . . . . 72.540000000000006 110.505 -0.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 35.5 t -76.64 130.24 77.13 Favored Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 120.376 -0.53 . . . . 53.450000000000003 110.192 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.18 -29.45 39.34 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.505 2.137 . . . . 75.439999999999998 112.839 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.25 -29.54 12.19 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 119.858 -1.163 . . . . 73.010000000000005 115.691 171.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.39 -115.84 2.24 Favored Glycine 0 C--N 1.314 -0.653 0 C-N-CA 119.791 -1.195 . . . . 71.129999999999995 112.486 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.0 p -70.19 -16.8 63.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.696 0.76 . . . . 73.109999999999999 110.814 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.5 22.26 36.34 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.903 -0.879 . . . . 70.349999999999994 110.903 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.5 t -115.44 115.28 26.27 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-O 121.596 0.712 . . . . 71.129999999999995 111.057 174.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -80.94 61.22 4.46 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.327 -0.99 . . . . 73.219999999999999 108.327 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.713 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 m -155.17 16.16 0.41 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.639 1.175 . . . . 74.099999999999994 111.011 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -69.75 -13.34 62.24 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.008 0.433 . . . . 71.129999999999995 110.979 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.2 t -142.78 20.46 1.99 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.647 -0.871 . . . . 75.010000000000005 108.647 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.54 -72.4 0.68 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.024 -0.534 . . . . 74.019999999999996 110.903 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -120.8 82.96 1.99 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.984 -0.747 . . . . 74.430000000000007 108.984 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.4 m -100.01 -174.25 2.64 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.431 -0.804 . . . . 75.209999999999994 109.411 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 -104.78 3.08 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.451 -0.88 . . . . 62.5 111.598 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.52 128.31 8.13 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 111.036 -0.826 . . . . 71.200000000000003 111.036 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.02 122.59 37.72 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.905 -0.776 . . . . 72.25 108.905 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.41 99.69 1.63 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.349 -0.612 . . . . 74.109999999999999 109.349 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 N-CA-C 108.189 -1.964 . . . . 64.209999999999994 108.189 -172.923 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.871 0 N-CA-C 107.524 -1.288 . . . . 71.439999999999998 107.524 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.7 45.78 10.43 Favored Glycine 0 CA--C 1.495 -1.162 0 N-CA-C 106.426 -2.67 . . . . 74.420000000000002 106.426 -171.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.1 m -60.23 142.41 54.57 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 113.312 -1.444 . . . . 64.319999999999993 113.623 -171.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -143.37 -168.94 2.94 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 104.488 -2.412 . . . . 64.409999999999997 104.488 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.85 -29.28 62.03 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.205 -1.405 . . . . 71.450000000000003 107.205 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.71 -11.72 39.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.265 -1.334 . . . . 74.299999999999997 110.856 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -92.85 -19.3 21.84 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.548 -0.538 . . . . 71.120000000000005 109.548 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.03 52.71 Favored Glycine 0 C--O 1.209 -1.465 0 N-CA-C 109.665 -1.374 . . . . 72.129999999999995 109.665 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -113.95 176.51 5.01 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 122.862 0.465 . . . . 74.209999999999994 109.863 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.93 154.55 37.13 Favored 'General case' 0 C--O 1.25 1.097 0 O-C-N 124.204 0.94 . . . . 72.450000000000003 108.599 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.26 108.86 10.4 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.542 -0.54 . . . . 74.409999999999997 109.542 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.78 152.06 97.73 Favored 'Cis proline' 0 C--O 1.24 0.62 0 C-N-CA 123.549 -1.438 . . . . 73.109999999999999 110.934 -0.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.4 t -87.75 134.69 35.06 Favored Pre-proline 0 C--N 1.292 -1.896 0 N-CA-C 108.177 -1.046 . . . . 72.299999999999997 108.177 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -70.79 -37.55 6.57 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 121.83 1.687 . . . . 75.019999999999996 112.259 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.63 124.94 5.33 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.65 -0.98 . . . . 72.209999999999994 110.65 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 -75.8 1.39 Allowed Glycine 0 C--N 1.314 -0.665 0 N-CA-C 109.858 -1.297 . . . . 74.420000000000002 109.858 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.5 m -81.51 134.64 35.55 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.682 -1.599 . . . . 74.430000000000007 106.682 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.08 6.82 80.65 Favored Glycine 0 C--O 1.243 0.701 0 CA-C-O 122.411 1.006 . . . . 74.319999999999993 110.654 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.73 81.76 3.21 Favored 'General case' 0 N--CA 1.384 -3.737 0 O-C-N 121.694 -0.886 . . . . 61.219999999999999 110.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -79.12 68.17 5.01 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 123.124 1.44 . . . . 75.439999999999998 110.152 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.2 -50.57 3.13 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 112.447 -2.16 . . . . 63.310000000000002 105.423 170.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -69.04 132.02 45.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.697 -1.138 . . . . 74.129999999999995 108.915 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.9 m 73.14 -4.71 2.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.661 1.184 . . . . 73.109999999999999 111.493 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.26 -11.35 19.55 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 115.909 -0.587 . . . . 74.140000000000001 109.89 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -141.09 124.04 16.28 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.834 -1.543 . . . . 74.450000000000003 106.834 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 m -89.97 119.0 29.96 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.326 0.584 . . . . 74.420000000000002 112.433 -173.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.84 -92.83 1.82 Allowed Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 115.553 -0.749 . . . . 71.329999999999998 111.33 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.32 89.32 1.61 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.582 -1.007 . . . . 73.219999999999999 110.582 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.78 81.82 8.59 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.373 0.606 . . . . 75.019999999999996 110.082 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.48 101.91 11.22 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.264 -1.013 . . . . 65.109999999999999 108.264 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.28 3.014 0 C-N-CA 120.058 -1.068 . . . . 72.150000000000006 111.965 -179.204 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.403 -2.792 0 N-CA-C 113.183 0.809 . . . . 60.219999999999999 113.183 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -136.95 -166.03 1.84 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 105.277 -2.12 . . . . 73.040000000000006 105.277 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -71.12 -22.33 62.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.594 0.634 . . . . 52.32 110.289 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -76.01 -10.57 59.52 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.095 0.474 . . . . 43.43 110.044 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 t -87.39 -19.14 28.53 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 119.663 -0.815 . . . . 72.230000000000004 109.816 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 12.85 81.22 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.146 -1.181 . . . . 44.25 110.146 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -101.43 -179.08 3.92 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 114.586 -0.807 . . . . 70.340000000000003 109.166 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.67 157.8 37.34 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.837 -0.801 . . . . 52.43 108.837 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -135.25 106.36 10.23 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 110.18 -0.304 . . . . 72.120000000000005 110.18 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.04 159.35 97.77 Favored 'Cis proline' 0 C--O 1.248 1.015 0 C-N-CA 123.704 -1.373 . . . . 73.430000000000007 110.401 -0.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.5 t -89.23 126.36 58.96 Favored Pre-proline 0 N--CA 1.408 -2.551 0 C-N-CA 119.435 -0.906 . . . . 72.340000000000003 109.56 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -84.41 13.81 2.63 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.114 2.543 . . . . 71.129999999999995 114.221 -172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.85 -42.82 2.09 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.383 0.913 . . . . 43.210000000000001 115.383 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.25 -99.95 2.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.962 -0.637 . . . . 31.329999999999998 114.124 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 m -59.19 -38.31 79.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.886 0.874 . . . . 72.299999999999997 112.279 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.6 4.46 81.93 Favored Glycine 0 C--O 1.253 1.338 0 C-N-CA 120.043 -1.075 . . . . 74.430000000000007 112.298 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.8 t -97.34 81.1 2.96 Favored 'General case' 0 N--CA 1.399 -3.008 0 O-C-N 121.427 -1.043 . . . . 71.329999999999998 111.46 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.68 72.93 10.51 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 122.564 1.174 . . . . 55.210000000000001 109.075 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.115 0 CA-C-N 113.218 -1.81 . . . . 74.219999999999999 107.235 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.361 -0.607 . . . . 61.219999999999999 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -138.66 -168.36 2.38 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 107.433 -1.321 . . . . 64.340000000000003 107.433 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.27 -36.1 70.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.101 1.361 . . . . 73.439999999999998 112.033 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -73.6 -1.77 20.17 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.167 -0.924 . . . . 73.430000000000007 111.872 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -99.26 -19.07 17.28 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.332 0.587 . . . . 71.540000000000006 109.959 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.542 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . 88.29 -3.65 85.43 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 110.574 -1.011 . . . . 61.119999999999997 110.574 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.14 178.78 8.19 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.767 -0.717 . . . . 72.409999999999997 109.522 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.96 155.99 34.9 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 109.021 -0.733 . . . . 74.219999999999999 109.021 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.79 109.01 11.92 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 122.926 0.141 . . . . 72.140000000000001 110.75 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.96 159.4 98.05 Favored 'Cis proline' 0 C--O 1.241 0.642 0 C-N-CA 123.322 -1.533 . . . . 71.340000000000003 109.318 -0.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 t -83.61 125.0 74.72 Favored Pre-proline 0 N--CA 1.416 -2.171 0 C-N-CA 119.024 -1.071 . . . . 34.229999999999997 109.522 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.04 0.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.21 2.606 . . . . 62.229999999999997 114.413 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.04 -27.31 5.03 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 121.335 -0.46 . . . . 63.140000000000001 114.152 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.25 -121.18 1.95 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.909 -0.663 . . . . 42.130000000000003 113.433 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.9 m -62.98 -30.11 71.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.388 1.075 . . . . 40.43 110.875 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.8 -6.15 71.59 Favored Glycine 0 C--O 1.257 1.556 0 CA-C-N 115.79 -0.641 . . . . 73.450000000000003 112.12 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 16.3 t -90.81 84.37 5.82 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 118.834 -1.146 . . . . 71.030000000000001 110.573 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' GLY . 5.1 ptm180 -78.64 68.61 4.66 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.744 1.259 . . . . 75.209999999999994 109.775 172.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.1 m . . . . . 0 C--N 1.299 -1.605 0 CA-C-N 112.024 -2.353 . . . . 60.420000000000002 108.116 171.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 N--CA 1.434 -1.26 0 CA-C-O 121.005 0.431 . . . . 74.129999999999995 111.262 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.649 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 10.4 t70 -153.19 -168.82 3.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.749 -2.315 . . . . 60.229999999999997 104.749 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.53 -22.52 58.99 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.942 0.792 . . . . 61.340000000000003 109.291 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -77.09 -8.81 58.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.874 -1.057 . . . . 71.230000000000004 109.948 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.649 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 1.6 t -87.23 -23.04 24.87 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.041 -0.527 . . . . 62.100000000000001 109.592 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.04 -4.86 71.69 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.379 -1.488 . . . . 33.43 109.379 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 m -86.75 167.56 14.32 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 114.769 -0.716 . . . . 60.130000000000003 110.594 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 153.57 43.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.867 -1.16 . . . . 75.310000000000002 107.867 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 t -131.59 111.25 14.96 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.082 -1.081 . . . . 75.540000000000006 108.082 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.69 150.26 95.35 Favored 'Cis proline' 0 C--O 1.243 0.743 0 C-N-CA 124.175 -1.177 . . . . 74.349999999999994 111.847 0.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.5 134.34 42.73 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 109.285 -0.635 . . . . 45.100000000000001 109.285 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.87 -11.01 16.79 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.845 2.363 . . . . 73.450000000000003 113.649 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.9 -40.55 3.08 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.341 -0.457 . . . . 41.310000000000002 113.154 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.43 -117.3 2.13 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.336 -0.705 . . . . 72.319999999999993 111.336 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.6 m -72.18 115.31 11.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.962 -0.755 . . . . 74.510000000000005 108.962 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.64 -9.34 7.69 Favored Glycine 0 C--N 1.288 -2.089 0 N-CA-C 107.662 -2.175 . . . . 73.239999999999995 107.662 -172.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 t -87.95 82.25 7.29 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.709 -0.746 . . . . 74.409999999999997 109.822 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -79.57 70.64 6.09 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 123.251 1.5 . . . . 73.010000000000005 110.645 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.288 -2.07 0 CA-C-N 111.08 -2.782 . . . . 74.450000000000003 106.828 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.0 m . . . . . 0 N--CA 1.414 -2.229 0 N-CA-C 109.35 -0.611 . . . . 71.450000000000003 109.35 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.18 -173.39 2.66 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.076 -0.713 . . . . 71.5 109.076 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.71 -23.37 42.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 121.757 0.789 . . . . 71.010000000000005 109.113 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -74.47 -12.12 60.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.616 -1.174 . . . . 54.399999999999999 109.056 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.02 -17.47 35.13 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.396 -0.82 . . . . 74.150000000000006 109.603 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 87.54 -3.82 86.19 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.744 -1.342 . . . . 33.219999999999999 109.744 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.4 m -87.58 172.06 10.03 Favored 'General case' 0 N--CA 1.404 -2.732 0 CA-C-N 113.906 -1.147 . . . . 62.340000000000003 110.364 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.61 155.65 40.46 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 124.316 1.01 . . . . 52.030000000000001 108.517 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.64 108.79 10.09 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 108.159 -1.052 . . . . 65.030000000000001 108.159 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.36 150.52 95.06 Favored 'Cis proline' 0 C--O 1.242 0.691 0 C-N-CA 124.055 -1.227 . . . . 54.43 111.387 0.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -84.7 127.84 63.56 Favored Pre-proline 0 N--CA 1.413 -2.283 0 N-CA-C 108.242 -1.021 . . . . 72.25 108.242 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.72 -24.26 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.583 2.189 . . . . 73.209999999999994 113.404 -172.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -36.74 4.08 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.55 -0.833 . . . . 61.119999999999997 112.6 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.36 -118.56 0.54 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.857 -0.687 . . . . 73.329999999999998 113.37 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -65.1 -24.59 67.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.466 0.65 . . . . 73.120000000000005 111.906 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.06 -9.13 75.78 Favored Glycine 0 C--O 1.257 1.535 0 CA-C-N 115.613 -0.721 . . . . 51.020000000000003 111.36 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 11.4 t -90.73 92.41 8.8 Favored 'General case' 0 N--CA 1.395 -3.191 0 C-N-CA 118.991 -1.084 . . . . 73.129999999999995 110.712 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 92.8 mtt180 -83.1 66.2 8.56 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.438 1.114 . . . . 71.310000000000002 108.192 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.5 m . . . . . 0 C--N 1.299 -1.617 0 CA-C-N 112.037 -2.347 . . . . 64.409999999999997 106.541 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 N--CA 1.416 -2.164 0 N-CA-C 109.899 -0.408 . . . . 74.120000000000005 109.899 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.71 -159.07 0.96 Allowed 'General case' 0 C--O 1.267 2.008 0 N-CA-C 105.9 -1.889 . . . . 64.230000000000004 105.9 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.594 1.088 . . . . 54.25 111.203 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -65.92 -21.75 66.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.566 0.58 . . . . 72.439999999999998 112.566 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.2 t -81.97 -35.65 28.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.043 0.449 . . . . 74.310000000000002 110.114 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.21 4.54 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 108.56 -1.816 . . . . 55.219999999999999 108.56 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.33 179.32 5.98 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.099 -1.074 . . . . 62.030000000000001 108.099 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.39 154.36 40.31 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.994 -0.743 . . . . 51.329999999999998 108.994 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.35 106.56 24.25 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 73.019999999999996 108.632 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.68 161.25 86.75 Favored 'Cis proline' 0 C--O 1.249 1.061 0 C-N-CA 123.607 -1.414 . . . . 75.120000000000005 109.969 0.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 16.7 t -85.4 118.6 71.06 Favored Pre-proline 0 N--CA 1.422 -1.846 0 C-N-CA 118.832 -1.147 . . . . 74.219999999999999 110.111 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 60.9 Cg_endo -92.17 -18.15 0.84 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.034 2.49 . . . . 71.319999999999993 114.181 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.05 -171.57 16.23 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.194 -1.562 . . . . 64.239999999999995 109.194 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.35 -130.3 49.49 Favored Glycine 0 C--O 1.245 0.791 0 CA-C-N 117.212 0.506 . . . . 74.109999999999999 113.015 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.2 m -67.96 -29.43 68.47 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.552 0.741 . . . . 72.409999999999997 110.721 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.07 -19.16 73.58 Favored Glycine 0 C--O 1.259 1.682 0 N-CA-C 110.991 -0.844 . . . . 54.340000000000003 110.991 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.5 t -88.58 88.41 7.6 Favored 'General case' 0 N--CA 1.392 -3.331 0 C-N-CA 119.153 -1.019 . . . . 72.439999999999998 110.199 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -71.41 57.17 0.25 Allowed 'General case' 0 C--O 1.208 -1.116 0 CA-C-O 121.846 0.832 . . . . 60.420000000000002 109.997 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.2 m . . . . . 0 C--N 1.298 -1.67 0 C-N-CA 125.417 1.487 . . . . 54.130000000000003 108.02 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 N--CA 1.432 -1.349 0 N-CA-C 112.335 0.495 . . . . 73.140000000000001 112.335 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 6' ' ' LYS . 20.4 t70 -127.33 -172.7 2.72 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 107.05 -1.463 . . . . 74.430000000000007 107.05 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.06 -19.47 61.17 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.843 0.857 . . . . 73.420000000000002 109.038 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HG2' ' OD2' ' A' ' 4' ' ' ASP . 42.9 mmtm -53.23 -35.59 60.1 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.081 1.352 . . . . 71.319999999999993 110.013 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 m -71.16 -45.52 63.31 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.286 -1.325 . . . . 62.25 112.594 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.39 17.93 40.72 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 107.68 -2.168 . . . . 63.210000000000001 107.68 -163.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.69 173.13 7.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.957 -1.127 . . . . 75.230000000000004 107.957 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -67.53 149.12 50.57 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 123.964 0.79 . . . . 64.239999999999995 109.083 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 t -132.84 106.08 12.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.072 -0.714 . . . . 64.430000000000007 109.072 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.22 159.6 97.55 Favored 'Cis proline' 0 C--O 1.248 0.983 0 C-N-CA 123.915 -1.286 . . . . 65.329999999999998 111.0 -0.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 46.6 t -98.15 141.72 23.41 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 109.094 -0.706 . . . . 54.140000000000001 109.094 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 21.1 Cg_endo -64.09 -23.54 67.05 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.76 2.307 . . . . 64.310000000000002 113.045 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.13 -47.46 2.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 114.962 0.745 . . . . 42.219999999999999 114.962 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.23 -116.22 0.94 Allowed Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.712 -0.756 . . . . 55.329999999999998 114.192 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.7 m -62.04 -30.08 70.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.253 0.621 . . . . 72.120000000000005 111.189 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.46 14.52 40.26 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 116.058 -0.519 . . . . 33.219999999999999 112.34 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 41.9 t -102.44 130.61 49.27 Favored 'General case' 0 N--CA 1.404 -2.73 0 O-C-N 121.623 -0.928 . . . . 55.399999999999999 110.445 175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.32 27.38 0.59 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.395 -0.82 . . . . 64.120000000000005 111.056 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.763 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.1 m . . . . . 0 C--N 1.323 -0.581 0 C-N-CA 124.672 1.189 . . . . 62.140000000000001 109.131 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 112.497 0.554 . . . . 42.140000000000001 112.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -169.13 -173.43 1.76 Allowed 'General case' 0 C--O 1.253 1.248 0 N-CA-C 104.896 -2.261 . . . . 75.230000000000004 104.896 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.05 -26.55 63.13 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.683 -1.229 . . . . 63.009999999999998 107.683 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -66.28 -14.89 62.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.251 -1.341 . . . . 64.239999999999995 111.082 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 t -88.31 -31.0 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.281 -0.636 . . . . 63.149999999999999 109.281 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.66 3.67 59.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.326 -1.11 . . . . 73.049999999999997 110.326 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.5 174.33 8.16 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.011 -0.594 . . . . 74.329999999999998 109.862 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 153.14 42.3 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.004 -0.739 . . . . 64.219999999999999 109.004 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.46 109.91 11.36 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 118.533 0.606 . . . . 74.010000000000005 109.85 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 149.5 94.26 Favored 'Cis proline' 0 C--O 1.241 0.648 0 C-N-CA 124.045 -1.231 . . . . 71.409999999999997 111.349 0.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.1 t -81.62 128.46 69.29 Favored Pre-proline 0 N--CA 1.424 -1.751 0 N-CA-C 109.674 -0.491 . . . . 42.32 109.674 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.68 -2.4 7.45 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.047 2.498 . . . . 54.310000000000002 114.557 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.43 5.66 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.796 0.678 . . . . 60.409999999999997 114.796 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 -113.42 2.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.256 -0.973 . . . . 41.030000000000001 111.939 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -57.91 -37.75 74.62 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.408 0.683 . . . . 75.129999999999995 111.235 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.22 -2.7 73.96 Favored Glycine 0 C--O 1.256 1.488 0 C-N-CA 120.977 -0.63 . . . . 72.200000000000003 112.974 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 18.9 t -95.11 96.62 9.35 Favored 'General case' 0 N--CA 1.402 -2.854 0 C-N-CA 118.658 -1.217 . . . . 72.420000000000002 110.844 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -79.23 57.16 2.22 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.347 1.07 . . . . 75.400000000000006 108.681 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.4 m . . . . . 0 C--N 1.309 -1.18 0 C-N-CA 126.774 2.029 . . . . 73.420000000000002 107.793 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.8 m . . . . . 0 N--CA 1.415 -2.183 0 N-CA-C 109.92 -0.4 . . . . 75.420000000000002 109.92 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 6.9 p-10 -146.25 -168.58 3.04 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 108.373 -0.973 . . . . 72.109999999999999 108.373 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.33 -29.76 61.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.132 0.573 . . . . 53.240000000000002 111.857 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -90.75 -5.34 55.82 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 120.922 0.391 . . . . 63.520000000000003 109.949 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 6.5 t -67.71 -31.83 72.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.637 -0.875 . . . . 63.25 108.637 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 0.95 55.15 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 109.512 -1.435 . . . . 53.049999999999997 109.512 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -95.1 173.81 7.38 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.791 -0.704 . . . . 74.040000000000006 110.712 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 157.61 36.73 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.221 0.95 . . . . 33.130000000000003 108.944 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.88 110.79 11.07 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.944 -0.761 . . . . 55.340000000000003 108.944 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.39 144.36 74.88 Favored 'Cis proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.416 -1.493 . . . . 45.530000000000001 110.756 -0.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -76.55 130.9 75.49 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.509 -0.923 . . . . 64.420000000000002 108.509 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.75 -40.23 47.05 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.659 2.239 . . . . 64.200000000000003 112.069 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.34 -46.2 1.12 Allowed Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.177 -1.011 . . . . 53.009999999999998 113.443 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.27 -84.32 1.62 Allowed Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.132 -1.187 . . . . 52.420000000000002 110.132 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -67.34 131.42 45.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.73 -1.581 . . . . 74.519999999999996 106.73 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.77 -9.21 77.37 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.25 -0.976 . . . . 73.140000000000001 111.26 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 45.1 t -85.09 90.4 7.85 Favored 'General case' 0 N--CA 1.412 -2.335 0 C-N-CA 118.71 -1.196 . . . . 65.510000000000005 110.72 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 2.0 ptp180 -77.15 70.34 3.53 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-O 123.401 1.572 . . . . 64.239999999999995 111.035 172.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.292 -1.927 0 CA-C-N 110.645 -2.98 . . . . 64.519999999999996 105.661 170.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.6 m . . . . . 0 N--CA 1.435 -1.186 0 N-CA-C 106.377 -1.712 . . . . 72.25 106.377 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -124.7 -171.38 2.34 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.654 -0.498 . . . . 72.049999999999997 109.654 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.74 -40.49 88.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.329 1.052 . . . . 61.549999999999997 111.376 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.07 0.37 36.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.821 -0.627 . . . . 73.5 111.127 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -89.14 -14.66 35.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.915 -0.772 . . . . 74.310000000000002 108.915 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.568 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 76.44 30.52 56.54 Favored Glycine 0 C--O 1.204 -1.767 0 N-CA-C 109.502 -1.439 . . . . 63.200000000000003 109.502 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.8 176.65 6.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.926 -0.768 . . . . 72.530000000000001 108.926 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 157.08 34.09 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.034 0.833 . . . . 52.219999999999999 108.828 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.37 102.44 10.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.767 -0.457 . . . . 74.439999999999998 109.767 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.99 163.22 90.6 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.796 -1.335 . . . . 52.43 110.721 0.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 19.9 t -92.43 129.85 39.45 Favored Pre-proline 0 N--CA 1.41 -2.458 0 C-N-CA 120.074 -0.651 . . . . 71.25 110.187 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.29 -25.93 6.63 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.003 2.468 . . . . 65.120000000000005 113.714 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.67 -33.6 5.56 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.268 -0.968 . . . . 45.140000000000001 113.916 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.57 -118.0 1.07 Allowed Glycine 0 C--O 1.229 -0.205 0 C-N-CA 120.493 -0.861 . . . . 41.5 113.738 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -62.77 -31.89 72.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.313 0.578 . . . . 72.209999999999994 110.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.34 -12.61 66.46 Favored Glycine 0 C--O 1.254 1.398 0 CA-C-N 115.696 -0.684 . . . . 50.130000000000003 111.789 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.7 t -88.91 75.21 8.09 Favored 'General case' 0 N--CA 1.4 -2.939 0 C-N-CA 118.928 -1.109 . . . . 74.219999999999999 109.955 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 11.5 ptm180 -77.97 68.14 3.96 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-O 123.531 1.634 . . . . 71.510000000000005 110.274 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.501 0 CA-C-N 111.156 -2.747 . . . . 75.409999999999997 106.728 172.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.8 m . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 109.027 -0.731 . . . . 75.450000000000003 109.027 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -144.03 -165.89 2.23 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.133 -1.062 . . . . 65.409999999999997 108.133 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -75.43 -17.0 60.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.622 0.769 . . . . 74.329999999999998 109.875 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -65.32 -23.81 67.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.367 -0.833 . . . . 54.409999999999997 110.148 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m -76.23 -50.47 14.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.075 -0.966 . . . . 63.200000000000003 111.079 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.78 2.6 39.92 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 107.822 -2.111 . . . . 65.150000000000006 107.822 -165.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.58 170.5 16.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 109.021 -0.733 . . . . 65.209999999999994 109.021 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -68.26 155.11 40.39 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.152 -1.055 . . . . 62.210000000000001 108.152 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.61 110.45 8.8 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.95 -1.13 . . . . 73.099999999999994 107.95 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.77 142.24 74.16 Favored 'Cis proline' 0 C--O 1.24 0.584 0 C-N-CA 124.065 -1.223 . . . . 43.299999999999997 111.186 0.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 41.9 t -78.33 125.46 84.81 Favored Pre-proline 0 N--CA 1.424 -1.76 0 N-CA-C 109.382 -0.599 . . . . 61.509999999999998 109.382 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.23 -16.5 22.28 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.628 2.219 . . . . 75.319999999999993 113.244 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.71 -36.99 3.63 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.858 -0.687 . . . . 72.329999999999998 113.59 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.74 -110.14 0.99 Allowed Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.422 -0.894 . . . . 75.450000000000003 113.139 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -56.87 -39.96 75.28 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.57 1.148 . . . . 72.340000000000003 111.059 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.24 0.99 72.13 Favored Glycine 0 C--O 1.258 1.626 0 CA-C-N 115.763 -0.653 . . . . 74.040000000000006 113.043 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 29.8 t -89.41 96.61 10.78 Favored 'General case' 0 N--CA 1.396 -3.125 0 C-N-CA 118.219 -1.392 . . . . 73.129999999999995 110.953 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -78.02 63.0 2.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.317 -0.856 . . . . 70.340000000000003 108.997 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.3 m . . . . . 0 C--N 1.3 -1.556 0 C-N-CA 126.629 1.972 . . . . 75.439999999999998 107.034 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 N--CA 1.435 -1.197 0 CA-C-O 120.643 0.258 . . . . 71.420000000000002 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -136.61 -170.17 2.62 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 116.07 -0.513 . . . . 74.420000000000002 109.985 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.6 -29.21 69.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.462 1.105 . . . . 60.119999999999997 112.219 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -80.31 -7.96 59.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.394 -0.522 . . . . 44.030000000000001 111.717 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.82 -25.94 29.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.235 -0.986 . . . . 63.340000000000003 111.427 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.8 8.89 69.11 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 109.396 -1.481 . . . . 73.329999999999998 109.396 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -100.68 173.31 6.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.333 -0.988 . . . . 70.450000000000003 108.333 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 158.1 31.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 123.724 0.64 . . . . 71.230000000000004 109.735 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 t -132.83 104.64 12.85 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.22 -0.659 . . . . 41.399999999999999 109.22 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.69 159.91 95.66 Favored 'Cis proline' 0 C--O 1.236 0.377 0 C-N-CA 124.031 -1.237 . . . . 63.420000000000002 109.817 -0.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 42.3 t -85.97 128.45 58.1 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 108.571 -0.9 . . . . 64.120000000000005 108.571 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.49 -10.63 3.12 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.023 2.482 . . . . 73.519999999999996 114.389 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.96 -175.77 35.51 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.173 -1.171 . . . . 41.439999999999998 110.173 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -123.07 29.33 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 116.853 0.326 . . . . 70.109999999999999 113.493 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 m -72.27 -21.7 61.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.432 0.634 . . . . 54.229999999999997 110.173 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.05 -14.65 78.93 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.286 -0.725 . . . . 71.519999999999996 111.286 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 30.0 t -90.44 91.06 8.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 118.119 -1.432 . . . . 64.219999999999999 110.81 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 71.05 3.13 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.605 1.193 . . . . 64.340000000000003 108.754 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.0 m . . . . . 0 C--N 1.291 -1.942 0 CA-C-N 111.23 -2.713 . . . . 74.109999999999999 108.632 172.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 N--CA 1.426 -1.628 0 N-CA-C 108.997 -0.742 . . . . 73.420000000000002 108.997 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -140.76 -169.09 2.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.419 -1.697 . . . . 74.150000000000006 106.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.38 -18.23 63.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 122.281 1.038 . . . . 71.430000000000007 110.197 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -81.18 2.49 27.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.478 -1.237 . . . . 72.099999999999994 110.603 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.41 -21.97 12.93 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.795 -0.762 . . . . 65.430000000000007 112.574 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.53 16.59 68.22 Favored Glycine 0 C--O 1.212 -1.259 0 N-CA-C 109.685 -1.366 . . . . 63.32 109.685 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -106.41 179.87 4.14 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 123.283 0.633 . . . . 75.219999999999999 109.932 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.06 42.12 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.967 -1.123 . . . . 63.229999999999997 107.967 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.25 107.07 11.21 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.29 -0.633 . . . . 75.430000000000007 109.29 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.25 157.62 99.29 Favored 'Cis proline' 0 C--O 1.246 0.908 0 C-N-CA 123.79 -1.338 . . . . 54.109999999999999 110.644 0.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.9 t -89.31 132.71 36.65 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 109.192 -0.669 . . . . 45.219999999999999 109.192 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HG2' ' H ' ' A' ' 18' ' ' GLY . 69.5 Cg_endo -84.38 4.43 6.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.816 2.344 . . . . 70.109999999999999 113.065 -175.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.07 -40.21 3.09 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 115.498 0.959 . . . . 32.399999999999999 115.498 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.91 -77.11 0.66 Allowed Glycine 0 C--N 1.311 -0.855 0 C-N-CA 119.95 -1.119 . . . . 62.340000000000003 113.042 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.4 m -47.01 -41.65 16.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.626 1.57 . . . . 60.039999999999999 113.708 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 14' ' ' PRO . . . -116.03 27.36 8.25 Favored Glycine 0 C--O 1.256 1.492 0 C-N-CA 120.917 -0.659 . . . . 75.5 111.674 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.1 t -92.74 84.43 5.0 Favored 'General case' 0 N--CA 1.403 -2.81 0 C-N-CA 118.38 -1.328 . . . . 54.229999999999997 109.774 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -77.91 65.41 3.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 122.338 1.066 . . . . 75.219999999999999 108.825 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.481 0 CA-C-N 112.235 -2.257 . . . . 72.409999999999997 105.518 172.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 109.33 -0.619 . . . . 74.349999999999994 109.33 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -140.22 -159.7 0.99 Allowed 'General case' 0 C--O 1.261 1.661 0 N-CA-C 107.019 -1.474 . . . . 75.510000000000005 107.019 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.03 -10.05 59.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 74.040000000000006 110.765 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.75 -27.44 60.35 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.306 -0.627 . . . . 70.120000000000005 109.306 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -82.77 -37.78 24.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.699 0.629 . . . . 74.010000000000005 112.699 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.04 27.22 9.59 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 119.164 -1.493 . . . . 62.329999999999998 109.546 -170.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.5 -178.44 3.38 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.2 -1.407 . . . . 72.239999999999995 107.2 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.81 154.87 39.74 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.948 0.78 . . . . 62.119999999999997 109.695 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.1 t -131.04 107.18 15.04 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.644 -0.873 . . . . 71.209999999999994 108.644 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.5 155.55 89.55 Favored 'Cis proline' 0 C--O 1.247 0.938 0 C-N-CA 124.313 -1.119 . . . . 73.209999999999994 109.582 0.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.4 t -83.36 123.46 76.91 Favored Pre-proline 0 N--CA 1.412 -2.374 0 C-N-CA 119.666 -0.814 . . . . 63.439999999999998 109.668 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.7 4.5 6.57 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 123.895 3.063 . . . . 71.219999999999999 115.451 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.67 -34.13 3.97 Favored Glycine 0 C--N 1.315 -0.586 0 N-CA-C 116.196 1.238 . . . . 75.349999999999994 116.196 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.71 -101.62 2.62 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 119.678 -1.248 . . . . 73.209999999999994 113.337 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 m -61.17 -36.74 80.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.261 1.025 . . . . 64.019999999999996 110.22 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.22 -1.44 88.11 Favored Glycine 0 C--O 1.254 1.375 0 C-N-CA 120.468 -0.873 . . . . 75.540000000000006 112.247 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 21.5 t -96.88 97.24 9.12 Favored 'General case' 0 N--CA 1.401 -2.903 0 C-N-CA 118.518 -1.273 . . . . 63.219999999999999 110.411 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -77.46 57.55 1.56 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 109.456 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.1 m . . . . . 0 C--N 1.315 -0.927 0 C-N-CA 127.074 2.149 . . . . 71.140000000000001 107.444 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.434 -1.261 0 N-CA-C 108.34 -0.985 . . . . 73.230000000000004 108.34 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -133.93 -170.16 2.45 Favored 'General case' 0 C--O 1.258 1.508 0 N-CA-C 108.747 -0.834 . . . . 71.329999999999998 108.747 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.36 -45.35 84.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.03 1.122 . . . . 71.329999999999998 114.03 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.4 -5.61 40.95 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.359 0.503 . . . . 71.540000000000006 112.359 -172.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.42 -28.02 34.45 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.461 -0.57 . . . . 64.510000000000005 109.461 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.74 12.15 59.67 Favored Glycine 0 CA--C 1.498 -0.98 0 N-CA-C 109.501 -1.44 . . . . 74.329999999999998 109.501 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.51 -178.33 3.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.505 -0.848 . . . . 73.120000000000005 108.861 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.454 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . . . -79.75 161.78 25.54 Favored 'General case' 0 C--O 1.259 1.559 0 N-CA-C 108.261 -1.015 . . . . 74.319999999999993 108.261 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 t -137.12 107.54 8.79 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.488 -0.56 . . . . 71.019999999999996 109.488 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.88 157.12 99.07 Favored 'Cis proline' 0 C--O 1.24 0.596 0 C-N-CA 124.282 -1.133 . . . . 71.200000000000003 111.153 -0.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.8 t -86.89 129.07 53.71 Favored Pre-proline 0 N--CA 1.411 -2.385 0 N-CA-C 109.557 -0.534 . . . . 71.209999999999994 109.557 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 22.7 Cg_exo -64.38 -35.63 49.08 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.958 2.439 . . . . 64.019999999999996 113.313 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.17 -46.8 1.11 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.011 -1.09 . . . . 64.200000000000003 112.967 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.56 -95.31 2.24 Favored Glycine 0 C--O 1.25 1.153 0 N-CA-C 110.131 -1.188 . . . . 71.519999999999996 110.131 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 m -69.38 123.57 21.57 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.913 -1.514 . . . . 52.340000000000003 106.913 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.66 -22.58 21.61 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 109.54 -1.424 . . . . 60.109999999999999 109.54 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.8 t -96.65 91.86 5.93 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.945 -1.102 . . . . 71.120000000000005 109.677 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -54.52 -24.83 22.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.504 -0.771 . . . . 73.209999999999994 111.578 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 37.1 m . . . . . 0 C--O 1.215 -0.729 0 CA-C-N 115.478 -0.783 . . . . 61.530000000000001 112.01 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.7 m . . . . . 0 N--CA 1.428 -1.553 0 CA-C-O 120.562 0.22 . . . . 71.310000000000002 111.334 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -139.32 -171.4 3.11 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 107.129 -1.434 . . . . 74.230000000000004 107.129 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.99 -28.04 49.22 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.766 -0.828 . . . . 74.099999999999994 108.766 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -74.52 -10.38 59.5 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.962 -1.472 . . . . 71.340000000000003 110.198 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -34.13 49.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.94 -1.027 . . . . 75.439999999999998 108.434 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.56 56.18 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.08 -1.608 . . . . 61.450000000000003 109.08 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.1 m -97.39 173.6 7.11 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 113.773 -1.213 . . . . 62.219999999999999 109.183 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.01 163.8 27.64 Favored 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.987 0.804 . . . . 55.340000000000003 109.796 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 t -137.2 108.42 8.82 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.003 -0.74 . . . . 75.310000000000002 109.003 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.17 150.17 93.13 Favored 'Cis proline' 0 CA--C 1.514 -0.476 0 C-N-CA 123.989 -1.255 . . . . 73.409999999999997 110.476 0.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.7 t -79.86 119.04 75.43 Favored Pre-proline 0 N--CA 1.416 -2.148 0 C-N-CA 120.212 -0.595 . . . . 34.450000000000003 109.68 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -86.22 0.78 8.05 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.137 2.558 . . . . 74.209999999999994 114.296 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.45 -156.45 30.56 Favored Glycine 0 C--N 1.302 -1.33 0 N-CA-C 110.113 -1.195 . . . . 71.510000000000005 110.113 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -136.42 47.44 Favored Glycine 0 C--O 1.254 1.381 0 O-C-N 123.801 0.353 . . . . 65.239999999999995 113.724 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -79.94 -23.62 41.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.238 -0.653 . . . . 71.150000000000006 109.238 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.3 -20.32 71.26 Favored Glycine 0 C--O 1.251 1.186 0 CA-C-N 115.322 -0.854 . . . . 75.420000000000002 111.187 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.3 t -86.91 99.8 12.11 Favored 'General case' 0 N--CA 1.4 -2.949 0 O-C-N 121.687 -0.89 . . . . 61.439999999999998 109.895 176.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -73.45 64.42 0.84 Allowed 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.925 0.869 . . . . 73.209999999999994 109.094 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.891 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.6 m . . . . . 0 C--N 1.285 -2.2 0 CA-C-N 113.252 -1.795 . . . . 71.430000000000007 110.876 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 93.7 m . . . . . 0 N--CA 1.425 -1.72 0 N-CA-C 110.164 -0.31 . . . . 73.530000000000001 110.164 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -131.24 -174.68 3.46 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.435 -0.95 . . . . 74.329999999999998 108.435 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.34 -32.89 70.8 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 112.279 0.474 . . . . 61.219999999999999 112.279 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -76.48 -1.66 28.33 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.788 0.804 . . . . 70.150000000000006 110.523 -177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.9 t -80.8 -28.57 36.26 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 114.903 -1.044 . . . . 64.420000000000002 108.404 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 8.63 58.92 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 108.875 -1.69 . . . . 63.219999999999999 108.875 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.1 m -106.87 166.18 10.78 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-N 114.347 -0.926 . . . . 75.129999999999995 110.591 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -65.42 154.58 38.04 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.629 1.205 . . . . 61.32 108.926 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.9 t -134.1 105.34 11.39 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.606 -0.887 . . . . 73.329999999999998 108.606 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.26 157.36 99.37 Favored 'Cis proline' 0 C--O 1.246 0.891 0 C-N-CA 124.066 -1.222 . . . . 63.5 112.096 -0.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 43.8 t -99.96 141.06 22.06 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 108.463 -0.94 . . . . 73.239999999999995 108.463 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.58 -41.01 34.3 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.523 2.149 . . . . 73.329999999999998 113.052 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.38 -44.41 1.31 Allowed Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.002 -1.094 . . . . 70.019999999999996 113.959 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.99 -69.73 0.26 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.774 -1.203 . . . . 64.019999999999996 113.39 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 m -50.43 -57.24 8.48 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.543 1.137 . . . . 53.439999999999998 112.267 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 49.97 0.83 Allowed Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.347 -1.101 . . . . 53.130000000000003 110.347 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.8 t -110.25 109.03 19.35 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-O 121.893 0.854 . . . . 41.240000000000002 111.574 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.71 68.59 4.72 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 123.078 1.418 . . . . 75.530000000000001 109.275 172.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 6.6 m . . . . . 0 C--N 1.285 -2.209 0 CA-C-N 111.264 -2.698 . . . . 62.439999999999998 107.376 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 N--CA 1.429 -1.501 0 CA-C-O 121.701 0.763 . . . . 71.230000000000004 112.785 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.483 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 18.3 t70 -139.91 -171.79 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 72.140000000000001 105.821 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.74 -25.37 32.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.767 -1.197 . . . . 74.219999999999999 107.767 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.14 -7.81 53.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.689 -1.141 . . . . 65.150000000000006 109.449 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 5.9 t -85.82 -24.54 26.72 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.861 -1.163 . . . . 63.119999999999997 107.861 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.9 6.42 60.5 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.652 -1.379 . . . . 73.310000000000002 109.652 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 m -99.54 -178.97 4.06 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 114.18 -1.01 . . . . 64.450000000000003 109.879 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.4 159.32 21.83 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.393 -0.965 . . . . 63.530000000000001 108.393 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -137.5 109.44 8.74 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 108.925 -0.769 . . . . 55.25 108.925 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.75 149.56 94.06 Favored 'Cis proline' 0 C--O 1.25 1.106 0 C-N-CA 123.756 -1.352 . . . . 75.420000000000002 111.792 0.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.41 131.9 46.57 Favored Pre-proline 0 N--CA 1.427 -1.599 0 N-CA-C 108.228 -1.026 . . . . 52.310000000000002 108.228 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.09 -19.74 6.7 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.264 1.976 . . . . 73.230000000000004 115.07 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.04 -44.74 1.42 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.329 -0.939 . . . . 32.229999999999997 113.451 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.06 -117.56 1.8 Allowed Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.32 -0.943 . . . . 53.210000000000001 110.961 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 m -70.11 112.98 6.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.847 -1.168 . . . . 64.329999999999998 107.847 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.43 -21.5 4.81 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 108.274 -1.93 . . . . 62.409999999999997 108.274 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.1 t -92.66 93.92 8.75 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.879 -0.728 . . . . 65.239999999999995 110.721 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -77.5 64.11 2.77 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.035 0.922 . . . . 73.010000000000005 109.186 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 20.1 m . . . . . 0 C--N 1.31 -1.125 0 C-N-CA 126.765 2.026 . . . . 55.109999999999999 109.92 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.419 -2.013 0 N-CA-C 112.956 0.724 . . . . 71.200000000000003 112.956 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 4.5 p-10 -132.42 -170.13 2.37 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.01 -1.478 . . . . 64.519999999999996 107.01 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.52 -33.01 74.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 71.319999999999993 111.535 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -82.1 -0.15 43.35 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.396 0.617 . . . . 72.439999999999998 111.291 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.1 t -87.86 -16.14 34.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.034 -1.098 . . . . 42.530000000000001 108.034 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 90.92 -4.9 81.96 Favored Glycine 0 CA--C 1.496 -1.141 0 N-CA-C 109.503 -1.439 . . . . 70.140000000000001 109.503 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 m -90.43 171.75 9.22 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.077 -1.061 . . . . 75.219999999999999 110.616 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.2 158.98 35.48 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.908 -1.042 . . . . 75.010000000000005 108.352 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 t -135.77 107.96 9.91 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 109.566 -0.531 . . . . 71.420000000000002 109.566 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.3 152.1 97.31 Favored 'Cis proline' 0 C--O 1.245 0.849 0 C-N-CA 123.633 -1.403 . . . . 73.340000000000003 110.489 -0.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.3 t -77.22 131.54 72.11 Favored Pre-proline 0 N--CA 1.419 -2.024 0 N-CA-C 109.812 -0.44 . . . . 74.430000000000007 109.812 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.73 -9.62 13.25 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.863 2.375 . . . . 73.329999999999998 113.774 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.61 -32.95 4.55 Favored Glycine 0 C--N 1.31 -0.88 0 C-N-CA 120.847 -0.692 . . . . 74.329999999999998 114.217 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.34 -127.52 0.57 Allowed Glycine 0 C--N 1.32 -0.321 0 C-N-CA 120.94 -0.648 . . . . 61.229999999999997 113.673 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -60.08 -29.26 68.46 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.889 0.875 . . . . 74.120000000000005 110.339 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.72 -3.49 63.44 Favored Glycine 0 C--O 1.256 1.507 0 CA-C-N 115.103 -0.953 . . . . 55.25 112.334 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 35.5 t -89.03 93.59 9.65 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 118.563 -1.255 . . . . 72.310000000000002 109.605 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 72.3 mtt180 -77.88 64.34 3.09 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.912 -1.04 . . . . 75.209999999999994 109.084 174.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 7.3 m . . . . . 0 C--N 1.299 -1.598 0 C-N-CA 126.682 1.993 . . . . 75.0 107.794 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.42 -1.947 0 CA-C-O 121.195 0.521 . . . . 74.420000000000002 112.382 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.544 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.7 t70 -140.18 -177.68 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.108 -1.812 . . . . 72.129999999999995 106.108 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.67 -35.35 72.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.382 -0.97 . . . . 72.140000000000001 108.382 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -74.12 -7.17 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.928 -1.033 . . . . 74.439999999999998 111.068 178.211 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.5 t -83.32 -16.85 44.56 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.313 -0.995 . . . . 73.340000000000003 108.313 176.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.82 10.52 78.84 Favored Glycine 0 CA--C 1.485 -1.799 0 N-CA-C 109.715 -1.354 . . . . 53.310000000000002 109.715 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -104.26 172.17 6.94 Favored 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 113.911 -1.144 . . . . 43.219999999999999 109.625 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -70.64 159.61 34.1 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.194 -0.912 . . . . 62.399999999999999 108.856 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.13 112.8 6.77 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.347 -0.612 . . . . 72.549999999999997 109.347 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.24 140.82 69.45 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.54 -1.442 . . . . 72.540000000000006 110.505 -0.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 35.5 t -76.64 130.24 77.13 Favored Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 120.376 -0.53 . . . . 53.450000000000003 110.192 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.18 -29.45 39.34 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.505 2.137 . . . . 75.439999999999998 112.839 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.25 -29.54 12.19 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 119.858 -1.163 . . . . 73.010000000000005 115.691 171.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.39 -115.84 2.24 Favored Glycine 0 C--N 1.314 -0.653 0 C-N-CA 119.791 -1.195 . . . . 71.129999999999995 112.486 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.0 p -70.19 -16.8 63.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.696 0.76 . . . . 53.109999999999999 110.814 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.5 22.26 36.34 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.903 -0.879 . . . . 63.109999999999999 110.903 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.5 t -115.44 115.28 26.27 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-O 121.596 0.712 . . . . 64.420000000000002 111.057 174.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -80.94 61.22 4.46 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.327 -0.99 . . . . 73.219999999999999 108.327 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 m . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 124.639 1.175 . . . . 63.43 111.011 173.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.431 -1.4 0 N-CA-C 113.623 0.971 . . . . 44.409999999999997 113.623 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.0 t70 -143.37 -168.94 2.94 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 104.488 -2.412 . . . . 63.350000000000001 104.488 175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.85 -29.28 62.03 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.205 -1.405 . . . . 71.450000000000003 107.205 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.71 -11.72 39.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.265 -1.334 . . . . 72.239999999999995 110.856 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 7.3 t -92.85 -19.3 21.84 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.548 -0.538 . . . . 64.409999999999997 109.548 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.03 52.71 Favored Glycine 0 C--O 1.209 -1.465 0 N-CA-C 109.665 -1.374 . . . . 72.129999999999995 109.665 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -113.95 176.51 5.01 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 122.862 0.465 . . . . 74.209999999999994 109.863 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.93 154.55 37.13 Favored 'General case' 0 C--O 1.25 1.097 0 O-C-N 124.204 0.94 . . . . 43.43 108.599 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.26 108.86 10.4 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.542 -0.54 . . . . 74.409999999999997 109.542 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.78 152.06 97.73 Favored 'Cis proline' 0 C--O 1.24 0.62 0 C-N-CA 123.549 -1.438 . . . . 70.409999999999997 110.934 -0.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 48.4 t -87.75 134.69 35.06 Favored Pre-proline 0 C--N 1.292 -1.896 0 N-CA-C 108.177 -1.046 . . . . 72.299999999999997 108.177 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 9.1 Cg_exo -70.79 -37.55 6.57 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 121.83 1.687 . . . . 75.019999999999996 112.259 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.63 124.94 5.33 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.65 -0.98 . . . . 61.409999999999997 110.65 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 -75.8 1.39 Allowed Glycine 0 C--N 1.314 -0.665 0 N-CA-C 109.858 -1.297 . . . . 43.310000000000002 109.858 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.5 m -81.51 134.64 35.55 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.682 -1.599 . . . . 74.430000000000007 106.682 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.08 6.82 80.65 Favored Glycine 0 C--O 1.243 0.701 0 CA-C-O 122.411 1.006 . . . . 74.319999999999993 110.654 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.73 81.76 3.21 Favored 'General case' 0 N--CA 1.384 -3.737 0 O-C-N 121.694 -0.886 . . . . 60.140000000000001 110.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -79.12 68.17 5.01 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 123.124 1.44 . . . . 60.32 110.152 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.101 0 CA-C-N 112.447 -2.16 . . . . 62.43 105.423 170.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.663 0 N-CA-C 108.052 -1.092 . . . . 60.240000000000002 108.052 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.7 125.38 7.52 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 106.26 -2.736 . . . . 64.329999999999998 106.26 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 39.5 m -118.46 124.07 46.72 Favored 'General case' 0 N--CA 1.403 -2.792 0 C-N-CA 119.351 -0.94 . . . . 60.219999999999999 113.183 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -136.95 -166.03 1.84 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 105.277 -2.12 . . . . 73.040000000000006 105.277 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -71.12 -22.33 62.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.594 0.634 . . . . 52.32 110.289 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -76.01 -10.57 59.52 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.095 0.474 . . . . 43.43 110.044 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' SG ' ' HA3' ' A' ' 31' ' ' GLY . 8.0 t -87.39 -19.14 28.53 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 119.663 -0.815 . . . . 72.230000000000004 109.816 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 12.85 81.22 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.146 -1.181 . . . . 44.25 110.146 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -101.43 -179.08 3.92 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 114.586 -0.807 . . . . 70.340000000000003 109.166 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.67 157.8 37.34 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.837 -0.801 . . . . 52.43 108.837 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -135.25 106.36 10.23 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 110.18 -0.304 . . . . 72.120000000000005 110.18 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.04 159.35 97.77 Favored 'Cis proline' 0 C--O 1.248 1.015 0 C-N-CA 123.704 -1.373 . . . . 73.430000000000007 110.401 -0.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.5 t -89.23 126.36 58.96 Favored Pre-proline 0 N--CA 1.408 -2.551 0 C-N-CA 119.435 -0.906 . . . . 72.340000000000003 109.56 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -84.41 13.81 2.63 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.114 2.543 . . . . 71.129999999999995 114.221 -172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.85 -42.82 2.09 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.383 0.913 . . . . 43.210000000000001 115.383 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.25 -99.95 2.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.962 -0.637 . . . . 31.329999999999998 114.124 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 m -59.19 -38.31 79.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.886 0.874 . . . . 72.299999999999997 112.279 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.6 4.46 81.93 Favored Glycine 0 C--O 1.253 1.338 0 C-N-CA 120.043 -1.075 . . . . 74.430000000000007 112.298 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.8 t -97.34 81.1 2.96 Favored 'General case' 0 N--CA 1.399 -3.008 0 O-C-N 121.427 -1.043 . . . . 71.329999999999998 111.46 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.68 72.93 10.51 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 122.564 1.174 . . . . 55.210000000000001 109.075 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 -0.37 17.51 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.218 -1.81 . . . . 74.219999999999999 107.235 170.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -131.07 138.45 49.58 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 106.833 -1.543 . . . . 75.400000000000006 106.833 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.2 m 58.9 28.81 18.04 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.327 -0.99 . . . . 73.140000000000001 108.327 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.11 129.47 35.71 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.076 -0.966 . . . . 53.240000000000002 112.649 -170.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -99.94 -25.61 14.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.911 -1.144 . . . . 71.319999999999993 107.911 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.9 m -72.99 -56.11 5.6 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.421 -0.809 . . . . 72.140000000000001 111.0 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.97 138.66 2.65 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.536 -0.84 . . . . 15.35 111.836 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.09 -34.03 0.04 OUTLIER Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.857 -0.687 . . . . 64.319999999999993 111.866 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.3 111.57 0.9 Allowed 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.487 0.715 . . . . 74.219999999999999 111.278 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 64.02 20.7 12.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.637 1.175 . . . . 71.340000000000003 111.304 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.581 ' HA3' ' SG ' ' A' ' 7' ' ' CYS . . . . . . . . 1 C--O 1.31 4.868 0 CA-C-N 116.142 -0.481 . . . . 73.329999999999998 113.798 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.432 0.634 . . . . 64.030000000000001 109.853 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.85 151.66 20.19 Favored Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 110.111 -1.196 . . . . 42.340000000000003 110.111 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.0 m -108.92 163.61 13.14 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.361 -0.607 . . . . 61.219999999999999 109.361 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -138.66 -168.36 2.38 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 107.433 -1.321 . . . . 64.340000000000003 107.433 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.27 -36.1 70.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.101 1.361 . . . . 73.439999999999998 112.033 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -73.6 -1.77 20.17 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.167 -0.924 . . . . 73.430000000000007 111.872 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -99.26 -19.07 17.28 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.332 0.587 . . . . 71.540000000000006 109.959 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.542 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . 88.29 -3.65 85.43 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 110.574 -1.011 . . . . 61.119999999999997 110.574 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.14 178.78 8.19 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.767 -0.717 . . . . 72.409999999999997 109.522 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.96 155.99 34.9 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 109.021 -0.733 . . . . 74.219999999999999 109.021 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.79 109.01 11.92 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 122.926 0.141 . . . . 72.140000000000001 110.75 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.96 159.4 98.05 Favored 'Cis proline' 0 C--O 1.241 0.642 0 C-N-CA 123.322 -1.533 . . . . 71.340000000000003 109.318 -0.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 t -83.61 125.0 74.72 Favored Pre-proline 0 N--CA 1.416 -2.171 0 C-N-CA 119.024 -1.071 . . . . 34.229999999999997 109.522 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.04 0.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.21 2.606 . . . . 62.229999999999997 114.413 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.04 -27.31 5.03 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 121.335 -0.46 . . . . 63.140000000000001 114.152 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.25 -121.18 1.95 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.909 -0.663 . . . . 42.130000000000003 113.433 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.9 m -62.98 -30.11 71.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.388 1.075 . . . . 40.43 110.875 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.8 -6.15 71.59 Favored Glycine 0 C--O 1.257 1.556 0 CA-C-N 115.79 -0.641 . . . . 73.450000000000003 112.12 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 16.3 t -90.81 84.37 5.82 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 118.834 -1.146 . . . . 71.030000000000001 110.573 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' GLY . 5.1 ptm180 -78.64 68.61 4.66 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.744 1.259 . . . . 75.209999999999994 109.775 172.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.1 m -136.04 12.83 3.35 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.024 -2.353 . . . . 60.420000000000002 108.116 171.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -75.85 -33.53 60.02 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.378 -0.828 . . . . 75.239999999999995 109.737 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 t -145.08 11.65 1.37 Allowed 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.402 -0.817 . . . . 53.32 108.923 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . -128.46 88.76 2.79 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.275 -0.639 . . . . 61.420000000000002 109.275 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -79.96 115.19 19.4 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.754 0.787 . . . . 63.219999999999999 112.368 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.4 m -156.02 142.33 18.41 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.54 -1.282 . . . . 73.219999999999999 107.54 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.19 -64.42 1.53 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.65 -0.98 . . . . 74.420000000000002 110.65 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.71 -65.83 2.46 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.685 -0.566 . . . . 63.409999999999997 111.685 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -114.64 139.12 49.9 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.909 -1.145 . . . . 73.140000000000001 107.909 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.24 96.4 8.45 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.89 0.376 . . . . 41.32 110.628 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.022 0 N-CA-C 109.775 -1.33 . . . . 61.340000000000003 109.775 178.119 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 108.91 -0.774 . . . . 65.129999999999995 108.91 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.32 49.27 5.3 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 108.111 -1.996 . . . . 63.530000000000001 108.111 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 57.1 m -63.0 147.31 51.03 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.14 -1.03 . . . . 74.129999999999995 111.262 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.649 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 10.4 t70 -153.19 -168.82 3.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.749 -2.315 . . . . 60.229999999999997 104.749 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.53 -22.52 58.99 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.942 0.792 . . . . 61.340000000000003 109.291 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -77.09 -8.81 58.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.874 -1.057 . . . . 71.230000000000004 109.948 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.649 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 1.6 t -87.23 -23.04 24.87 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.041 -0.527 . . . . 62.100000000000001 109.592 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.04 -4.86 71.69 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.379 -1.488 . . . . 33.43 109.379 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 m -86.75 167.56 14.32 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 114.769 -0.716 . . . . 60.130000000000003 110.594 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 153.57 43.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.867 -1.16 . . . . 75.310000000000002 107.867 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 t -131.59 111.25 14.96 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.082 -1.081 . . . . 75.540000000000006 108.082 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.69 150.26 95.35 Favored 'Cis proline' 0 C--O 1.243 0.743 0 C-N-CA 124.175 -1.177 . . . . 74.349999999999994 111.847 0.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.5 134.34 42.73 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 109.285 -0.635 . . . . 45.100000000000001 109.285 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.87 -11.01 16.79 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.845 2.363 . . . . 73.450000000000003 113.649 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.9 -40.55 3.08 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.341 -0.457 . . . . 41.310000000000002 113.154 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.43 -117.3 2.13 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.336 -0.705 . . . . 72.319999999999993 111.336 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.6 m -72.18 115.31 11.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.962 -0.755 . . . . 74.510000000000005 108.962 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.64 -9.34 7.69 Favored Glycine 0 C--N 1.288 -2.089 0 N-CA-C 107.662 -2.175 . . . . 73.239999999999995 107.662 -172.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 t -87.95 82.25 7.29 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.709 -0.746 . . . . 74.409999999999997 109.822 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -79.57 70.64 6.09 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 123.251 1.5 . . . . 73.010000000000005 110.645 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' ' HA3' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -119.82 -37.65 3.08 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 111.08 -2.782 . . . . 74.450000000000003 106.828 169.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 t -60.29 104.73 0.35 Allowed 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.91 -1.041 . . . . 51.119999999999997 109.488 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.9 t 71.14 35.01 1.69 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.545 1.138 . . . . 70.230000000000004 109.909 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.34 -14.31 53.16 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.351 0.596 . . . . 54.530000000000001 109.72 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -178.61 -41.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.121 -1.807 . . . . 63.399999999999999 106.121 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 t -131.41 -175.77 3.81 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.38 -1.711 . . . . 72.209999999999994 106.38 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.31 -177.16 14.86 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 110.939 -0.864 . . . . 63.240000000000002 110.939 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.03 -98.51 2.45 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.665 -0.974 . . . . 71.340000000000003 110.665 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.99 114.16 8.57 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.109 -0.7 . . . . 42.25 109.109 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.13 164.82 25.15 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.767 -1.568 . . . . 74.230000000000004 106.767 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 21' ' ' CYS . . . . . . . . 0 C--O 1.266 2.117 0 O-C-N 124.159 0.912 . . . . 40.299999999999997 113.965 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.593 0 N-CA-C 108.367 -0.975 . . . . 72.230000000000004 108.367 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.55 -165.22 12.04 Favored Glycine 0 N--CA 1.411 -3.018 0 CA-C-N 115.012 -0.994 . . . . 65.219999999999999 112.066 175.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.0 m -134.85 155.37 50.78 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 109.35 -0.611 . . . . 71.450000000000003 109.35 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.18 -173.39 2.66 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.076 -0.713 . . . . 71.5 109.076 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.71 -23.37 42.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 121.757 0.789 . . . . 71.010000000000005 109.113 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -74.47 -12.12 60.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.616 -1.174 . . . . 54.399999999999999 109.056 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.02 -17.47 35.13 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.396 -0.82 . . . . 74.150000000000006 109.603 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 87.54 -3.82 86.19 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.744 -1.342 . . . . 33.219999999999999 109.744 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.4 m -87.58 172.06 10.03 Favored 'General case' 0 N--CA 1.404 -2.732 0 CA-C-N 113.906 -1.147 . . . . 62.340000000000003 110.364 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.61 155.65 40.46 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 124.316 1.01 . . . . 52.030000000000001 108.517 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.64 108.79 10.09 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 108.159 -1.052 . . . . 65.030000000000001 108.159 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.36 150.52 95.06 Favored 'Cis proline' 0 C--O 1.242 0.691 0 C-N-CA 124.055 -1.227 . . . . 54.43 111.387 0.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -84.7 127.84 63.56 Favored Pre-proline 0 N--CA 1.413 -2.283 0 N-CA-C 108.242 -1.021 . . . . 72.25 108.242 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.72 -24.26 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.583 2.189 . . . . 73.209999999999994 113.404 -172.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -36.74 4.08 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.55 -0.833 . . . . 61.119999999999997 112.6 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.36 -118.56 0.54 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.857 -0.687 . . . . 73.329999999999998 113.37 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -65.1 -24.59 67.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.466 0.65 . . . . 73.120000000000005 111.906 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.06 -9.13 75.78 Favored Glycine 0 C--O 1.257 1.535 0 CA-C-N 115.613 -0.721 . . . . 51.020000000000003 111.36 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 11.4 t -90.73 92.41 8.8 Favored 'General case' 0 N--CA 1.395 -3.191 0 C-N-CA 118.991 -1.084 . . . . 73.129999999999995 110.712 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 92.8 mtt180 -83.1 66.2 8.56 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.438 1.114 . . . . 71.310000000000002 108.192 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.5 m -147.36 23.33 1.16 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 112.037 -2.347 . . . . 64.409999999999997 106.541 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 p -116.66 -56.44 2.28 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.005 -0.998 . . . . 64.150000000000006 111.95 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m -78.79 -30.33 45.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.079 -0.509 . . . . 61.200000000000003 111.026 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.14 165.9 11.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.446 -0.576 . . . . 61.100000000000001 109.446 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.59 92.27 5.92 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.089 0.471 . . . . 73.329999999999998 109.819 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -154.09 142.1 20.25 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.728 -1.212 . . . . 74.319999999999993 107.728 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.4 -60.02 0.09 OUTLIER Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.205 -0.998 . . . . 72.129999999999995 111.409 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.37 -109.29 3.05 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.502 -1.039 . . . . 62.399999999999999 110.502 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.69 92.47 1.92 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.09 0.471 . . . . 75.420000000000002 111.025 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.22 112.91 6.9 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.801 -0.636 . . . . 73.299999999999997 109.639 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.636 0 N-CA-C 109.541 -1.424 . . . . 60.509999999999998 109.541 -177.507 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.665 0 CA-C-O 121.563 0.697 . . . . 64.310000000000002 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.33 127.17 8.56 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 108.811 -1.715 . . . . 55.350000000000001 108.811 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.8 m -126.88 144.6 50.94 Favored 'General case' 0 N--CA 1.416 -2.164 0 O-C-N 122.467 -0.431 . . . . 74.120000000000005 109.899 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.71 -159.07 0.96 Allowed 'General case' 0 C--O 1.267 2.008 0 N-CA-C 105.9 -1.889 . . . . 64.230000000000004 105.9 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.594 1.088 . . . . 54.25 111.203 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -65.92 -21.75 66.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.566 0.58 . . . . 72.439999999999998 112.566 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.2 t -81.97 -35.65 28.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.043 0.449 . . . . 74.310000000000002 110.114 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.21 4.54 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 108.56 -1.816 . . . . 55.219999999999999 108.56 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.33 179.32 5.98 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.099 -1.074 . . . . 62.030000000000001 108.099 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.39 154.36 40.31 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.994 -0.743 . . . . 51.329999999999998 108.994 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.35 106.56 24.25 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 73.019999999999996 108.632 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.68 161.25 86.75 Favored 'Cis proline' 0 C--O 1.249 1.061 0 C-N-CA 123.607 -1.414 . . . . 75.120000000000005 109.969 0.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 16.7 t -85.4 118.6 71.06 Favored Pre-proline 0 N--CA 1.422 -1.846 0 C-N-CA 118.832 -1.147 . . . . 74.219999999999999 110.111 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 60.9 Cg_endo -92.17 -18.15 0.84 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.034 2.49 . . . . 71.319999999999993 114.181 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.05 -171.57 16.23 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.194 -1.562 . . . . 64.239999999999995 109.194 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.35 -130.3 49.49 Favored Glycine 0 C--O 1.245 0.791 0 CA-C-N 117.212 0.506 . . . . 74.109999999999999 113.015 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.2 m -67.96 -29.43 68.47 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.552 0.741 . . . . 72.409999999999997 110.721 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.07 -19.16 73.58 Favored Glycine 0 C--O 1.259 1.682 0 N-CA-C 110.991 -0.844 . . . . 54.340000000000003 110.991 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.5 t -88.58 88.41 7.6 Favored 'General case' 0 N--CA 1.392 -3.331 0 C-N-CA 119.153 -1.019 . . . . 72.439999999999998 110.199 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -71.41 57.17 0.25 Allowed 'General case' 0 C--O 1.208 -1.116 0 CA-C-O 121.846 0.832 . . . . 60.420000000000002 109.997 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.2 m -129.54 -5.35 4.72 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 125.417 1.487 . . . . 54.130000000000003 108.02 173.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -108.71 -9.73 15.23 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.419 -0.956 . . . . 72.230000000000004 108.419 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 m -117.44 16.26 14.69 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.215 -0.902 . . . . 53.409999999999997 109.453 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.77 -18.19 24.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.733 -0.667 . . . . 71.420000000000002 111.265 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 64.21 20.65 12.27 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.541 0.736 . . . . 74.540000000000006 111.776 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 t -165.73 178.33 6.66 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.498 -1.297 . . . . 70.329999999999998 107.498 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.72 -88.89 0.83 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 121.274 -0.488 . . . . 70.319999999999993 111.907 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.18 67.9 1.5 Allowed Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 109.736 -1.346 . . . . 71.329999999999998 109.736 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 70.66 84.52 0.14 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 125.02 1.328 . . . . 73.510000000000005 110.384 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.63 119.45 16.24 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.997 -1.001 . . . . 72.109999999999999 110.255 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 CA-C-N 116.282 -0.417 . . . . 53.299999999999997 113.254 175.115 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 N-CA-C 112.012 0.375 . . . . 73.400000000000006 112.012 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.77 96.64 0.45 Allowed Glycine 0 N--CA 1.465 0.588 0 O-C-N 124.092 0.87 . . . . 73.340000000000003 111.195 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.7 m -114.87 157.42 23.33 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 112.335 0.495 . . . . 73.140000000000001 112.335 -172.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 6' ' ' LYS . 20.4 t70 -127.33 -172.7 2.72 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 107.05 -1.463 . . . . 74.430000000000007 107.05 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.06 -19.47 61.17 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.843 0.857 . . . . 73.420000000000002 109.038 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HG2' ' OD2' ' A' ' 4' ' ' ASP . 42.9 mmtm -53.23 -35.59 60.1 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.081 1.352 . . . . 71.319999999999993 110.013 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 m -71.16 -45.52 63.31 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.286 -1.325 . . . . 62.25 112.594 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.39 17.93 40.72 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 107.68 -2.168 . . . . 63.210000000000001 107.68 -163.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.69 173.13 7.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.957 -1.127 . . . . 75.230000000000004 107.957 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -67.53 149.12 50.57 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 123.964 0.79 . . . . 64.239999999999995 109.083 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 t -132.84 106.08 12.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.072 -0.714 . . . . 64.430000000000007 109.072 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.22 159.6 97.55 Favored 'Cis proline' 0 C--O 1.248 0.983 0 C-N-CA 123.915 -1.286 . . . . 65.329999999999998 111.0 -0.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 46.6 t -98.15 141.72 23.41 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 109.094 -0.706 . . . . 54.140000000000001 109.094 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 21.1 Cg_endo -64.09 -23.54 67.05 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.76 2.307 . . . . 64.310000000000002 113.045 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.13 -47.46 2.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 114.962 0.745 . . . . 42.219999999999999 114.962 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.23 -116.22 0.94 Allowed Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.712 -0.756 . . . . 55.329999999999998 114.192 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.7 m -62.04 -30.08 70.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.253 0.621 . . . . 72.120000000000005 111.189 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.46 14.52 40.26 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 116.058 -0.519 . . . . 33.219999999999999 112.34 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 41.9 t -102.44 130.61 49.27 Favored 'General case' 0 N--CA 1.404 -2.73 0 O-C-N 121.623 -0.928 . . . . 55.399999999999999 110.445 175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.32 27.38 0.59 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.395 -0.82 . . . . 64.120000000000005 111.056 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.763 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.1 m -134.63 19.64 3.58 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.672 1.189 . . . . 62.140000000000001 109.131 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 17.5 m -103.38 -34.61 8.68 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.814 -0.63 . . . . 72.430000000000007 110.629 -175.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -107.18 19.18 20.74 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.657 0.741 . . . . 62.530000000000001 109.103 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.68 151.85 46.24 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.155 -1.054 . . . . 32.25 108.155 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -119.47 95.84 4.96 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.36 -0.608 . . . . 75.140000000000001 109.36 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.9 m -87.72 -0.7 57.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.472 -0.786 . . . . 72.099999999999994 111.224 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.28 -175.64 16.4 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.814 -0.707 . . . . 73.310000000000002 111.867 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.24 -35.76 70.31 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.074 -0.81 . . . . 62.149999999999999 111.074 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.51 83.5 7.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.324 -0.621 . . . . 73.299999999999997 109.324 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.79 172.5 2.07 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 106.333 -1.728 . . . . 72.140000000000001 106.333 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.78 0 C-N-CA 119.12 -1.514 . . . . 45.219999999999999 114.198 177.816 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 112.661 0.615 . . . . 71.329999999999998 112.661 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.5 73.38 2.68 Favored Glycine 0 C--N 1.307 -1.061 0 N-CA-C 108.764 -1.734 . . . . 73.310000000000002 108.764 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 m -119.11 167.29 11.94 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 112.497 0.554 . . . . 42.140000000000001 112.497 -170.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -169.13 -173.43 1.76 Allowed 'General case' 0 C--O 1.253 1.248 0 N-CA-C 104.896 -2.261 . . . . 75.230000000000004 104.896 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.05 -26.55 63.13 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.683 -1.229 . . . . 63.009999999999998 107.683 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -66.28 -14.89 62.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.251 -1.341 . . . . 64.239999999999995 111.082 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 t -88.31 -31.0 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.281 -0.636 . . . . 63.149999999999999 109.281 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.66 3.67 59.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.326 -1.11 . . . . 73.049999999999997 110.326 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.5 174.33 8.16 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.011 -0.594 . . . . 74.329999999999998 109.862 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 153.14 42.3 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.004 -0.739 . . . . 64.219999999999999 109.004 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.46 109.91 11.36 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 118.533 0.606 . . . . 74.010000000000005 109.85 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 149.5 94.26 Favored 'Cis proline' 0 C--O 1.241 0.648 0 C-N-CA 124.045 -1.231 . . . . 71.409999999999997 111.349 0.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.1 t -81.62 128.46 69.29 Favored Pre-proline 0 N--CA 1.424 -1.751 0 N-CA-C 109.674 -0.491 . . . . 42.32 109.674 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.68 -2.4 7.45 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.047 2.498 . . . . 54.310000000000002 114.557 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.43 5.66 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.796 0.678 . . . . 60.409999999999997 114.796 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 -113.42 2.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.256 -0.973 . . . . 41.030000000000001 111.939 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -57.91 -37.75 74.62 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.408 0.683 . . . . 75.129999999999995 111.235 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.22 -2.7 73.96 Favored Glycine 0 C--O 1.256 1.488 0 C-N-CA 120.977 -0.63 . . . . 72.200000000000003 112.974 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 18.9 t -95.11 96.62 9.35 Favored 'General case' 0 N--CA 1.402 -2.854 0 C-N-CA 118.658 -1.217 . . . . 72.420000000000002 110.844 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -79.23 57.16 2.22 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.347 1.07 . . . . 75.400000000000006 108.681 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.4 m -145.17 -35.44 0.32 Allowed 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 126.774 2.029 . . . . 73.420000000000002 107.793 176.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 m -63.0 109.26 1.41 Allowed 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.51 -0.922 . . . . 44.43 108.51 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.9 m 72.3 17.67 4.82 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.433 1.093 . . . . 74.140000000000001 111.258 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.1 133.76 37.81 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.259 -0.645 . . . . 55.329999999999998 109.259 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -74.86 -63.76 1.19 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.824 -0.625 . . . . 74.049999999999997 111.377 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 m -110.15 98.09 7.43 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.055 0.455 . . . . 74.430000000000007 110.69 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -145.84 9.2 1.57 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.243 -0.979 . . . . 73.230000000000004 112.601 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.34 -114.02 6.17 Favored Glycine 0 C--O 1.241 0.577 0 N-CA-C 110.696 -0.962 . . . . 64.439999999999998 110.696 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.1 97.55 8.85 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.441 -0.948 . . . . 65.129999999999995 108.441 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.94 95.97 10.11 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.116 -0.493 . . . . 51.539999999999999 110.865 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.277 2.804 0 C-N-CA 120.996 -0.621 . . . . 75.420000000000002 112.538 179.713 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.896 0 N-CA-C 108.56 -0.904 . . . . 73.420000000000002 108.56 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.61 147.9 39.2 Favored Glycine 0 C--O 1.25 1.138 0 O-C-N 124.417 1.073 . . . . 73.319999999999993 112.425 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.8 m -136.51 167.43 21.38 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 109.92 -0.4 . . . . 75.420000000000002 109.92 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 6.9 p-10 -146.25 -168.58 3.04 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 108.373 -0.973 . . . . 72.109999999999999 108.373 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.33 -29.76 61.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.132 0.573 . . . . 53.240000000000002 111.857 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -90.75 -5.34 55.82 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 120.922 0.391 . . . . 63.520000000000003 109.949 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 6.5 t -67.71 -31.83 72.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.637 -0.875 . . . . 63.25 108.637 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 0.95 55.15 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 109.512 -1.435 . . . . 53.049999999999997 109.512 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -95.1 173.81 7.38 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.791 -0.704 . . . . 74.040000000000006 110.712 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 157.61 36.73 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.221 0.95 . . . . 33.130000000000003 108.944 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.88 110.79 11.07 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.944 -0.761 . . . . 55.340000000000003 108.944 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.39 144.36 74.88 Favored 'Cis proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.416 -1.493 . . . . 45.530000000000001 110.756 -0.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -76.55 130.9 75.49 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.509 -0.923 . . . . 64.420000000000002 108.509 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.75 -40.23 47.05 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.659 2.239 . . . . 64.200000000000003 112.069 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.34 -46.2 1.12 Allowed Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.177 -1.011 . . . . 53.009999999999998 113.443 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.27 -84.32 1.62 Allowed Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.132 -1.187 . . . . 52.420000000000002 110.132 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -67.34 131.42 45.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.73 -1.581 . . . . 74.519999999999996 106.73 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.77 -9.21 77.37 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.25 -0.976 . . . . 73.140000000000001 111.26 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 45.1 t -85.09 90.4 7.85 Favored 'General case' 0 N--CA 1.412 -2.335 0 C-N-CA 118.71 -1.196 . . . . 65.510000000000005 110.72 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 2.0 ptp180 -77.15 70.34 3.53 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-O 123.401 1.572 . . . . 64.239999999999995 111.035 172.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -145.01 -51.82 0.27 Allowed 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 110.645 -2.98 . . . . 64.519999999999996 105.661 170.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 m -59.04 99.22 0.05 OUTLIER 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 113.911 -1.495 . . . . 73.340000000000003 109.92 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m 67.65 23.36 8.77 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.174 0.99 . . . . 73.299999999999997 111.008 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.34 -41.82 84.58 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.922 -0.769 . . . . 65.319999999999993 108.922 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -142.91 -40.93 0.32 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.435 -1.257 . . . . 75.400000000000006 107.825 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.4 t -138.69 -172.98 3.43 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.554 -1.647 . . . . 62.149999999999999 106.554 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.07 -86.25 1.71 Allowed Glycine 0 C--N 1.303 -1.273 0 C-N-CA 120.477 -0.868 . . . . 63.299999999999997 111.306 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.75 -118.72 7.21 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 121.445 -0.407 . . . . 71.129999999999995 112.818 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.52 68.63 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.073 0.549 . . . . 74.329999999999998 111.901 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 67.45 -67.29 0.18 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.053 1.341 . . . . 73.310000000000002 111.933 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.542 0 N-CA-C 111.389 -0.684 . . . . 73.200000000000003 111.389 179.348 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 N-CA-C 106.076 -1.824 . . . . 75.430000000000007 106.076 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.36 -88.12 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 105.32 -3.112 . . . . 64.340000000000003 105.32 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.6 m -128.27 143.8 51.06 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.377 -1.712 . . . . 72.25 106.377 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -124.7 -171.38 2.34 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.654 -0.498 . . . . 72.049999999999997 109.654 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.74 -40.49 88.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.329 1.052 . . . . 61.549999999999997 111.376 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.07 0.37 36.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.821 -0.627 . . . . 73.5 111.127 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -89.14 -14.66 35.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.915 -0.772 . . . . 74.310000000000002 108.915 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.568 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 76.44 30.52 56.54 Favored Glycine 0 C--O 1.204 -1.767 0 N-CA-C 109.502 -1.439 . . . . 63.200000000000003 109.502 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.8 176.65 6.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.926 -0.768 . . . . 72.530000000000001 108.926 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 157.08 34.09 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.034 0.833 . . . . 52.219999999999999 108.828 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.37 102.44 10.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.767 -0.457 . . . . 74.439999999999998 109.767 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.99 163.22 90.6 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.796 -1.335 . . . . 52.43 110.721 0.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 19.9 t -92.43 129.85 39.45 Favored Pre-proline 0 N--CA 1.41 -2.458 0 C-N-CA 120.074 -0.651 . . . . 71.25 110.187 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.29 -25.93 6.63 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.003 2.468 . . . . 65.120000000000005 113.714 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.67 -33.6 5.56 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.268 -0.968 . . . . 45.140000000000001 113.916 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.57 -118.0 1.07 Allowed Glycine 0 C--O 1.229 -0.205 0 C-N-CA 120.493 -0.861 . . . . 41.5 113.738 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -62.77 -31.89 72.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.313 0.578 . . . . 72.209999999999994 110.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.34 -12.61 66.46 Favored Glycine 0 C--O 1.254 1.398 0 CA-C-N 115.696 -0.684 . . . . 50.130000000000003 111.789 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.7 t -88.91 75.21 8.09 Favored 'General case' 0 N--CA 1.4 -2.939 0 C-N-CA 118.928 -1.109 . . . . 74.219999999999999 109.955 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 11.5 ptm180 -77.97 68.14 3.96 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-O 123.531 1.634 . . . . 71.510000000000005 110.274 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -120.66 -28.7 4.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 111.156 -2.747 . . . . 75.409999999999997 106.728 172.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t -95.99 -8.17 34.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.409 -0.814 . . . . 63.409999999999997 110.847 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -126.08 17.97 7.79 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.814 -0.809 . . . . 74.010000000000005 108.814 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.25 154.47 27.28 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.057 -1.09 . . . . 72.329999999999998 108.057 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -121.51 10.55 10.47 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.374 0.607 . . . . 72.319999999999993 110.37 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.9 m -104.66 154.29 20.15 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.916 -0.583 . . . . 63.310000000000002 109.506 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.77 142.37 5.35 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.467 -0.873 . . . . 31.010000000000002 112.077 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.84 50.04 3.24 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 114.125 0.41 . . . . 74.349999999999994 114.125 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.84 -84.14 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.026 1.331 . . . . 65.209999999999994 114.002 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.53 168.12 23.56 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.977 0.417 . . . . 40.439999999999998 111.376 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.31 0 N-CA-C 107.685 -2.166 . . . . 54.32 107.685 175.8 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 109.727 -0.472 . . . . 61.219999999999999 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.0 142.64 16.14 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.821 -0.627 . . . . 63.25 111.941 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.8 m -140.28 167.48 22.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 123.999 0.92 . . . . 75.450000000000003 109.027 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -144.03 -165.89 2.23 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.133 -1.062 . . . . 65.409999999999997 108.133 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -75.43 -17.0 60.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.622 0.769 . . . . 74.329999999999998 109.875 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -65.32 -23.81 67.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.367 -0.833 . . . . 54.409999999999997 110.148 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m -76.23 -50.47 14.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.075 -0.966 . . . . 63.200000000000003 111.079 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.78 2.6 39.92 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 107.822 -2.111 . . . . 65.150000000000006 107.822 -165.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.58 170.5 16.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 109.021 -0.733 . . . . 65.209999999999994 109.021 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -68.26 155.11 40.39 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.152 -1.055 . . . . 62.210000000000001 108.152 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.61 110.45 8.8 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.95 -1.13 . . . . 73.099999999999994 107.95 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.77 142.24 74.16 Favored 'Cis proline' 0 C--O 1.24 0.584 0 C-N-CA 124.065 -1.223 . . . . 43.299999999999997 111.186 0.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 41.9 t -78.33 125.46 84.81 Favored Pre-proline 0 N--CA 1.424 -1.76 0 N-CA-C 109.382 -0.599 . . . . 61.509999999999998 109.382 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.23 -16.5 22.28 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.628 2.219 . . . . 75.319999999999993 113.244 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.71 -36.99 3.63 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.858 -0.687 . . . . 72.329999999999998 113.59 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.74 -110.14 0.99 Allowed Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.422 -0.894 . . . . 75.450000000000003 113.139 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -56.87 -39.96 75.28 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.57 1.148 . . . . 72.340000000000003 111.059 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.24 0.99 72.13 Favored Glycine 0 C--O 1.258 1.626 0 CA-C-N 115.763 -0.653 . . . . 74.040000000000006 113.043 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 29.8 t -89.41 96.61 10.78 Favored 'General case' 0 N--CA 1.396 -3.125 0 C-N-CA 118.219 -1.392 . . . . 73.129999999999995 110.953 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -78.02 63.0 2.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.317 -0.856 . . . . 70.340000000000003 108.997 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.3 m -150.92 25.3 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 126.629 1.972 . . . . 75.439999999999998 107.034 172.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -93.23 -9.93 37.44 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.694 -1.139 . . . . 52.100000000000001 108.781 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -130.15 22.66 5.26 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.313 -1.366 . . . . 32.43 107.313 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.38 154.26 48.93 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.727 -0.669 . . . . 34.340000000000003 109.937 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -80.83 72.1 7.79 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.414 0.626 . . . . 54.109999999999999 110.657 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.596 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 49.4 m -157.62 26.0 0.28 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.046 -1.465 . . . . 72.129999999999995 107.046 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.03 144.36 10.61 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.414 -1.474 . . . . 50.039999999999999 109.414 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.39 -61.9 1.77 Allowed Glycine 0 C--N 1.3 -1.442 0 C-N-CA 120.576 -0.821 . . . . 70.5 112.066 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.11 -13.08 31.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.96 0.409 . . . . 73.209999999999994 110.966 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.53 -174.42 0.99 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.555 -1.646 . . . . 73.129999999999995 106.555 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.32 0 C-N-CA 120.579 -0.82 . . . . 60.219999999999999 112.73 174.95 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 121.154 0.502 . . . . 14.41 109.65 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.92 76.17 0.04 OUTLIER Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 110.156 -1.178 . . . . 72.109999999999999 110.156 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.6 m -73.78 152.23 40.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.26 -0.47 . . . . 71.420000000000002 110.354 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -136.61 -170.17 2.62 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 116.07 -0.513 . . . . 74.420000000000002 109.985 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.6 -29.21 69.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.462 1.105 . . . . 60.119999999999997 112.219 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -80.31 -7.96 59.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.394 -0.522 . . . . 44.030000000000001 111.717 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.82 -25.94 29.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.235 -0.986 . . . . 63.340000000000003 111.427 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.8 8.89 69.11 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 109.396 -1.481 . . . . 73.329999999999998 109.396 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -100.68 173.31 6.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.333 -0.988 . . . . 70.450000000000003 108.333 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 158.1 31.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 123.724 0.64 . . . . 71.230000000000004 109.735 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 t -132.83 104.64 12.85 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.22 -0.659 . . . . 41.399999999999999 109.22 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.69 159.91 95.66 Favored 'Cis proline' 0 C--O 1.236 0.377 0 C-N-CA 124.031 -1.237 . . . . 63.420000000000002 109.817 -0.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 42.3 t -85.97 128.45 58.1 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 108.571 -0.9 . . . . 64.120000000000005 108.571 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.49 -10.63 3.12 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.023 2.482 . . . . 73.519999999999996 114.389 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.96 -175.77 35.51 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.173 -1.171 . . . . 41.439999999999998 110.173 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -123.07 29.33 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 116.853 0.326 . . . . 70.109999999999999 113.493 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 m -72.27 -21.7 61.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.432 0.634 . . . . 54.229999999999997 110.173 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.05 -14.65 78.93 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.286 -0.725 . . . . 71.519999999999996 111.286 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 30.0 t -90.44 91.06 8.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 118.119 -1.432 . . . . 64.219999999999999 110.81 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 71.05 3.13 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.605 1.193 . . . . 64.340000000000003 108.754 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.0 m -157.07 15.6 0.27 Allowed 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 111.23 -2.713 . . . . 74.109999999999999 108.632 172.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -119.86 -42.6 2.6 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.848 -0.741 . . . . 71.420000000000002 112.495 -169.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 m -88.38 -18.87 27.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.165 0.507 . . . . 74.230000000000004 111.251 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.18 162.51 21.22 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.323 -0.621 . . . . 65.439999999999998 109.323 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 35.6 mmt180 -79.4 90.15 5.02 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.826 0.822 . . . . 72.209999999999994 111.158 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.4 m -97.05 17.26 17.43 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.4 -1.273 . . . . 71.340000000000003 109.809 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.69 -91.58 0.98 Allowed Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.669 -0.696 . . . . 75.540000000000006 112.03 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.15 123.42 1.03 Allowed Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 109.345 -1.502 . . . . 73.140000000000001 109.345 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.67 101.55 9.32 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.532 -0.544 . . . . 74.400000000000006 109.532 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.03 104.38 6.53 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.49 -0.777 . . . . 62.329999999999998 109.344 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.356 0 C-N-CA 120.549 -0.834 . . . . 75.319999999999993 111.017 -177.436 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.369 0.604 . . . . 72.439999999999998 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.83 81.0 0.46 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 111.282 -0.727 . . . . 65.510000000000005 111.282 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 76.1 m -108.55 147.84 31.16 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.997 -0.742 . . . . 73.420000000000002 108.997 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -140.76 -169.09 2.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.419 -1.697 . . . . 74.150000000000006 106.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.38 -18.23 63.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 122.281 1.038 . . . . 71.430000000000007 110.197 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -81.18 2.49 27.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.478 -1.237 . . . . 72.099999999999994 110.603 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.41 -21.97 12.93 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.795 -0.762 . . . . 65.430000000000007 112.574 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.53 16.59 68.22 Favored Glycine 0 C--O 1.212 -1.259 0 N-CA-C 109.685 -1.366 . . . . 63.32 109.685 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -106.41 179.87 4.14 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 123.283 0.633 . . . . 75.219999999999999 109.932 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.06 42.12 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.967 -1.123 . . . . 63.229999999999997 107.967 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.25 107.07 11.21 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.29 -0.633 . . . . 75.430000000000007 109.29 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.25 157.62 99.29 Favored 'Cis proline' 0 C--O 1.246 0.908 0 C-N-CA 123.79 -1.338 . . . . 54.109999999999999 110.644 0.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.9 t -89.31 132.71 36.65 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 109.192 -0.669 . . . . 45.219999999999999 109.192 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HG2' ' H ' ' A' ' 18' ' ' GLY . 69.5 Cg_endo -84.38 4.43 6.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.816 2.344 . . . . 70.109999999999999 113.065 -175.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.07 -40.21 3.09 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 115.498 0.959 . . . . 32.399999999999999 115.498 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.91 -77.11 0.66 Allowed Glycine 0 C--N 1.311 -0.855 0 C-N-CA 119.95 -1.119 . . . . 62.340000000000003 113.042 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.4 m -47.01 -41.65 16.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.626 1.57 . . . . 60.039999999999999 113.708 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 14' ' ' PRO . . . -116.03 27.36 8.25 Favored Glycine 0 C--O 1.256 1.492 0 C-N-CA 120.917 -0.659 . . . . 75.5 111.674 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.1 t -92.74 84.43 5.0 Favored 'General case' 0 N--CA 1.403 -2.81 0 C-N-CA 118.38 -1.328 . . . . 54.229999999999997 109.774 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -77.91 65.41 3.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 122.338 1.066 . . . . 75.219999999999999 108.825 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -134.31 15.35 3.79 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 112.235 -2.257 . . . . 72.409999999999997 105.518 172.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.2 t -81.0 -15.29 56.62 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.717 -1.129 . . . . 53.140000000000001 110.897 -172.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.0 m -106.96 -22.94 12.51 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.596 -0.89 . . . . 73.530000000000001 108.596 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.34 99.03 7.71 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.267 -0.879 . . . . 51.210000000000001 110.314 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -87.38 96.32 10.32 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.284 -1.006 . . . . 72.120000000000005 108.284 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.4 t -125.15 104.63 8.62 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.341 -0.985 . . . . 64.099999999999994 108.341 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.45 1.43 76.12 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.637 -0.711 . . . . 54.310000000000002 112.099 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.59 -90.88 1.99 Allowed Glycine 0 N--CA 1.425 -2.036 0 N-CA-C 111.23 -0.748 . . . . 74.010000000000005 111.23 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.35 95.53 10.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.455 -0.202 . . . . 65.0 110.455 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.7 145.16 0.52 Allowed 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.968 1.307 . . . . 72.140000000000001 107.802 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.696 0 C-N-CA 120.478 -0.868 . . . . 71.239999999999995 111.314 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 112.371 0.508 . . . . 42.409999999999997 112.371 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.87 122.93 30.26 Favored Glycine 0 C--O 1.242 0.613 0 O-C-N 123.583 0.552 . . . . 64.109999999999999 112.771 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m -142.06 156.91 45.42 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.33 -0.619 . . . . 74.349999999999994 109.33 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -140.22 -159.7 0.99 Allowed 'General case' 0 C--O 1.261 1.661 0 N-CA-C 107.019 -1.474 . . . . 75.510000000000005 107.019 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.03 -10.05 59.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 74.040000000000006 110.765 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.75 -27.44 60.35 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.306 -0.627 . . . . 70.120000000000005 109.306 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -82.77 -37.78 24.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.699 0.629 . . . . 74.010000000000005 112.699 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.04 27.22 9.59 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 119.164 -1.493 . . . . 62.329999999999998 109.546 -170.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.5 -178.44 3.38 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.2 -1.407 . . . . 72.239999999999995 107.2 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.81 154.87 39.74 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.948 0.78 . . . . 62.119999999999997 109.695 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.1 t -131.04 107.18 15.04 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.644 -0.873 . . . . 71.209999999999994 108.644 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.5 155.55 89.55 Favored 'Cis proline' 0 C--O 1.247 0.938 0 C-N-CA 124.313 -1.119 . . . . 73.209999999999994 109.582 0.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.4 t -83.36 123.46 76.91 Favored Pre-proline 0 N--CA 1.412 -2.374 0 C-N-CA 119.666 -0.814 . . . . 63.439999999999998 109.668 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.7 4.5 6.57 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 123.895 3.063 . . . . 71.219999999999999 115.451 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.67 -34.13 3.97 Favored Glycine 0 C--N 1.315 -0.586 0 N-CA-C 116.196 1.238 . . . . 75.349999999999994 116.196 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.71 -101.62 2.62 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 119.678 -1.248 . . . . 73.209999999999994 113.337 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 m -61.17 -36.74 80.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.261 1.025 . . . . 64.019999999999996 110.22 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.22 -1.44 88.11 Favored Glycine 0 C--O 1.254 1.375 0 C-N-CA 120.468 -0.873 . . . . 75.540000000000006 112.247 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 21.5 t -96.88 97.24 9.12 Favored 'General case' 0 N--CA 1.401 -2.903 0 C-N-CA 118.518 -1.273 . . . . 63.219999999999999 110.411 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -77.46 57.55 1.56 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.116 -0.947 . . . . 74.510000000000005 109.456 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.1 m -153.94 36.24 0.44 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 127.074 2.149 . . . . 71.140000000000001 107.444 175.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -81.15 -17.81 48.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.487 -0.931 . . . . 74.5 108.487 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -115.49 -40.21 3.44 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.377 -0.971 . . . . 42.219999999999999 108.377 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.58 138.29 41.36 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.458 -0.792 . . . . 53.409999999999997 109.469 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 27.4 mmt180 -102.16 -1.27 31.74 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.367 -0.533 . . . . 72.25 112.372 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.8 m -80.1 84.87 5.74 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.29 -1.004 . . . . 61.340000000000003 108.29 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 31' ' ' GLY . . . 88.31 43.65 5.52 Favored Glycine 0 C--O 1.277 2.834 0 N-CA-C 110.539 -1.024 . . . . 42.43 110.539 -176.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.539 ' HA3' ' HB3' ' A' ' 21' ' ' CYS . . . -176.96 44.21 0.1 Allowed Glycine 0 C--O 1.243 0.683 0 CA-C-N 114.841 -0.679 . . . . 75.329999999999998 111.692 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.53 -59.26 0.68 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.608 -0.886 . . . . 63.299999999999997 108.608 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.66 -63.04 1.1 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.013 -1.106 . . . . 41.240000000000002 108.013 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' O ' ' HA2' ' A' ' 27' ' ' GLY . . . . . . . . 0 N--CA 1.436 -1.347 0 N-CA-C 109.493 -1.443 . . . . 64.010000000000005 109.493 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.284 2.9 0 CA-C-O 120.581 0.229 . . . . 75.120000000000005 111.191 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.56 134.49 41.64 Favored Glycine 0 CA--C 1.501 -0.784 0 O-C-N 124.676 1.235 . . . . 72.120000000000005 112.598 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 73.0 m -152.02 178.34 9.54 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.243 1.017 . . . . 73.230000000000004 108.34 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -133.93 -170.16 2.45 Favored 'General case' 0 C--O 1.258 1.508 0 N-CA-C 108.747 -0.834 . . . . 71.329999999999998 108.747 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.36 -45.35 84.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.03 1.122 . . . . 71.329999999999998 114.03 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.4 -5.61 40.95 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.359 0.503 . . . . 71.540000000000006 112.359 -172.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.42 -28.02 34.45 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.461 -0.57 . . . . 64.510000000000005 109.461 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.74 12.15 59.67 Favored Glycine 0 CA--C 1.498 -0.98 0 N-CA-C 109.501 -1.44 . . . . 74.329999999999998 109.501 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.51 -178.33 3.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.505 -0.848 . . . . 73.120000000000005 108.861 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.454 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . . . -79.75 161.78 25.54 Favored 'General case' 0 C--O 1.259 1.559 0 N-CA-C 108.261 -1.015 . . . . 74.319999999999993 108.261 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 t -137.12 107.54 8.79 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.488 -0.56 . . . . 71.019999999999996 109.488 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.88 157.12 99.07 Favored 'Cis proline' 0 C--O 1.24 0.596 0 C-N-CA 124.282 -1.133 . . . . 71.200000000000003 111.153 -0.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.8 t -86.89 129.07 53.71 Favored Pre-proline 0 N--CA 1.411 -2.385 0 N-CA-C 109.557 -0.534 . . . . 71.209999999999994 109.557 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 22.7 Cg_exo -64.38 -35.63 49.08 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.958 2.439 . . . . 64.019999999999996 113.313 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.17 -46.8 1.11 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.011 -1.09 . . . . 64.200000000000003 112.967 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.56 -95.31 2.24 Favored Glycine 0 C--O 1.25 1.153 0 N-CA-C 110.131 -1.188 . . . . 71.519999999999996 110.131 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 m -69.38 123.57 21.57 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.913 -1.514 . . . . 52.340000000000003 106.913 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.66 -22.58 21.61 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 109.54 -1.424 . . . . 60.109999999999999 109.54 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.8 t -96.65 91.86 5.93 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.945 -1.102 . . . . 71.120000000000005 109.677 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -54.52 -24.83 22.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.504 -0.771 . . . . 73.209999999999994 111.578 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 37.1 m -64.0 -27.88 69.42 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.478 -0.783 . . . . 61.530000000000001 112.01 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 t -72.15 -8.61 55.63 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.146 0.498 . . . . 61.420000000000002 111.763 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -110.76 11.45 22.57 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 120.898 0.38 . . . . 71.409999999999997 110.79 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.0 -56.97 0.42 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.299 0.571 . . . . 64.299999999999997 111.168 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -163.7 108.06 1.02 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.283 -1.377 . . . . 64.129999999999995 107.283 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 m -57.99 -52.82 63.91 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.501 0.5 . . . . 73.129999999999995 110.384 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.85 -44.5 0.75 Allowed Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.191 -0.764 . . . . 54.439999999999998 111.191 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.1 -113.59 0.72 Allowed Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.237 -1.145 . . . . 63.409999999999997 110.237 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.4 -43.99 79.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.784 0.802 . . . . 73.310000000000002 108.893 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.45 140.11 47.46 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.424 -1.324 . . . . 73.319999999999993 107.424 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.306 0 C-N-CA 119.433 -1.365 . . . . 71.319999999999993 113.08 -179.555 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 108.891 -0.781 . . . . 60.219999999999999 108.891 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.47 68.46 1.4 Allowed Glycine 0 C--N 1.301 -1.362 0 N-CA-C 109.479 -1.448 . . . . 50.5 109.479 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.7 m -117.12 169.98 9.01 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.706 -0.247 . . . . 71.310000000000002 111.334 -173.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -139.32 -171.4 3.11 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 107.129 -1.434 . . . . 74.230000000000004 107.129 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.99 -28.04 49.22 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.766 -0.828 . . . . 74.099999999999994 108.766 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -74.52 -10.38 59.5 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.962 -1.472 . . . . 71.340000000000003 110.198 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -34.13 49.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.94 -1.027 . . . . 75.439999999999998 108.434 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.56 56.18 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.08 -1.608 . . . . 61.450000000000003 109.08 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.1 m -97.39 173.6 7.11 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 113.773 -1.213 . . . . 62.219999999999999 109.183 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.01 163.8 27.64 Favored 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.987 0.804 . . . . 55.340000000000003 109.796 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 t -137.2 108.42 8.82 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.003 -0.74 . . . . 75.310000000000002 109.003 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.17 150.17 93.13 Favored 'Cis proline' 0 CA--C 1.514 -0.476 0 C-N-CA 123.989 -1.255 . . . . 73.409999999999997 110.476 0.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.7 t -79.86 119.04 75.43 Favored Pre-proline 0 N--CA 1.416 -2.148 0 C-N-CA 120.212 -0.595 . . . . 34.450000000000003 109.68 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -86.22 0.78 8.05 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.137 2.558 . . . . 74.209999999999994 114.296 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.45 -156.45 30.56 Favored Glycine 0 C--N 1.302 -1.33 0 N-CA-C 110.113 -1.195 . . . . 71.510000000000005 110.113 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -136.42 47.44 Favored Glycine 0 C--O 1.254 1.381 0 O-C-N 123.801 0.353 . . . . 65.239999999999995 113.724 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -79.94 -23.62 41.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.238 -0.653 . . . . 71.150000000000006 109.238 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.3 -20.32 71.26 Favored Glycine 0 C--O 1.251 1.186 0 CA-C-N 115.322 -0.854 . . . . 75.420000000000002 111.187 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.3 t -86.91 99.8 12.11 Favored 'General case' 0 N--CA 1.4 -2.949 0 O-C-N 121.687 -0.89 . . . . 61.439999999999998 109.895 176.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -73.45 64.42 0.84 Allowed 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.925 0.869 . . . . 73.209999999999994 109.094 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.891 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.6 m -154.56 -24.39 0.12 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.252 -1.795 . . . . 71.430000000000007 110.876 176.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -68.71 -50.05 53.96 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.265 0.555 . . . . 70.450000000000003 111.792 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -89.78 -25.78 20.93 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.951 -0.759 . . . . 75.209999999999994 108.951 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . . . -65.6 -42.85 91.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.625 -0.716 . . . . 70.010000000000005 111.108 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -90.83 103.71 16.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 108.61 -0.885 . . . . 64.299999999999997 108.61 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -88.69 120.37 30.02 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 116.301 -0.409 . . . . 73.019999999999996 110.049 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.5 45.61 0.15 Allowed Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.54 -0.838 . . . . 62.520000000000003 112.526 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.68 48.73 64.71 Favored Glycine 0 C--O 1.236 0.277 0 O-C-N 123.586 0.227 . . . . 72.510000000000005 113.503 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.29 146.59 52.09 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.628 -0.508 . . . . 74.049999999999997 109.628 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.88 -44.27 4.04 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.797 0.332 . . . . 62.130000000000003 110.937 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 21' ' ' CYS . . . . . . . . 0 C--O 1.273 2.558 0 CA-C-N 116.198 -0.455 . . . . 40.450000000000003 113.174 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 120.87 0.367 . . . . 72.510000000000005 110.505 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.03 132.04 7.24 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 111.217 -0.753 . . . . 42.109999999999999 111.217 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 93.7 m -120.42 162.65 19.16 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 110.164 -0.31 . . . . 73.530000000000001 110.164 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -131.24 -174.68 3.46 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.435 -0.95 . . . . 74.329999999999998 108.435 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.34 -32.89 70.8 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 112.279 0.474 . . . . 61.219999999999999 112.279 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -76.48 -1.66 28.33 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.788 0.804 . . . . 70.150000000000006 110.523 -177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.665 ' SG ' ' HB1' ' A' ' 29' ' ' ALA . 2.9 t -80.8 -28.57 36.26 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 114.903 -1.044 . . . . 64.420000000000002 108.404 175.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 8.63 58.92 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 108.875 -1.69 . . . . 63.219999999999999 108.875 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.1 m -106.87 166.18 10.78 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-N 114.347 -0.926 . . . . 75.129999999999995 110.591 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -65.42 154.58 38.04 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.629 1.205 . . . . 61.32 108.926 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.9 t -134.1 105.34 11.39 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.606 -0.887 . . . . 73.329999999999998 108.606 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.26 157.36 99.37 Favored 'Cis proline' 0 C--O 1.246 0.891 0 C-N-CA 124.066 -1.222 . . . . 63.5 112.096 -0.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 43.8 t -99.96 141.06 22.06 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 108.463 -0.94 . . . . 73.239999999999995 108.463 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.58 -41.01 34.3 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.523 2.149 . . . . 73.329999999999998 113.052 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.38 -44.41 1.31 Allowed Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.002 -1.094 . . . . 70.019999999999996 113.959 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.99 -69.73 0.26 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.774 -1.203 . . . . 64.019999999999996 113.39 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 m -50.43 -57.24 8.48 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.543 1.137 . . . . 53.439999999999998 112.267 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 49.97 0.83 Allowed Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.347 -1.101 . . . . 53.130000000000003 110.347 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.8 t -110.25 109.03 19.35 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-O 121.893 0.854 . . . . 41.240000000000002 111.574 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.71 68.59 4.72 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 123.078 1.418 . . . . 75.530000000000001 109.275 172.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 6.6 m -158.88 -36.53 0.06 Allowed 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 111.264 -2.698 . . . . 62.439999999999998 107.376 172.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 p -94.22 -37.86 11.34 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.589 0.709 . . . . 70.219999999999999 109.219 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.9 m -101.75 18.11 21.27 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.629 -0.714 . . . . 74.219999999999999 111.168 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.97 148.92 22.75 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.897 -1.149 . . . . 70.239999999999995 107.897 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -93.53 75.62 4.42 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.592 0.96 . . . . 53.549999999999997 113.592 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.1 m -97.02 136.84 37.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.899 -1.148 . . . . 52.299999999999997 107.899 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.55 -92.29 0.68 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.52 -0.847 . . . . 74.099999999999994 112.075 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.21 69.76 3.28 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 110.66 -0.976 . . . . 71.230000000000004 110.66 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.665 ' HB1' ' SG ' ' A' ' 7' ' ' CYS . . . -147.97 14.92 1.05 Allowed 'General case' 0 C--O 1.251 1.148 0 CA-C-O 121.935 0.874 . . . . 72.209999999999994 109.711 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.02 160.87 14.13 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.473 -0.785 . . . . 72.25 109.911 -177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.656 0 N-CA-C 110.321 -1.112 . . . . 50.350000000000001 110.321 -177.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.846 0 N-CA-C 107.922 -1.14 . . . . 55.299999999999997 107.922 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.41 93.24 2.21 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 108.1 -2.0 . . . . 52.240000000000002 108.1 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.1 m -79.33 153.65 29.66 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.701 0.763 . . . . 71.230000000000004 112.785 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.483 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 18.3 t70 -139.91 -171.79 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 72.140000000000001 105.821 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.74 -25.37 32.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.767 -1.197 . . . . 74.219999999999999 107.767 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.14 -7.81 53.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.689 -1.141 . . . . 65.150000000000006 109.449 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 5.9 t -85.82 -24.54 26.72 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.861 -1.163 . . . . 63.119999999999997 107.861 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.9 6.42 60.5 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.652 -1.379 . . . . 73.310000000000002 109.652 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 m -99.54 -178.97 4.06 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 114.18 -1.01 . . . . 64.450000000000003 109.879 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.4 159.32 21.83 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.393 -0.965 . . . . 63.530000000000001 108.393 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -137.5 109.44 8.74 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 108.925 -0.769 . . . . 55.25 108.925 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.75 149.56 94.06 Favored 'Cis proline' 0 C--O 1.25 1.106 0 C-N-CA 123.756 -1.352 . . . . 75.420000000000002 111.792 0.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.41 131.9 46.57 Favored Pre-proline 0 N--CA 1.427 -1.599 0 N-CA-C 108.228 -1.026 . . . . 52.310000000000002 108.228 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.09 -19.74 6.7 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.264 1.976 . . . . 73.230000000000004 115.07 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.04 -44.74 1.42 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.329 -0.939 . . . . 32.229999999999997 113.451 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.06 -117.56 1.8 Allowed Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.32 -0.943 . . . . 53.210000000000001 110.961 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 m -70.11 112.98 6.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.847 -1.168 . . . . 64.329999999999998 107.847 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.43 -21.5 4.81 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 108.274 -1.93 . . . . 62.409999999999997 108.274 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.1 t -92.66 93.92 8.75 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.879 -0.728 . . . . 65.239999999999995 110.721 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -77.5 64.11 2.77 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.035 0.922 . . . . 73.010000000000005 109.186 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 20.1 m -156.68 -24.97 0.1 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 126.765 2.026 . . . . 55.109999999999999 109.92 175.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 p -85.65 -56.88 3.28 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.689 -0.404 . . . . 73.329999999999998 110.694 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.0 m -104.24 22.79 14.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.609 0.718 . . . . 73.439999999999998 110.006 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.4 157.17 47.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.751 -0.833 . . . . 74.010000000000005 108.751 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -88.81 122.46 32.23 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 123.437 0.46 . . . . 73.150000000000006 111.179 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.2 t -136.01 127.56 28.77 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.92 -1.511 . . . . 74.400000000000006 106.92 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.97 142.79 7.45 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 110.076 -1.21 . . . . 51.520000000000003 110.076 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.45 -43.45 1.15 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 110.678 -0.969 . . . . 32.210000000000001 110.678 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.3 154.25 49.02 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.906 -1.146 . . . . 62.350000000000001 107.906 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.16 101.65 12.01 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.905 -0.776 . . . . 63.43 108.905 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.693 0 C-N-CA 120.7 -0.762 . . . . 71.109999999999999 112.829 -177.559 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.604 0 N-CA-C 107.405 -1.332 . . . . 72.319999999999993 107.405 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.21 42.49 57.79 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 107.283 -2.327 . . . . 32.409999999999997 107.283 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.2 m -61.13 132.14 52.79 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 113.016 -1.592 . . . . 71.200000000000003 112.956 -173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 4.5 p-10 -132.42 -170.13 2.37 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.01 -1.478 . . . . 64.519999999999996 107.01 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.52 -33.01 74.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 71.319999999999993 111.535 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -82.1 -0.15 43.35 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.396 0.617 . . . . 72.439999999999998 111.291 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.1 t -87.86 -16.14 34.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.034 -1.098 . . . . 42.530000000000001 108.034 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 90.92 -4.9 81.96 Favored Glycine 0 CA--C 1.496 -1.141 0 N-CA-C 109.503 -1.439 . . . . 70.140000000000001 109.503 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 m -90.43 171.75 9.22 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.077 -1.061 . . . . 75.219999999999999 110.616 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.2 158.98 35.48 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.908 -1.042 . . . . 75.010000000000005 108.352 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 t -135.77 107.96 9.91 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 109.566 -0.531 . . . . 71.420000000000002 109.566 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.3 152.1 97.31 Favored 'Cis proline' 0 C--O 1.245 0.849 0 C-N-CA 123.633 -1.403 . . . . 73.340000000000003 110.489 -0.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.3 t -77.22 131.54 72.11 Favored Pre-proline 0 N--CA 1.419 -2.024 0 N-CA-C 109.812 -0.44 . . . . 74.430000000000007 109.812 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.73 -9.62 13.25 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.863 2.375 . . . . 73.329999999999998 113.774 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.61 -32.95 4.55 Favored Glycine 0 C--N 1.31 -0.88 0 C-N-CA 120.847 -0.692 . . . . 74.329999999999998 114.217 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.34 -127.52 0.57 Allowed Glycine 0 C--N 1.32 -0.321 0 C-N-CA 120.94 -0.648 . . . . 61.229999999999997 113.673 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -60.08 -29.26 68.46 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.889 0.875 . . . . 74.120000000000005 110.339 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.72 -3.49 63.44 Favored Glycine 0 C--O 1.256 1.507 0 CA-C-N 115.103 -0.953 . . . . 55.25 112.334 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 35.5 t -89.03 93.59 9.65 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 118.563 -1.255 . . . . 72.310000000000002 109.605 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 72.3 mtt180 -77.88 64.34 3.09 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.912 -1.04 . . . . 75.209999999999994 109.084 174.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 7.3 m -154.64 21.54 0.46 Allowed 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 126.682 1.993 . . . . 75.0 107.794 173.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 19' ' ' CYS . 11.1 t -148.5 171.77 15.56 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.18 -1.415 . . . . 60.439999999999998 107.18 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 m -81.43 66.79 7.12 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.026 0.917 . . . . 72.5 111.754 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.94 -54.47 2.61 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.62 -1.993 . . . . 73.109999999999999 105.62 173.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -140.34 -73.31 0.35 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.732 -1.122 . . . . 73.25 108.429 168.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 5.3 m -79.27 99.54 7.12 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.621 -0.718 . . . . 71.530000000000001 110.385 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.41 -12.48 78.38 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.918 -0.873 . . . . 65.049999999999997 110.918 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.42 101.84 1.11 Allowed Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 110.217 -1.153 . . . . 71.209999999999994 110.217 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.2 100.26 7.39 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 120.925 0.393 . . . . 32.009999999999998 111.09 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.39 -31.76 69.12 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.687 -0.857 . . . . 73.439999999999998 108.687 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.289 3.537 0 C-N-CA 119.613 -1.28 . . . . 65.140000000000001 114.763 176.865 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 108.926 -0.768 . . . . 72.349999999999994 108.926 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.9 32.75 83.68 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 124.496 1.122 . . . . 64.129999999999995 112.156 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.0 m -144.27 161.0 40.03 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 121.195 0.521 . . . . 74.420000000000002 112.382 -172.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.544 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.7 t70 -140.18 -177.68 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.108 -1.812 . . . . 72.129999999999995 106.108 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.67 -35.35 72.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.382 -0.97 . . . . 72.140000000000001 108.382 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -74.12 -7.17 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.928 -1.033 . . . . 74.439999999999998 111.068 178.211 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.5 t -83.32 -16.85 44.56 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.313 -0.995 . . . . 73.340000000000003 108.313 176.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.82 10.52 78.84 Favored Glycine 0 CA--C 1.485 -1.799 0 N-CA-C 109.715 -1.354 . . . . 53.310000000000002 109.715 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -104.26 172.17 6.94 Favored 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 113.911 -1.144 . . . . 43.219999999999999 109.625 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -70.64 159.61 34.1 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.194 -0.912 . . . . 62.399999999999999 108.856 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.13 112.8 6.77 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.347 -0.612 . . . . 72.549999999999997 109.347 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.24 140.82 69.45 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.54 -1.442 . . . . 72.540000000000006 110.505 -0.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 35.5 t -76.64 130.24 77.13 Favored Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 120.376 -0.53 . . . . 53.450000000000003 110.192 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.18 -29.45 39.34 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.505 2.137 . . . . 75.439999999999998 112.839 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.25 -29.54 12.19 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 119.858 -1.163 . . . . 73.010000000000005 115.691 171.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.39 -115.84 2.24 Favored Glycine 0 C--N 1.314 -0.653 0 C-N-CA 119.791 -1.195 . . . . 71.129999999999995 112.486 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.0 p -70.19 -16.8 63.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.696 0.76 . . . . 53.109999999999999 110.814 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.5 22.26 36.34 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.903 -0.879 . . . . 63.109999999999999 110.903 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.5 t -115.44 115.28 26.27 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-O 121.596 0.712 . . . . 64.420000000000002 111.057 174.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -80.94 61.22 4.46 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.327 -0.99 . . . . 73.219999999999999 108.327 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 m -155.17 16.16 0.41 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.639 1.175 . . . . 63.43 111.011 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -69.75 -13.34 62.24 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.008 0.433 . . . . 54.130000000000003 110.979 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.2 t -142.78 20.46 1.99 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.647 -0.871 . . . . 75.010000000000005 108.647 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . . . -123.54 -72.4 0.68 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.024 -0.534 . . . . 64.409999999999997 110.903 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -120.8 82.96 1.99 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.984 -0.747 . . . . 74.319999999999993 108.984 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.4 m -100.01 -174.25 2.64 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.431 -0.804 . . . . 75.209999999999994 109.411 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 -104.78 3.08 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.451 -0.88 . . . . 62.5 111.598 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.52 128.31 8.13 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 111.036 -0.826 . . . . 71.200000000000003 111.036 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.02 122.59 37.72 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.905 -0.776 . . . . 72.25 108.905 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.41 99.69 1.63 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.349 -0.612 . . . . 74.109999999999999 109.349 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 N-CA-C 108.189 -1.964 . . . . 64.209999999999994 108.189 -172.923 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.871 0 N-CA-C 107.524 -1.288 . . . . 71.439999999999998 107.524 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.7 45.78 10.43 Favored Glycine 0 CA--C 1.495 -1.162 0 N-CA-C 106.426 -2.67 . . . . 74.420000000000002 106.426 -171.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.1 m -60.23 142.41 54.57 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 113.312 -1.444 . . . . 44.409999999999997 113.623 -171.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.0 t70 -143.37 -168.94 2.94 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 104.488 -2.412 . . . . 63.350000000000001 104.488 175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.85 -29.28 62.03 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.205 -1.405 . . . . 71.450000000000003 107.205 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.71 -11.72 39.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.265 -1.334 . . . . 72.239999999999995 110.856 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 7.3 t -92.85 -19.3 21.84 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.548 -0.538 . . . . 64.409999999999997 109.548 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.03 52.71 Favored Glycine 0 C--O 1.209 -1.465 0 N-CA-C 109.665 -1.374 . . . . 72.129999999999995 109.665 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -113.95 176.51 5.01 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 122.862 0.465 . . . . 74.209999999999994 109.863 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.93 154.55 37.13 Favored 'General case' 0 C--O 1.25 1.097 0 O-C-N 124.204 0.94 . . . . 43.43 108.599 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.26 108.86 10.4 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.542 -0.54 . . . . 74.409999999999997 109.542 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.78 152.06 97.73 Favored 'Cis proline' 0 C--O 1.24 0.62 0 C-N-CA 123.549 -1.438 . . . . 70.409999999999997 110.934 -0.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 48.4 t -87.75 134.69 35.06 Favored Pre-proline 0 C--N 1.292 -1.896 0 N-CA-C 108.177 -1.046 . . . . 72.299999999999997 108.177 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 9.1 Cg_exo -70.79 -37.55 6.57 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 121.83 1.687 . . . . 75.019999999999996 112.259 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.63 124.94 5.33 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.65 -0.98 . . . . 61.409999999999997 110.65 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 -75.8 1.39 Allowed Glycine 0 C--N 1.314 -0.665 0 N-CA-C 109.858 -1.297 . . . . 43.310000000000002 109.858 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.5 m -81.51 134.64 35.55 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.682 -1.599 . . . . 74.430000000000007 106.682 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.08 6.82 80.65 Favored Glycine 0 C--O 1.243 0.701 0 CA-C-O 122.411 1.006 . . . . 74.319999999999993 110.654 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.73 81.76 3.21 Favored 'General case' 0 N--CA 1.384 -3.737 0 O-C-N 121.694 -0.886 . . . . 60.140000000000001 110.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -79.12 68.17 5.01 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 123.124 1.44 . . . . 60.32 110.152 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.2 -50.57 3.13 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 112.447 -2.16 . . . . 62.43 105.423 170.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -69.04 132.02 45.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.697 -1.138 . . . . 74.129999999999995 108.915 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.9 m 73.14 -4.71 2.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.661 1.184 . . . . 63.450000000000003 111.493 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.26 -11.35 19.55 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 115.909 -0.587 . . . . 74.140000000000001 109.89 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' A' ' 25' ' ' ARG . 7.9 tpt180 -141.09 124.04 16.28 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.834 -1.543 . . . . 74.450000000000003 106.834 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 m -89.97 119.0 29.96 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.326 0.584 . . . . 41.43 112.433 -173.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.84 -92.83 1.82 Allowed Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 115.553 -0.749 . . . . 71.329999999999998 111.33 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.32 89.32 1.61 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.582 -1.007 . . . . 73.219999999999999 110.582 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.78 81.82 8.59 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.373 0.606 . . . . 75.019999999999996 110.082 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.48 101.91 11.22 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.264 -1.013 . . . . 54.340000000000003 108.264 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.28 3.014 0 C-N-CA 120.058 -1.068 . . . . 72.150000000000006 111.965 -179.204 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.403 -2.792 0 N-CA-C 113.183 0.809 . . . . 60.22 113.183 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -136.95 -166.03 1.84 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 105.277 -2.12 . . . . 73.04 105.277 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -71.12 -22.33 62.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.594 0.634 . . . . 52.32 110.289 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -76.01 -10.57 59.52 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.095 0.474 . . . . 43.43 110.044 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 t -87.39 -19.14 28.53 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 119.663 -0.815 . . . . 72.23 109.816 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 12.85 81.22 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.146 -1.181 . . . . 44.25 110.146 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -101.43 -179.08 3.92 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 114.586 -0.807 . . . . 70.34 109.166 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.67 157.8 37.34 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.837 -0.801 . . . . 52.43 108.837 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -135.25 106.36 10.23 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 110.18 -0.304 . . . . 72.12 110.18 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.04 159.35 97.77 Favored 'Cis proline' 0 C--O 1.248 1.015 0 C-N-CA 123.704 -1.373 . . . . 73.43 110.401 -0.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.5 t -89.23 126.36 58.96 Favored Pre-proline 0 N--CA 1.408 -2.551 0 C-N-CA 119.435 -0.906 . . . . 72.34 109.56 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -84.41 13.81 2.63 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.114 2.543 . . . . 71.13 114.221 -172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.85 -42.82 2.09 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.383 0.913 . . . . 43.21 115.383 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.25 -99.95 2.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.962 -0.637 . . . . 31.33 114.124 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 m -59.19 -38.31 79.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.886 0.874 . . . . 72.3 112.279 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.6 4.46 81.93 Favored Glycine 0 C--O 1.253 1.338 0 C-N-CA 120.043 -1.075 . . . . 74.43 112.298 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.8 t -97.34 81.1 2.96 Favored 'General case' 0 N--CA 1.399 -3.008 0 O-C-N 121.427 -1.043 . . . . 71.33 111.46 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.68 72.93 10.51 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 122.564 1.174 . . . . 55.21 109.075 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.115 0 CA-C-N 113.218 -1.81 . . . . 74.22 107.235 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 109.361 -0.607 . . . . 61.22 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -138.66 -168.36 2.38 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 107.433 -1.321 . . . . 64.34 107.433 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.27 -36.1 70.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.101 1.361 . . . . 73.44 112.033 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -73.6 -1.77 20.17 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.167 -0.924 . . . . 73.43 111.872 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -99.26 -19.07 17.28 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.332 0.587 . . . . 71.54 109.959 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.542 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . 88.29 -3.65 85.43 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 110.574 -1.011 . . . . 61.12 110.574 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.14 178.78 8.19 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.767 -0.717 . . . . 72.41 109.522 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.96 155.99 34.9 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 109.021 -0.733 . . . . 74.22 109.021 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.79 109.01 11.92 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 122.926 0.141 . . . . 72.14 110.75 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.96 159.4 98.05 Favored 'Cis proline' 0 C--O 1.241 0.642 0 C-N-CA 123.322 -1.533 . . . . 71.34 109.318 -0.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 t -83.61 125.0 74.72 Favored Pre-proline 0 N--CA 1.416 -2.171 0 C-N-CA 119.024 -1.071 . . . . 34.23 109.522 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.04 0.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.21 2.606 . . . . 62.23 114.413 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.04 -27.31 5.03 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 121.335 -0.46 . . . . 63.14 114.152 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.25 -121.18 1.95 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.909 -0.663 . . . . 42.13 113.433 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.9 m -62.98 -30.11 71.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.388 1.075 . . . . 40.43 110.875 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.8 -6.15 71.59 Favored Glycine 0 C--O 1.257 1.556 0 CA-C-N 115.79 -0.641 . . . . 73.45 112.12 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 16.3 t -90.81 84.37 5.82 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 118.834 -1.146 . . . . 71.03 110.573 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' GLY . 5.1 ptm180 -78.64 68.61 4.66 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.744 1.259 . . . . 75.21 109.775 172.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.1 m . . . . . 0 C--N 1.299 -1.605 0 CA-C-N 112.024 -2.353 . . . . 60.42 108.116 171.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 N--CA 1.434 -1.26 0 CA-C-O 121.005 0.431 . . . . 74.13 111.262 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.649 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 10.4 t70 -153.19 -168.82 3.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.749 -2.315 . . . . 60.23 104.749 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.53 -22.52 58.99 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.942 0.792 . . . . 61.34 109.291 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -77.09 -8.81 58.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.874 -1.057 . . . . 71.23 109.948 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.649 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 1.6 t -87.23 -23.04 24.87 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.041 -0.527 . . . . 62.1 109.592 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.04 -4.86 71.69 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.379 -1.488 . . . . 33.43 109.379 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 m -86.75 167.56 14.32 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 114.769 -0.716 . . . . 60.13 110.594 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 153.57 43.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.867 -1.16 . . . . 75.31 107.867 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 t -131.59 111.25 14.96 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.082 -1.081 . . . . 75.54 108.082 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.69 150.26 95.35 Favored 'Cis proline' 0 C--O 1.243 0.743 0 C-N-CA 124.175 -1.177 . . . . 74.35 111.847 0.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.5 134.34 42.73 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 109.285 -0.635 . . . . 45.1 109.285 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.87 -11.01 16.79 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.845 2.363 . . . . 73.45 113.649 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.9 -40.55 3.08 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.341 -0.457 . . . . 41.31 113.154 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.43 -117.3 2.13 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.336 -0.705 . . . . 72.32 111.336 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.6 m -72.18 115.31 11.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.962 -0.755 . . . . 74.51 108.962 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.64 -9.34 7.69 Favored Glycine 0 C--N 1.288 -2.089 0 N-CA-C 107.662 -2.175 . . . . 73.24 107.662 -172.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 t -87.95 82.25 7.29 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.709 -0.746 . . . . 74.41 109.822 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -79.57 70.64 6.09 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 123.251 1.5 . . . . 73.01 110.645 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.288 -2.07 0 CA-C-N 111.08 -2.782 . . . . 74.45 106.828 169.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.0 m . . . . . 0 N--CA 1.414 -2.229 0 N-CA-C 109.35 -0.611 . . . . 71.45 109.35 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.18 -173.39 2.66 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.076 -0.713 . . . . 71.5 109.076 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.71 -23.37 42.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 121.757 0.789 . . . . 71.01 109.113 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -74.47 -12.12 60.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.616 -1.174 . . . . 54.4 109.056 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.02 -17.47 35.13 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.396 -0.82 . . . . 74.15 109.603 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 87.54 -3.82 86.19 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.744 -1.342 . . . . 33.22 109.744 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.4 m -87.58 172.06 10.03 Favored 'General case' 0 N--CA 1.404 -2.732 0 CA-C-N 113.906 -1.147 . . . . 62.34 110.364 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.61 155.65 40.46 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 124.316 1.01 . . . . 52.03 108.517 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.64 108.79 10.09 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 108.159 -1.052 . . . . 65.03 108.159 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.36 150.52 95.06 Favored 'Cis proline' 0 C--O 1.242 0.691 0 C-N-CA 124.055 -1.227 . . . . 54.43 111.387 0.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -84.7 127.84 63.56 Favored Pre-proline 0 N--CA 1.413 -2.283 0 N-CA-C 108.242 -1.021 . . . . 72.25 108.242 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.72 -24.26 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.583 2.189 . . . . 73.21 113.404 -172.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -36.74 4.08 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.55 -0.833 . . . . 61.12 112.6 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.36 -118.56 0.54 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.857 -0.687 . . . . 73.33 113.37 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -65.1 -24.59 67.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.466 0.65 . . . . 73.12 111.906 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.06 -9.13 75.78 Favored Glycine 0 C--O 1.257 1.535 0 CA-C-N 115.613 -0.721 . . . . 51.02 111.36 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 11.4 t -90.73 92.41 8.8 Favored 'General case' 0 N--CA 1.395 -3.191 0 C-N-CA 118.991 -1.084 . . . . 73.13 110.712 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 92.8 mtt180 -83.1 66.2 8.56 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.438 1.114 . . . . 71.31 108.192 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.5 m . . . . . 0 C--N 1.299 -1.617 0 CA-C-N 112.037 -2.347 . . . . 64.41 106.541 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 N--CA 1.416 -2.164 0 N-CA-C 109.899 -0.408 . . . . 74.12 109.899 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.71 -159.07 0.96 Allowed 'General case' 0 C--O 1.267 2.008 0 N-CA-C 105.9 -1.889 . . . . 64.23 105.9 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.594 1.088 . . . . 54.25 111.203 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -65.92 -21.75 66.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.566 0.58 . . . . 72.44 112.566 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.2 t -81.97 -35.65 28.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.043 0.449 . . . . 74.31 110.114 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.21 4.54 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 108.56 -1.816 . . . . 55.22 108.56 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.33 179.32 5.98 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.099 -1.074 . . . . 62.03 108.099 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.39 154.36 40.31 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.994 -0.743 . . . . 51.33 108.994 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.35 106.56 24.25 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 73.02 108.632 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.68 161.25 86.75 Favored 'Cis proline' 0 C--O 1.249 1.061 0 C-N-CA 123.607 -1.414 . . . . 75.12 109.969 0.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 16.7 t -85.4 118.6 71.06 Favored Pre-proline 0 N--CA 1.422 -1.846 0 C-N-CA 118.832 -1.147 . . . . 74.22 110.111 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 60.9 Cg_endo -92.17 -18.15 0.84 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.034 2.49 . . . . 71.32 114.181 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.05 -171.57 16.23 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.194 -1.562 . . . . 64.24 109.194 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.35 -130.3 49.49 Favored Glycine 0 C--O 1.245 0.791 0 CA-C-N 117.212 0.506 . . . . 74.11 113.015 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.2 m -67.96 -29.43 68.47 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.552 0.741 . . . . 72.41 110.721 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.07 -19.16 73.58 Favored Glycine 0 C--O 1.259 1.682 0 N-CA-C 110.991 -0.844 . . . . 54.34 110.991 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.5 t -88.58 88.41 7.6 Favored 'General case' 0 N--CA 1.392 -3.331 0 C-N-CA 119.153 -1.019 . . . . 72.44 110.199 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -71.41 57.17 0.25 Allowed 'General case' 0 C--O 1.208 -1.116 0 CA-C-O 121.846 0.832 . . . . 60.42 109.997 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.2 m . . . . . 0 C--N 1.298 -1.67 0 C-N-CA 125.417 1.487 . . . . 54.13 108.02 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 N--CA 1.432 -1.349 0 N-CA-C 112.335 0.495 . . . . 73.14 112.335 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 6' ' ' LYS . 20.4 t70 -127.33 -172.7 2.72 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 107.05 -1.463 . . . . 74.43 107.05 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.06 -19.47 61.17 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.843 0.857 . . . . 73.42 109.038 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HG2' ' OD2' ' A' ' 4' ' ' ASP . 42.9 mmtm -53.23 -35.59 60.1 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.081 1.352 . . . . 71.32 110.013 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 m -71.16 -45.52 63.31 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.286 -1.325 . . . . 62.25 112.594 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.39 17.93 40.72 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 107.68 -2.168 . . . . 63.21 107.68 -163.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.69 173.13 7.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.957 -1.127 . . . . 75.23 107.957 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -67.53 149.12 50.57 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 123.964 0.79 . . . . 64.24 109.083 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 t -132.84 106.08 12.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.072 -0.714 . . . . 64.43 109.072 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.22 159.6 97.55 Favored 'Cis proline' 0 C--O 1.248 0.983 0 C-N-CA 123.915 -1.286 . . . . 65.33 111.0 -0.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 46.6 t -98.15 141.72 23.41 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 109.094 -0.706 . . . . 54.14 109.094 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 21.1 Cg_endo -64.09 -23.54 67.05 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.76 2.307 . . . . 64.31 113.045 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.13 -47.46 2.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 114.962 0.745 . . . . 42.22 114.962 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.23 -116.22 0.94 Allowed Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.712 -0.756 . . . . 55.33 114.192 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.7 m -62.04 -30.08 70.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.253 0.621 . . . . 72.12 111.189 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.46 14.52 40.26 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 116.058 -0.519 . . . . 33.22 112.34 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 41.9 t -102.44 130.61 49.27 Favored 'General case' 0 N--CA 1.404 -2.73 0 O-C-N 121.623 -0.928 . . . . 55.4 110.445 175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.32 27.38 0.59 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.395 -0.82 . . . . 64.12 111.056 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.763 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.1 m . . . . . 0 C--N 1.323 -0.581 0 C-N-CA 124.672 1.189 . . . . 62.14 109.131 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 112.497 0.554 . . . . 42.14 112.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -169.13 -173.43 1.76 Allowed 'General case' 0 C--O 1.253 1.248 0 N-CA-C 104.896 -2.261 . . . . 75.23 104.896 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.05 -26.55 63.13 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.683 -1.229 . . . . 63.01 107.683 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -66.28 -14.89 62.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.251 -1.341 . . . . 64.24 111.082 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 t -88.31 -31.0 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.281 -0.636 . . . . 63.15 109.281 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.66 3.67 59.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.326 -1.11 . . . . 73.05 110.326 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.5 174.33 8.16 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.011 -0.594 . . . . 74.33 109.862 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 153.14 42.3 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.004 -0.739 . . . . 64.22 109.004 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.46 109.91 11.36 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 118.533 0.606 . . . . 74.01 109.85 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 149.5 94.26 Favored 'Cis proline' 0 C--O 1.241 0.648 0 C-N-CA 124.045 -1.231 . . . . 71.41 111.349 0.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.1 t -81.62 128.46 69.29 Favored Pre-proline 0 N--CA 1.424 -1.751 0 N-CA-C 109.674 -0.491 . . . . 42.32 109.674 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.68 -2.4 7.45 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.047 2.498 . . . . 54.31 114.557 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.43 5.66 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.796 0.678 . . . . 60.41 114.796 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 -113.42 2.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.256 -0.973 . . . . 41.03 111.939 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -57.91 -37.75 74.62 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.408 0.683 . . . . 75.13 111.235 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.22 -2.7 73.96 Favored Glycine 0 C--O 1.256 1.488 0 C-N-CA 120.977 -0.63 . . . . 72.2 112.974 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 18.9 t -95.11 96.62 9.35 Favored 'General case' 0 N--CA 1.402 -2.854 0 C-N-CA 118.658 -1.217 . . . . 72.42 110.844 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -79.23 57.16 2.22 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.347 1.07 . . . . 75.4 108.681 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.4 m . . . . . 0 C--N 1.309 -1.18 0 C-N-CA 126.774 2.029 . . . . 73.42 107.793 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.8 m . . . . . 0 N--CA 1.415 -2.183 0 N-CA-C 109.92 -0.4 . . . . 75.42 109.92 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 6.9 p-10 -146.25 -168.58 3.04 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 108.373 -0.973 . . . . 72.11 108.373 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.33 -29.76 61.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.132 0.573 . . . . 53.24 111.857 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -90.75 -5.34 55.82 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 120.922 0.391 . . . . 63.52 109.949 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 6.5 t -67.71 -31.83 72.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.637 -0.875 . . . . 63.25 108.637 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 0.95 55.15 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 109.512 -1.435 . . . . 53.05 109.512 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -95.1 173.81 7.38 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.791 -0.704 . . . . 74.04 110.712 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 157.61 36.73 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.221 0.95 . . . . 33.13 108.944 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.88 110.79 11.07 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.944 -0.761 . . . . 55.34 108.944 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.39 144.36 74.88 Favored 'Cis proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.416 -1.493 . . . . 45.53 110.756 -0.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -76.55 130.9 75.49 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.509 -0.923 . . . . 64.42 108.509 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.75 -40.23 47.05 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.659 2.239 . . . . 64.2 112.069 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.34 -46.2 1.12 Allowed Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.177 -1.011 . . . . 53.01 113.443 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.27 -84.32 1.62 Allowed Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.132 -1.187 . . . . 52.42 110.132 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -67.34 131.42 45.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.73 -1.581 . . . . 74.52 106.73 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.77 -9.21 77.37 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.25 -0.976 . . . . 73.14 111.26 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 45.1 t -85.09 90.4 7.85 Favored 'General case' 0 N--CA 1.412 -2.335 0 C-N-CA 118.71 -1.196 . . . . 65.51 110.72 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 2.0 ptp180 -77.15 70.34 3.53 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-O 123.401 1.572 . . . . 64.24 111.035 172.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.292 -1.927 0 CA-C-N 110.645 -2.98 . . . . 64.52 105.661 170.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.6 m . . . . . 0 N--CA 1.435 -1.186 0 N-CA-C 106.377 -1.712 . . . . 72.25 106.377 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -124.7 -171.38 2.34 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.654 -0.498 . . . . 72.05 109.654 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.74 -40.49 88.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.329 1.052 . . . . 61.55 111.376 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.07 0.37 36.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.821 -0.627 . . . . 73.5 111.127 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -89.14 -14.66 35.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.915 -0.772 . . . . 74.31 108.915 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.568 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 76.44 30.52 56.54 Favored Glycine 0 C--O 1.204 -1.767 0 N-CA-C 109.502 -1.439 . . . . 63.2 109.502 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.8 176.65 6.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.926 -0.768 . . . . 72.53 108.926 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 157.08 34.09 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.034 0.833 . . . . 52.22 108.828 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.37 102.44 10.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.767 -0.457 . . . . 74.44 109.767 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.99 163.22 90.6 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.796 -1.335 . . . . 52.43 110.721 0.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 19.9 t -92.43 129.85 39.45 Favored Pre-proline 0 N--CA 1.41 -2.458 0 C-N-CA 120.074 -0.651 . . . . 71.25 110.187 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.29 -25.93 6.63 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.003 2.468 . . . . 65.12 113.714 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.67 -33.6 5.56 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.268 -0.968 . . . . 45.14 113.916 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.57 -118.0 1.07 Allowed Glycine 0 C--O 1.229 -0.205 0 C-N-CA 120.493 -0.861 . . . . 41.5 113.738 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -62.77 -31.89 72.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.313 0.578 . . . . 72.21 110.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.34 -12.61 66.46 Favored Glycine 0 C--O 1.254 1.398 0 CA-C-N 115.696 -0.684 . . . . 50.13 111.789 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.7 t -88.91 75.21 8.09 Favored 'General case' 0 N--CA 1.4 -2.939 0 C-N-CA 118.928 -1.109 . . . . 74.22 109.955 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 11.5 ptm180 -77.97 68.14 3.96 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-O 123.531 1.634 . . . . 71.51 110.274 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.501 0 CA-C-N 111.156 -2.747 . . . . 75.41 106.728 172.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.8 m . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 109.027 -0.731 . . . . 75.45 109.027 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -144.03 -165.89 2.23 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.133 -1.062 . . . . 65.41 108.133 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -75.43 -17.0 60.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.622 0.769 . . . . 74.33 109.875 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -65.32 -23.81 67.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.367 -0.833 . . . . 54.41 110.148 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m -76.23 -50.47 14.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.075 -0.966 . . . . 63.2 111.079 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.78 2.6 39.92 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 107.822 -2.111 . . . . 65.15 107.822 -165.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.58 170.5 16.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 109.021 -0.733 . . . . 65.21 109.021 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -68.26 155.11 40.39 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.152 -1.055 . . . . 62.21 108.152 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.61 110.45 8.8 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.95 -1.13 . . . . 73.1 107.95 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.77 142.24 74.16 Favored 'Cis proline' 0 C--O 1.24 0.584 0 C-N-CA 124.065 -1.223 . . . . 43.3 111.186 0.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 41.9 t -78.33 125.46 84.81 Favored Pre-proline 0 N--CA 1.424 -1.76 0 N-CA-C 109.382 -0.599 . . . . 61.51 109.382 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.23 -16.5 22.28 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.628 2.219 . . . . 75.32 113.244 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.71 -36.99 3.63 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.858 -0.687 . . . . 72.33 113.59 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.74 -110.14 0.99 Allowed Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.422 -0.894 . . . . 75.45 113.139 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -56.87 -39.96 75.28 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.57 1.148 . . . . 72.34 111.059 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.24 0.99 72.13 Favored Glycine 0 C--O 1.258 1.626 0 CA-C-N 115.763 -0.653 . . . . 74.04 113.043 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 29.8 t -89.41 96.61 10.78 Favored 'General case' 0 N--CA 1.396 -3.125 0 C-N-CA 118.219 -1.392 . . . . 73.13 110.953 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -78.02 63.0 2.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.317 -0.856 . . . . 70.34 108.997 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.3 m . . . . . 0 C--N 1.3 -1.556 0 C-N-CA 126.629 1.972 . . . . 75.44 107.034 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 N--CA 1.435 -1.197 0 CA-C-O 120.643 0.258 . . . . 71.42 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -136.61 -170.17 2.62 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 116.07 -0.513 . . . . 74.42 109.985 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.6 -29.21 69.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.462 1.105 . . . . 60.12 112.219 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -80.31 -7.96 59.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.394 -0.522 . . . . 44.03 111.717 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.82 -25.94 29.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.235 -0.986 . . . . 63.34 111.427 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.8 8.89 69.11 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 109.396 -1.481 . . . . 73.33 109.396 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -100.68 173.31 6.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.333 -0.988 . . . . 70.45 108.333 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 158.1 31.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 123.724 0.64 . . . . 71.23 109.735 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 t -132.83 104.64 12.85 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.22 -0.659 . . . . 41.4 109.22 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.69 159.91 95.66 Favored 'Cis proline' 0 C--O 1.236 0.377 0 C-N-CA 124.031 -1.237 . . . . 63.42 109.817 -0.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 42.3 t -85.97 128.45 58.1 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 108.571 -0.9 . . . . 64.12 108.571 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.49 -10.63 3.12 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.023 2.482 . . . . 73.52 114.389 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.96 -175.77 35.51 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.173 -1.171 . . . . 41.44 110.173 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -123.07 29.33 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 116.853 0.326 . . . . 70.11 113.493 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 m -72.27 -21.7 61.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.432 0.634 . . . . 54.23 110.173 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.05 -14.65 78.93 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.286 -0.725 . . . . 71.52 111.286 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 30.0 t -90.44 91.06 8.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 118.119 -1.432 . . . . 64.22 110.81 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 71.05 3.13 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.605 1.193 . . . . 64.34 108.754 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.0 m . . . . . 0 C--N 1.291 -1.942 0 CA-C-N 111.23 -2.713 . . . . 74.11 108.632 172.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 N--CA 1.426 -1.628 0 N-CA-C 108.997 -0.742 . . . . 73.42 108.997 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -140.76 -169.09 2.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.419 -1.697 . . . . 74.15 106.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.38 -18.23 63.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 122.281 1.038 . . . . 71.43 110.197 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -81.18 2.49 27.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.478 -1.237 . . . . 72.1 110.603 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.41 -21.97 12.93 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.795 -0.762 . . . . 65.43 112.574 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.53 16.59 68.22 Favored Glycine 0 C--O 1.212 -1.259 0 N-CA-C 109.685 -1.366 . . . . 63.32 109.685 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -106.41 179.87 4.14 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 123.283 0.633 . . . . 75.22 109.932 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.06 42.12 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.967 -1.123 . . . . 63.23 107.967 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.25 107.07 11.21 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.29 -0.633 . . . . 75.43 109.29 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.25 157.62 99.29 Favored 'Cis proline' 0 C--O 1.246 0.908 0 C-N-CA 123.79 -1.338 . . . . 54.11 110.644 0.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.9 t -89.31 132.71 36.65 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 109.192 -0.669 . . . . 45.22 109.192 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HG2' ' H ' ' A' ' 18' ' ' GLY . 69.5 Cg_endo -84.38 4.43 6.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.816 2.344 . . . . 70.11 113.065 -175.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.07 -40.21 3.09 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 115.498 0.959 . . . . 32.4 115.498 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.91 -77.11 0.66 Allowed Glycine 0 C--N 1.311 -0.855 0 C-N-CA 119.95 -1.119 . . . . 62.34 113.042 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.4 m -47.01 -41.65 16.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.626 1.57 . . . . 60.04 113.708 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 14' ' ' PRO . . . -116.03 27.36 8.25 Favored Glycine 0 C--O 1.256 1.492 0 C-N-CA 120.917 -0.659 . . . . 75.5 111.674 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.1 t -92.74 84.43 5.0 Favored 'General case' 0 N--CA 1.403 -2.81 0 C-N-CA 118.38 -1.328 . . . . 54.23 109.774 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -77.91 65.41 3.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 122.338 1.066 . . . . 75.22 108.825 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.481 0 CA-C-N 112.235 -2.257 . . . . 72.41 105.518 172.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 109.33 -0.619 . . . . 74.35 109.33 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -140.22 -159.7 0.99 Allowed 'General case' 0 C--O 1.261 1.661 0 N-CA-C 107.019 -1.474 . . . . 75.51 107.019 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.03 -10.05 59.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 74.04 110.765 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.75 -27.44 60.35 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.306 -0.627 . . . . 70.12 109.306 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -82.77 -37.78 24.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.699 0.629 . . . . 74.01 112.699 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.04 27.22 9.59 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 119.164 -1.493 . . . . 62.33 109.546 -170.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.5 -178.44 3.38 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.2 -1.407 . . . . 72.24 107.2 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.81 154.87 39.74 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.948 0.78 . . . . 62.12 109.695 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.1 t -131.04 107.18 15.04 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.644 -0.873 . . . . 71.21 108.644 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.5 155.55 89.55 Favored 'Cis proline' 0 C--O 1.247 0.938 0 C-N-CA 124.313 -1.119 . . . . 73.21 109.582 0.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.4 t -83.36 123.46 76.91 Favored Pre-proline 0 N--CA 1.412 -2.374 0 C-N-CA 119.666 -0.814 . . . . 63.44 109.668 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.7 4.5 6.57 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 123.895 3.063 . . . . 71.22 115.451 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.67 -34.13 3.97 Favored Glycine 0 C--N 1.315 -0.586 0 N-CA-C 116.196 1.238 . . . . 75.35 116.196 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.71 -101.62 2.62 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 119.678 -1.248 . . . . 73.21 113.337 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 m -61.17 -36.74 80.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.261 1.025 . . . . 64.02 110.22 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.22 -1.44 88.11 Favored Glycine 0 C--O 1.254 1.375 0 C-N-CA 120.468 -0.873 . . . . 75.54 112.247 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 21.5 t -96.88 97.24 9.12 Favored 'General case' 0 N--CA 1.401 -2.903 0 C-N-CA 118.518 -1.273 . . . . 63.22 110.411 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -77.46 57.55 1.56 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.116 -0.947 . . . . 74.51 109.456 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.1 m . . . . . 0 C--N 1.315 -0.927 0 C-N-CA 127.074 2.149 . . . . 71.14 107.444 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.434 -1.261 0 N-CA-C 108.34 -0.985 . . . . 73.23 108.34 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -133.93 -170.16 2.45 Favored 'General case' 0 C--O 1.258 1.508 0 N-CA-C 108.747 -0.834 . . . . 71.33 108.747 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.36 -45.35 84.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.03 1.122 . . . . 71.33 114.03 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.4 -5.61 40.95 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.359 0.503 . . . . 71.54 112.359 -172.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.42 -28.02 34.45 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.461 -0.57 . . . . 64.51 109.461 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.74 12.15 59.67 Favored Glycine 0 CA--C 1.498 -0.98 0 N-CA-C 109.501 -1.44 . . . . 74.33 109.501 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.51 -178.33 3.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.505 -0.848 . . . . 73.12 108.861 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.454 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . . . -79.75 161.78 25.54 Favored 'General case' 0 C--O 1.259 1.559 0 N-CA-C 108.261 -1.015 . . . . 74.32 108.261 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 t -137.12 107.54 8.79 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.488 -0.56 . . . . 71.02 109.488 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.88 157.12 99.07 Favored 'Cis proline' 0 C--O 1.24 0.596 0 C-N-CA 124.282 -1.133 . . . . 71.2 111.153 -0.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.8 t -86.89 129.07 53.71 Favored Pre-proline 0 N--CA 1.411 -2.385 0 N-CA-C 109.557 -0.534 . . . . 71.21 109.557 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 22.7 Cg_exo -64.38 -35.63 49.08 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.958 2.439 . . . . 64.02 113.313 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.17 -46.8 1.11 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.011 -1.09 . . . . 64.2 112.967 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.56 -95.31 2.24 Favored Glycine 0 C--O 1.25 1.153 0 N-CA-C 110.131 -1.188 . . . . 71.52 110.131 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 m -69.38 123.57 21.57 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.913 -1.514 . . . . 52.34 106.913 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.66 -22.58 21.61 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 109.54 -1.424 . . . . 60.11 109.54 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.8 t -96.65 91.86 5.93 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.945 -1.102 . . . . 71.12 109.677 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -54.52 -24.83 22.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.504 -0.771 . . . . 73.21 111.578 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 37.1 m . . . . . 0 C--O 1.215 -0.729 0 CA-C-N 115.478 -0.783 . . . . 61.53 112.01 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.7 m . . . . . 0 N--CA 1.428 -1.553 0 CA-C-O 120.562 0.22 . . . . 71.31 111.334 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -139.32 -171.4 3.11 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 107.129 -1.434 . . . . 74.23 107.129 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.99 -28.04 49.22 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.766 -0.828 . . . . 74.1 108.766 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -74.52 -10.38 59.5 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.962 -1.472 . . . . 71.34 110.198 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -34.13 49.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.94 -1.027 . . . . 75.44 108.434 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.56 56.18 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.08 -1.608 . . . . 61.45 109.08 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.1 m -97.39 173.6 7.11 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 113.773 -1.213 . . . . 62.22 109.183 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.01 163.8 27.64 Favored 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.987 0.804 . . . . 55.34 109.796 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 t -137.2 108.42 8.82 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.003 -0.74 . . . . 75.31 109.003 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.17 150.17 93.13 Favored 'Cis proline' 0 CA--C 1.514 -0.476 0 C-N-CA 123.989 -1.255 . . . . 73.41 110.476 0.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.7 t -79.86 119.04 75.43 Favored Pre-proline 0 N--CA 1.416 -2.148 0 C-N-CA 120.212 -0.595 . . . . 34.45 109.68 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -86.22 0.78 8.05 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.137 2.558 . . . . 74.21 114.296 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.45 -156.45 30.56 Favored Glycine 0 C--N 1.302 -1.33 0 N-CA-C 110.113 -1.195 . . . . 71.51 110.113 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -136.42 47.44 Favored Glycine 0 C--O 1.254 1.381 0 O-C-N 123.801 0.353 . . . . 65.24 113.724 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -79.94 -23.62 41.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.238 -0.653 . . . . 71.15 109.238 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.3 -20.32 71.26 Favored Glycine 0 C--O 1.251 1.186 0 CA-C-N 115.322 -0.854 . . . . 75.42 111.187 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.3 t -86.91 99.8 12.11 Favored 'General case' 0 N--CA 1.4 -2.949 0 O-C-N 121.687 -0.89 . . . . 61.44 109.895 176.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -73.45 64.42 0.84 Allowed 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.925 0.869 . . . . 73.21 109.094 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.891 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.6 m . . . . . 0 C--N 1.285 -2.2 0 CA-C-N 113.252 -1.795 . . . . 71.43 110.876 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 93.7 m . . . . . 0 N--CA 1.425 -1.72 0 N-CA-C 110.164 -0.31 . . . . 73.53 110.164 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -131.24 -174.68 3.46 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.435 -0.95 . . . . 74.33 108.435 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.34 -32.89 70.8 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 112.279 0.474 . . . . 61.22 112.279 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -76.48 -1.66 28.33 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.788 0.804 . . . . 70.15 110.523 -177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.9 t -80.8 -28.57 36.26 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 114.903 -1.044 . . . . 64.42 108.404 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 8.63 58.92 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 108.875 -1.69 . . . . 63.22 108.875 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.1 m -106.87 166.18 10.78 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-N 114.347 -0.926 . . . . 75.13 110.591 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -65.42 154.58 38.04 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.629 1.205 . . . . 61.32 108.926 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.9 t -134.1 105.34 11.39 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.606 -0.887 . . . . 73.33 108.606 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.26 157.36 99.37 Favored 'Cis proline' 0 C--O 1.246 0.891 0 C-N-CA 124.066 -1.222 . . . . 63.5 112.096 -0.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 43.8 t -99.96 141.06 22.06 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 108.463 -0.94 . . . . 73.24 108.463 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.58 -41.01 34.3 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.523 2.149 . . . . 73.33 113.052 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.38 -44.41 1.31 Allowed Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.002 -1.094 . . . . 70.02 113.959 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.99 -69.73 0.26 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.774 -1.203 . . . . 64.02 113.39 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 m -50.43 -57.24 8.48 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.543 1.137 . . . . 53.44 112.267 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 49.97 0.83 Allowed Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.347 -1.101 . . . . 53.13 110.347 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.8 t -110.25 109.03 19.35 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-O 121.893 0.854 . . . . 41.24 111.574 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.71 68.59 4.72 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 123.078 1.418 . . . . 75.53 109.275 172.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 6.6 m . . . . . 0 C--N 1.285 -2.209 0 CA-C-N 111.264 -2.698 . . . . 62.44 107.376 172.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 N--CA 1.429 -1.501 0 CA-C-O 121.701 0.763 . . . . 71.23 112.785 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.483 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 18.3 t70 -139.91 -171.79 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 72.14 105.821 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.74 -25.37 32.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.767 -1.197 . . . . 74.22 107.767 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.14 -7.81 53.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.689 -1.141 . . . . 65.15 109.449 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 5.9 t -85.82 -24.54 26.72 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.861 -1.163 . . . . 63.12 107.861 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.9 6.42 60.5 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.652 -1.379 . . . . 73.31 109.652 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 m -99.54 -178.97 4.06 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 114.18 -1.01 . . . . 64.45 109.879 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.4 159.32 21.83 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.393 -0.965 . . . . 63.53 108.393 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -137.5 109.44 8.74 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 108.925 -0.769 . . . . 55.25 108.925 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.75 149.56 94.06 Favored 'Cis proline' 0 C--O 1.25 1.106 0 C-N-CA 123.756 -1.352 . . . . 75.42 111.792 0.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.41 131.9 46.57 Favored Pre-proline 0 N--CA 1.427 -1.599 0 N-CA-C 108.228 -1.026 . . . . 52.31 108.228 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.09 -19.74 6.7 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.264 1.976 . . . . 73.23 115.07 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.04 -44.74 1.42 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.329 -0.939 . . . . 32.23 113.451 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.06 -117.56 1.8 Allowed Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.32 -0.943 . . . . 53.21 110.961 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 m -70.11 112.98 6.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.847 -1.168 . . . . 64.33 107.847 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.43 -21.5 4.81 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 108.274 -1.93 . . . . 62.41 108.274 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.1 t -92.66 93.92 8.75 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.879 -0.728 . . . . 65.24 110.721 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -77.5 64.11 2.77 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.035 0.922 . . . . 73.01 109.186 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 20.1 m . . . . . 0 C--N 1.31 -1.125 0 C-N-CA 126.765 2.026 . . . . 55.11 109.92 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.419 -2.013 0 N-CA-C 112.956 0.724 . . . . 71.2 112.956 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 4.5 p-10 -132.42 -170.13 2.37 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.01 -1.478 . . . . 64.52 107.01 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.52 -33.01 74.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 71.32 111.535 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -82.1 -0.15 43.35 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.396 0.617 . . . . 72.44 111.291 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.1 t -87.86 -16.14 34.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.034 -1.098 . . . . 42.53 108.034 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 90.92 -4.9 81.96 Favored Glycine 0 CA--C 1.496 -1.141 0 N-CA-C 109.503 -1.439 . . . . 70.14 109.503 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 m -90.43 171.75 9.22 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.077 -1.061 . . . . 75.22 110.616 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.2 158.98 35.48 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.908 -1.042 . . . . 75.01 108.352 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 t -135.77 107.96 9.91 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 109.566 -0.531 . . . . 71.42 109.566 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.3 152.1 97.31 Favored 'Cis proline' 0 C--O 1.245 0.849 0 C-N-CA 123.633 -1.403 . . . . 73.34 110.489 -0.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.3 t -77.22 131.54 72.11 Favored Pre-proline 0 N--CA 1.419 -2.024 0 N-CA-C 109.812 -0.44 . . . . 74.43 109.812 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.73 -9.62 13.25 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.863 2.375 . . . . 73.33 113.774 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.61 -32.95 4.55 Favored Glycine 0 C--N 1.31 -0.88 0 C-N-CA 120.847 -0.692 . . . . 74.33 114.217 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.34 -127.52 0.57 Allowed Glycine 0 C--N 1.32 -0.321 0 C-N-CA 120.94 -0.648 . . . . 61.23 113.673 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -60.08 -29.26 68.46 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.889 0.875 . . . . 74.12 110.339 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.72 -3.49 63.44 Favored Glycine 0 C--O 1.256 1.507 0 CA-C-N 115.103 -0.953 . . . . 55.25 112.334 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 35.5 t -89.03 93.59 9.65 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 118.563 -1.255 . . . . 72.31 109.605 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 72.3 mtt180 -77.88 64.34 3.09 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.912 -1.04 . . . . 75.21 109.084 174.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 7.3 m . . . . . 0 C--N 1.299 -1.598 0 C-N-CA 126.682 1.993 . . . . 75.0 107.794 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.42 -1.947 0 CA-C-O 121.195 0.521 . . . . 74.42 112.382 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.544 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.7 t70 -140.18 -177.68 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.108 -1.812 . . . . 72.13 106.108 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.67 -35.35 72.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.382 -0.97 . . . . 72.14 108.382 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -74.12 -7.17 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.928 -1.033 . . . . 74.44 111.068 178.211 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.5 t -83.32 -16.85 44.56 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 176.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.82 10.52 78.84 Favored Glycine 0 CA--C 1.485 -1.799 0 N-CA-C 109.715 -1.354 . . . . 53.31 109.715 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -104.26 172.17 6.94 Favored 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 113.911 -1.144 . . . . 43.22 109.625 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -70.64 159.61 34.1 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.194 -0.912 . . . . 62.4 108.856 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.13 112.8 6.77 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.347 -0.612 . . . . 72.55 109.347 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.24 140.82 69.45 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.54 -1.442 . . . . 72.54 110.505 -0.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 35.5 t -76.64 130.24 77.13 Favored Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 120.376 -0.53 . . . . 53.45 110.192 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.18 -29.45 39.34 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.505 2.137 . . . . 75.44 112.839 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.25 -29.54 12.19 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 119.858 -1.163 . . . . 73.01 115.691 171.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.39 -115.84 2.24 Favored Glycine 0 C--N 1.314 -0.653 0 C-N-CA 119.791 -1.195 . . . . 71.13 112.486 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.0 p -70.19 -16.8 63.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.696 0.76 . . . . 53.11 110.814 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.5 22.26 36.34 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.903 -0.879 . . . . 63.11 110.903 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.5 t -115.44 115.28 26.27 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-O 121.596 0.712 . . . . 64.42 111.057 174.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -80.94 61.22 4.46 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.327 -0.99 . . . . 73.22 108.327 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 m . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 124.639 1.175 . . . . 63.43 111.011 173.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.431 -1.4 0 N-CA-C 113.623 0.971 . . . . 44.41 113.623 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.0 t70 -143.37 -168.94 2.94 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 104.488 -2.412 . . . . 63.35 104.488 175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.85 -29.28 62.03 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.205 -1.405 . . . . 71.45 107.205 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.71 -11.72 39.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.265 -1.334 . . . . 72.24 110.856 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 7.3 t -92.85 -19.3 21.84 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.548 -0.538 . . . . 64.41 109.548 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.03 52.71 Favored Glycine 0 C--O 1.209 -1.465 0 N-CA-C 109.665 -1.374 . . . . 72.13 109.665 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -113.95 176.51 5.01 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 122.862 0.465 . . . . 74.21 109.863 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.93 154.55 37.13 Favored 'General case' 0 C--O 1.25 1.097 0 O-C-N 124.204 0.94 . . . . 43.43 108.599 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.26 108.86 10.4 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.542 -0.54 . . . . 74.41 109.542 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.78 152.06 97.73 Favored 'Cis proline' 0 C--O 1.24 0.62 0 C-N-CA 123.549 -1.438 . . . . 70.41 110.934 -0.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 48.4 t -87.75 134.69 35.06 Favored Pre-proline 0 C--N 1.292 -1.896 0 N-CA-C 108.177 -1.046 . . . . 72.3 108.177 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 9.1 Cg_exo -70.79 -37.55 6.57 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 121.83 1.687 . . . . 75.02 112.259 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.63 124.94 5.33 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.65 -0.98 . . . . 61.41 110.65 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 -75.8 1.39 Allowed Glycine 0 C--N 1.314 -0.665 0 N-CA-C 109.858 -1.297 . . . . 43.31 109.858 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.5 m -81.51 134.64 35.55 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.682 -1.599 . . . . 74.43 106.682 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.08 6.82 80.65 Favored Glycine 0 C--O 1.243 0.701 0 CA-C-O 122.411 1.006 . . . . 74.32 110.654 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.73 81.76 3.21 Favored 'General case' 0 N--CA 1.384 -3.737 0 O-C-N 121.694 -0.886 . . . . 60.14 110.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -79.12 68.17 5.01 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 123.124 1.44 . . . . 60.32 110.152 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.101 0 CA-C-N 112.447 -2.16 . . . . 62.43 105.423 170.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.663 0 N-CA-C 108.052 -1.092 . . . . 60.24 108.052 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.7 125.38 7.52 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 106.26 -2.736 . . . . 64.33 106.26 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 39.5 m -118.46 124.07 46.72 Favored 'General case' 0 N--CA 1.403 -2.792 0 C-N-CA 119.351 -0.94 . . . . 60.22 113.183 -171.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -136.95 -166.03 1.84 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 105.277 -2.12 . . . . 73.04 105.277 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -71.12 -22.33 62.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.594 0.634 . . . . 52.32 110.289 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -76.01 -10.57 59.52 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.095 0.474 . . . . 43.43 110.044 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' SG ' ' HA3' ' A' ' 31' ' ' GLY . 8.0 t -87.39 -19.14 28.53 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 119.663 -0.815 . . . . 72.23 109.816 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 12.85 81.22 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.146 -1.181 . . . . 44.25 110.146 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -101.43 -179.08 3.92 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 114.586 -0.807 . . . . 70.34 109.166 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.67 157.8 37.34 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.837 -0.801 . . . . 52.43 108.837 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -135.25 106.36 10.23 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 110.18 -0.304 . . . . 72.12 110.18 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.04 159.35 97.77 Favored 'Cis proline' 0 C--O 1.248 1.015 0 C-N-CA 123.704 -1.373 . . . . 73.43 110.401 -0.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.5 t -89.23 126.36 58.96 Favored Pre-proline 0 N--CA 1.408 -2.551 0 C-N-CA 119.435 -0.906 . . . . 72.34 109.56 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -84.41 13.81 2.63 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.114 2.543 . . . . 71.13 114.221 -172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.85 -42.82 2.09 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.383 0.913 . . . . 43.21 115.383 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.25 -99.95 2.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.962 -0.637 . . . . 31.33 114.124 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 m -59.19 -38.31 79.55 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.886 0.874 . . . . 72.3 112.279 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.6 4.46 81.93 Favored Glycine 0 C--O 1.253 1.338 0 C-N-CA 120.043 -1.075 . . . . 74.43 112.298 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.8 t -97.34 81.1 2.96 Favored 'General case' 0 N--CA 1.399 -3.008 0 O-C-N 121.427 -1.043 . . . . 71.33 111.46 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.68 72.93 10.51 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 122.564 1.174 . . . . 55.21 109.075 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.44 -0.37 17.51 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 113.218 -1.81 . . . . 74.22 107.235 170.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -131.07 138.45 49.58 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 106.833 -1.543 . . . . 75.4 106.833 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.2 m 58.9 28.81 18.04 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.327 -0.99 . . . . 73.14 108.327 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.11 129.47 35.71 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.076 -0.966 . . . . 53.24 112.649 -170.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -99.94 -25.61 14.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.911 -1.144 . . . . 71.32 107.911 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.9 m -72.99 -56.11 5.6 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.421 -0.809 . . . . 72.14 111.0 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.97 138.66 2.65 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.536 -0.84 . . . . 15.35 111.836 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.09 -34.03 0.04 OUTLIER Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.857 -0.687 . . . . 64.32 111.866 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.3 111.57 0.9 Allowed 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.487 0.715 . . . . 74.22 111.278 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 64.02 20.7 12.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.637 1.175 . . . . 71.34 111.304 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.581 ' HA3' ' SG ' ' A' ' 7' ' ' CYS . . . . . . . . 1 C--O 1.31 4.868 0 CA-C-N 116.142 -0.481 . . . . 73.33 113.798 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.432 0.634 . . . . 64.03 109.853 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.85 151.66 20.19 Favored Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 110.111 -1.196 . . . . 42.34 110.111 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.0 m -108.92 163.61 13.14 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.361 -0.607 . . . . 61.22 109.361 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -138.66 -168.36 2.38 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 107.433 -1.321 . . . . 64.34 107.433 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.27 -36.1 70.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.101 1.361 . . . . 73.44 112.033 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -73.6 -1.77 20.17 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.167 -0.924 . . . . 73.43 111.872 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -99.26 -19.07 17.28 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.332 0.587 . . . . 71.54 109.959 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.542 ' O ' ' HD3' ' A' ' 20' ' ' ARG . . . 88.29 -3.65 85.43 Favored Glycine 0 C--O 1.214 -1.105 0 N-CA-C 110.574 -1.011 . . . . 61.12 110.574 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.14 178.78 8.19 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.767 -0.717 . . . . 72.41 109.522 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.96 155.99 34.9 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 109.021 -0.733 . . . . 74.22 109.021 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.79 109.01 11.92 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 122.926 0.141 . . . . 72.14 110.75 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.96 159.4 98.05 Favored 'Cis proline' 0 C--O 1.241 0.642 0 C-N-CA 123.322 -1.533 . . . . 71.34 109.318 -0.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 t -83.61 125.0 74.72 Favored Pre-proline 0 N--CA 1.416 -2.171 0 C-N-CA 119.024 -1.071 . . . . 34.23 109.522 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.04 0.4 9.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.21 2.606 . . . . 62.23 114.413 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.04 -27.31 5.03 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 121.335 -0.46 . . . . 63.14 114.152 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.25 -121.18 1.95 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.909 -0.663 . . . . 42.13 113.433 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.9 m -62.98 -30.11 71.33 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.388 1.075 . . . . 40.43 110.875 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.8 -6.15 71.59 Favored Glycine 0 C--O 1.257 1.556 0 CA-C-N 115.79 -0.641 . . . . 73.45 112.12 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 16.3 t -90.81 84.37 5.82 Favored 'General case' 0 N--CA 1.405 -2.678 0 C-N-CA 118.834 -1.146 . . . . 71.03 110.573 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' GLY . 5.1 ptm180 -78.64 68.61 4.66 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.744 1.259 . . . . 75.21 109.775 172.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.1 m -136.04 12.83 3.35 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.024 -2.353 . . . . 60.42 108.116 171.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -75.85 -33.53 60.02 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.378 -0.828 . . . . 75.24 109.737 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 t -145.08 11.65 1.37 Allowed 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.402 -0.817 . . . . 53.32 108.923 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 21' ' ' CYS . . . -128.46 88.76 2.79 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.275 -0.639 . . . . 61.42 109.275 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -79.96 115.19 19.4 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.754 0.787 . . . . 63.22 112.368 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.4 m -156.02 142.33 18.41 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.54 -1.282 . . . . 73.22 107.54 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.19 -64.42 1.53 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.65 -0.98 . . . . 74.42 110.65 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.71 -65.83 2.46 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.685 -0.566 . . . . 63.41 111.685 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -114.64 139.12 49.9 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.909 -1.145 . . . . 73.14 107.909 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.24 96.4 8.45 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.89 0.376 . . . . 41.32 110.628 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.022 0 N-CA-C 109.775 -1.33 . . . . 61.34 109.775 178.119 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 108.91 -0.774 . . . . 65.13 108.91 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.32 49.27 5.3 Favored Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 108.111 -1.996 . . . . 63.53 108.111 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 57.1 m -63.0 147.31 51.03 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.14 -1.03 . . . . 74.13 111.262 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.649 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 10.4 t70 -153.19 -168.82 3.13 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.749 -2.315 . . . . 60.23 104.749 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.53 -22.52 58.99 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.942 0.792 . . . . 61.34 109.291 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -77.09 -8.81 58.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.874 -1.057 . . . . 71.23 109.948 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.649 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 1.6 t -87.23 -23.04 24.87 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.041 -0.527 . . . . 62.1 109.592 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.04 -4.86 71.69 Favored Glycine 0 CA--C 1.49 -1.474 0 N-CA-C 109.379 -1.488 . . . . 33.43 109.379 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 m -86.75 167.56 14.32 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 114.769 -0.716 . . . . 60.13 110.594 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.82 153.57 43.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.867 -1.16 . . . . 75.31 107.867 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 t -131.59 111.25 14.96 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.082 -1.081 . . . . 75.54 108.082 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.69 150.26 95.35 Favored 'Cis proline' 0 C--O 1.243 0.743 0 C-N-CA 124.175 -1.177 . . . . 74.35 111.847 0.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.2 t -84.5 134.34 42.73 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 109.285 -0.635 . . . . 45.1 109.285 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.87 -11.01 16.79 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.845 2.363 . . . . 73.45 113.649 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.9 -40.55 3.08 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.341 -0.457 . . . . 41.31 113.154 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.43 -117.3 2.13 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.336 -0.705 . . . . 72.32 111.336 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.6 m -72.18 115.31 11.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.962 -0.755 . . . . 74.51 108.962 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.64 -9.34 7.69 Favored Glycine 0 C--N 1.288 -2.089 0 N-CA-C 107.662 -2.175 . . . . 73.24 107.662 -172.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 t -87.95 82.25 7.29 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 114.709 -0.746 . . . . 74.41 109.822 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -79.57 70.64 6.09 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 123.251 1.5 . . . . 73.01 110.645 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' ' HA3' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -119.82 -37.65 3.08 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 111.08 -2.782 . . . . 74.45 106.828 169.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 t -60.29 104.73 0.35 Allowed 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.91 -1.041 . . . . 51.12 109.488 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.9 t 71.14 35.01 1.69 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.545 1.138 . . . . 70.23 109.909 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.34 -14.31 53.16 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.351 0.596 . . . . 54.53 109.72 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -178.61 -41.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.121 -1.807 . . . . 63.4 106.121 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 t -131.41 -175.77 3.81 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.38 -1.711 . . . . 72.21 106.38 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.31 -177.16 14.86 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 110.939 -0.864 . . . . 63.24 110.939 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.03 -98.51 2.45 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.665 -0.974 . . . . 71.34 110.665 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.99 114.16 8.57 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.109 -0.7 . . . . 42.25 109.109 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.13 164.82 25.15 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.767 -1.568 . . . . 74.23 106.767 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 21' ' ' CYS . . . . . . . . 0 C--O 1.266 2.117 0 O-C-N 124.159 0.912 . . . . 40.3 113.965 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.593 0 N-CA-C 108.367 -0.975 . . . . 72.23 108.367 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.55 -165.22 12.04 Favored Glycine 0 N--CA 1.411 -3.018 0 CA-C-N 115.012 -0.994 . . . . 65.22 112.066 175.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.0 m -134.85 155.37 50.78 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 109.35 -0.611 . . . . 71.45 109.35 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.18 -173.39 2.66 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.076 -0.713 . . . . 71.5 109.076 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.71 -23.37 42.41 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 121.757 0.789 . . . . 71.01 109.113 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -74.47 -12.12 60.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.616 -1.174 . . . . 54.4 109.056 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.02 -17.47 35.13 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.396 -0.82 . . . . 74.15 109.603 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 87.54 -3.82 86.19 Favored Glycine 0 CA--C 1.5 -0.905 0 N-CA-C 109.744 -1.342 . . . . 33.22 109.744 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.4 m -87.58 172.06 10.03 Favored 'General case' 0 N--CA 1.404 -2.732 0 CA-C-N 113.906 -1.147 . . . . 62.34 110.364 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.61 155.65 40.46 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 124.316 1.01 . . . . 52.03 108.517 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.64 108.79 10.09 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 108.159 -1.052 . . . . 65.03 108.159 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.36 150.52 95.06 Favored 'Cis proline' 0 C--O 1.242 0.691 0 C-N-CA 124.055 -1.227 . . . . 54.43 111.387 0.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.4 t -84.7 127.84 63.56 Favored Pre-proline 0 N--CA 1.413 -2.283 0 N-CA-C 108.242 -1.021 . . . . 72.25 108.242 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.72 -24.26 5.16 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.583 2.189 . . . . 73.21 113.404 -172.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -36.74 4.08 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.55 -0.833 . . . . 61.12 112.6 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.36 -118.56 0.54 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.857 -0.687 . . . . 73.33 113.37 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 p -65.1 -24.59 67.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.466 0.65 . . . . 73.12 111.906 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.06 -9.13 75.78 Favored Glycine 0 C--O 1.257 1.535 0 CA-C-N 115.613 -0.721 . . . . 51.02 111.36 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 11.4 t -90.73 92.41 8.8 Favored 'General case' 0 N--CA 1.395 -3.191 0 C-N-CA 118.991 -1.084 . . . . 73.13 110.712 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 92.8 mtt180 -83.1 66.2 8.56 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.438 1.114 . . . . 71.31 108.192 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.65 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.5 m -147.36 23.33 1.16 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 112.037 -2.347 . . . . 64.41 106.541 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 p -116.66 -56.44 2.28 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.005 -0.998 . . . . 64.15 111.95 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m -78.79 -30.33 45.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.079 -0.509 . . . . 61.2 111.026 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.14 165.9 11.73 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.446 -0.576 . . . . 61.1 109.446 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.59 92.27 5.92 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.089 0.471 . . . . 73.33 109.819 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -154.09 142.1 20.25 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.728 -1.212 . . . . 74.32 107.728 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.4 -60.02 0.09 OUTLIER Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.205 -0.998 . . . . 72.13 111.409 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.37 -109.29 3.05 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.502 -1.039 . . . . 62.4 110.502 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.69 92.47 1.92 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.09 0.471 . . . . 75.42 111.025 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.22 112.91 6.9 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.801 -0.636 . . . . 73.3 109.639 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.636 0 N-CA-C 109.541 -1.424 . . . . 60.51 109.541 -177.507 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.665 0 CA-C-O 121.563 0.697 . . . . 64.31 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.33 127.17 8.56 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 108.811 -1.715 . . . . 55.35 108.811 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.8 m -126.88 144.6 50.94 Favored 'General case' 0 N--CA 1.416 -2.164 0 O-C-N 122.467 -0.431 . . . . 74.12 109.899 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.71 -159.07 0.96 Allowed 'General case' 0 C--O 1.267 2.008 0 N-CA-C 105.9 -1.889 . . . . 64.23 105.9 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.72 -28.62 66.99 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.594 1.088 . . . . 54.25 111.203 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -65.92 -21.75 66.45 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.566 0.58 . . . . 72.44 112.566 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.2 t -81.97 -35.65 28.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.043 0.449 . . . . 74.31 110.114 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.21 4.54 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 108.56 -1.816 . . . . 55.22 108.56 -170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.33 179.32 5.98 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.099 -1.074 . . . . 62.03 108.099 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.39 154.36 40.31 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.994 -0.743 . . . . 51.33 108.994 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.35 106.56 24.25 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 73.02 108.632 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.68 161.25 86.75 Favored 'Cis proline' 0 C--O 1.249 1.061 0 C-N-CA 123.607 -1.414 . . . . 75.12 109.969 0.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 16.7 t -85.4 118.6 71.06 Favored Pre-proline 0 N--CA 1.422 -1.846 0 C-N-CA 118.832 -1.147 . . . . 74.22 110.111 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 60.9 Cg_endo -92.17 -18.15 0.84 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.034 2.49 . . . . 71.32 114.181 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.05 -171.57 16.23 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.194 -1.562 . . . . 64.24 109.194 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.35 -130.3 49.49 Favored Glycine 0 C--O 1.245 0.791 0 CA-C-N 117.212 0.506 . . . . 74.11 113.015 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.2 m -67.96 -29.43 68.47 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.552 0.741 . . . . 72.41 110.721 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.07 -19.16 73.58 Favored Glycine 0 C--O 1.259 1.682 0 N-CA-C 110.991 -0.844 . . . . 54.34 110.991 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.5 t -88.58 88.41 7.6 Favored 'General case' 0 N--CA 1.392 -3.331 0 C-N-CA 119.153 -1.019 . . . . 72.44 110.199 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -71.41 57.17 0.25 Allowed 'General case' 0 C--O 1.208 -1.116 0 CA-C-O 121.846 0.832 . . . . 60.42 109.997 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.2 m -129.54 -5.35 4.72 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 125.417 1.487 . . . . 54.13 108.02 173.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -108.71 -9.73 15.23 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.419 -0.956 . . . . 72.23 108.419 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 m -117.44 16.26 14.69 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.215 -0.902 . . . . 53.41 109.453 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.77 -18.19 24.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.733 -0.667 . . . . 71.42 111.265 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 64.21 20.65 12.27 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.541 0.736 . . . . 74.54 111.776 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 t -165.73 178.33 6.66 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.498 -1.297 . . . . 70.33 107.498 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.72 -88.89 0.83 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 121.274 -0.488 . . . . 70.32 111.907 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.18 67.9 1.5 Allowed Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 109.736 -1.346 . . . . 71.33 109.736 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 70.66 84.52 0.14 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 125.02 1.328 . . . . 73.51 110.384 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.63 119.45 16.24 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.997 -1.001 . . . . 72.11 110.255 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 CA-C-N 116.282 -0.417 . . . . 53.3 113.254 175.115 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 N-CA-C 112.012 0.375 . . . . 73.4 112.012 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.77 96.64 0.45 Allowed Glycine 0 N--CA 1.465 0.588 0 O-C-N 124.092 0.87 . . . . 73.34 111.195 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.7 m -114.87 157.42 23.33 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 112.335 0.495 . . . . 73.14 112.335 -172.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 6' ' ' LYS . 20.4 t70 -127.33 -172.7 2.72 Favored 'General case' 0 C--O 1.258 1.517 0 N-CA-C 107.05 -1.463 . . . . 74.43 107.05 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.06 -19.47 61.17 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.843 0.857 . . . . 73.42 109.038 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HG2' ' OD2' ' A' ' 4' ' ' ASP . 42.9 mmtm -53.23 -35.59 60.1 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.081 1.352 . . . . 71.32 110.013 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 m -71.16 -45.52 63.31 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.286 -1.325 . . . . 62.25 112.594 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 93.39 17.93 40.72 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 107.68 -2.168 . . . . 63.21 107.68 -163.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.69 173.13 7.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.957 -1.127 . . . . 75.23 107.957 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -67.53 149.12 50.57 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 123.964 0.79 . . . . 64.24 109.083 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 t -132.84 106.08 12.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.072 -0.714 . . . . 64.43 109.072 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.22 159.6 97.55 Favored 'Cis proline' 0 C--O 1.248 0.983 0 C-N-CA 123.915 -1.286 . . . . 65.33 111.0 -0.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 46.6 t -98.15 141.72 23.41 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 109.094 -0.706 . . . . 54.14 109.094 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 21.1 Cg_endo -64.09 -23.54 67.05 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.76 2.307 . . . . 64.31 113.045 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.13 -47.46 2.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 114.962 0.745 . . . . 42.22 114.962 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.23 -116.22 0.94 Allowed Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.712 -0.756 . . . . 55.33 114.192 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.7 m -62.04 -30.08 70.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.253 0.621 . . . . 72.12 111.189 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.46 14.52 40.26 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 116.058 -0.519 . . . . 33.22 112.34 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 41.9 t -102.44 130.61 49.27 Favored 'General case' 0 N--CA 1.404 -2.73 0 O-C-N 121.623 -0.928 . . . . 55.4 110.445 175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.32 27.38 0.59 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.395 -0.82 . . . . 64.12 111.056 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.763 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.1 m -134.63 19.64 3.58 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.672 1.189 . . . . 62.14 109.131 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 17.5 m -103.38 -34.61 8.68 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.814 -0.63 . . . . 72.43 110.629 -175.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -107.18 19.18 20.74 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.657 0.741 . . . . 62.53 109.103 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.68 151.85 46.24 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.155 -1.054 . . . . 32.25 108.155 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -119.47 95.84 4.96 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.36 -0.608 . . . . 75.14 109.36 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.9 m -87.72 -0.7 57.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.472 -0.786 . . . . 72.1 111.224 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.28 -175.64 16.4 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 120.814 -0.707 . . . . 73.31 111.867 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.24 -35.76 70.31 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.074 -0.81 . . . . 62.15 111.074 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.51 83.5 7.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.324 -0.621 . . . . 73.3 109.324 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.79 172.5 2.07 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 106.333 -1.728 . . . . 72.14 106.333 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.78 0 C-N-CA 119.12 -1.514 . . . . 45.22 114.198 177.816 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 112.661 0.615 . . . . 71.33 112.661 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.5 73.38 2.68 Favored Glycine 0 C--N 1.307 -1.061 0 N-CA-C 108.764 -1.734 . . . . 73.31 108.764 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 m -119.11 167.29 11.94 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 112.497 0.554 . . . . 42.14 112.497 -170.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -169.13 -173.43 1.76 Allowed 'General case' 0 C--O 1.253 1.248 0 N-CA-C 104.896 -2.261 . . . . 75.23 104.896 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.05 -26.55 63.13 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.683 -1.229 . . . . 63.01 107.683 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -66.28 -14.89 62.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.251 -1.341 . . . . 64.24 111.082 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 t -88.31 -31.0 19.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.281 -0.636 . . . . 63.15 109.281 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.66 3.67 59.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.326 -1.11 . . . . 73.05 110.326 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.5 174.33 8.16 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.011 -0.594 . . . . 74.33 109.862 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.52 153.14 42.3 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.004 -0.739 . . . . 64.22 109.004 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -134.46 109.91 11.36 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 118.533 0.606 . . . . 74.01 109.85 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 149.5 94.26 Favored 'Cis proline' 0 C--O 1.241 0.648 0 C-N-CA 124.045 -1.231 . . . . 71.41 111.349 0.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.1 t -81.62 128.46 69.29 Favored Pre-proline 0 N--CA 1.424 -1.751 0 N-CA-C 109.674 -0.491 . . . . 42.32 109.674 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.68 -2.4 7.45 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.047 2.498 . . . . 54.31 114.557 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.43 5.66 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.796 0.678 . . . . 60.41 114.796 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 -113.42 2.37 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.256 -0.973 . . . . 41.03 111.939 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -57.91 -37.75 74.62 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.408 0.683 . . . . 75.13 111.235 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.22 -2.7 73.96 Favored Glycine 0 C--O 1.256 1.488 0 C-N-CA 120.977 -0.63 . . . . 72.2 112.974 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 18.9 t -95.11 96.62 9.35 Favored 'General case' 0 N--CA 1.402 -2.854 0 C-N-CA 118.658 -1.217 . . . . 72.42 110.844 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -79.23 57.16 2.22 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.347 1.07 . . . . 75.4 108.681 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.4 m -145.17 -35.44 0.32 Allowed 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 126.774 2.029 . . . . 73.42 107.793 176.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 m -63.0 109.26 1.41 Allowed 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.51 -0.922 . . . . 44.43 108.51 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.9 m 72.3 17.67 4.82 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.433 1.093 . . . . 74.14 111.258 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.1 133.76 37.81 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.259 -0.645 . . . . 55.33 109.259 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -74.86 -63.76 1.19 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.824 -0.625 . . . . 74.05 111.377 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 m -110.15 98.09 7.43 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.055 0.455 . . . . 74.43 110.69 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -145.84 9.2 1.57 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.243 -0.979 . . . . 73.23 112.601 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.34 -114.02 6.17 Favored Glycine 0 C--O 1.241 0.577 0 N-CA-C 110.696 -0.962 . . . . 64.44 110.696 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.1 97.55 8.85 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.441 -0.948 . . . . 65.13 108.441 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.94 95.97 10.11 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.116 -0.493 . . . . 51.54 110.865 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.277 2.804 0 C-N-CA 120.996 -0.621 . . . . 75.42 112.538 179.713 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.896 0 N-CA-C 108.56 -0.904 . . . . 73.42 108.56 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.61 147.9 39.2 Favored Glycine 0 C--O 1.25 1.138 0 O-C-N 124.417 1.073 . . . . 73.32 112.425 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.8 m -136.51 167.43 21.38 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 109.92 -0.4 . . . . 75.42 109.92 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 6.9 p-10 -146.25 -168.58 3.04 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 108.373 -0.973 . . . . 72.11 108.373 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.33 -29.76 61.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.132 0.573 . . . . 53.24 111.857 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -90.75 -5.34 55.82 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 120.922 0.391 . . . . 63.52 109.949 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 6.5 t -67.71 -31.83 72.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.637 -0.875 . . . . 63.25 108.637 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.81 0.95 55.15 Favored Glycine 0 N--CA 1.435 -1.372 0 N-CA-C 109.512 -1.435 . . . . 53.05 109.512 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -95.1 173.81 7.38 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.791 -0.704 . . . . 74.04 110.712 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.4 157.61 36.73 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.221 0.95 . . . . 33.13 108.944 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.88 110.79 11.07 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.944 -0.761 . . . . 55.34 108.944 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.39 144.36 74.88 Favored 'Cis proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.416 -1.493 . . . . 45.53 110.756 -0.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -76.55 130.9 75.49 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.509 -0.923 . . . . 64.42 108.509 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.75 -40.23 47.05 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.659 2.239 . . . . 64.2 112.069 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.34 -46.2 1.12 Allowed Glycine 0 C--N 1.314 -0.641 0 C-N-CA 120.177 -1.011 . . . . 53.01 113.443 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.27 -84.32 1.62 Allowed Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.132 -1.187 . . . . 52.42 110.132 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -67.34 131.42 45.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.73 -1.581 . . . . 74.52 106.73 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.77 -9.21 77.37 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.25 -0.976 . . . . 73.14 111.26 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 45.1 t -85.09 90.4 7.85 Favored 'General case' 0 N--CA 1.412 -2.335 0 C-N-CA 118.71 -1.196 . . . . 65.51 110.72 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 2.0 ptp180 -77.15 70.34 3.53 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-O 123.401 1.572 . . . . 64.24 111.035 172.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -145.01 -51.82 0.27 Allowed 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 110.645 -2.98 . . . . 64.52 105.661 170.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 m -59.04 99.22 0.05 OUTLIER 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 113.911 -1.495 . . . . 73.34 109.92 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m 67.65 23.36 8.77 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.174 0.99 . . . . 73.3 111.008 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.34 -41.82 84.58 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.922 -0.769 . . . . 65.32 108.922 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -142.91 -40.93 0.32 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.435 -1.257 . . . . 75.4 107.825 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.4 t -138.69 -172.98 3.43 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.554 -1.647 . . . . 62.15 106.554 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.07 -86.25 1.71 Allowed Glycine 0 C--N 1.303 -1.273 0 C-N-CA 120.477 -0.868 . . . . 63.3 111.306 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.75 -118.72 7.21 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 121.445 -0.407 . . . . 71.13 112.818 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.52 68.63 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.073 0.549 . . . . 74.33 111.901 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 67.45 -67.29 0.18 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.053 1.341 . . . . 73.31 111.933 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.542 0 N-CA-C 111.389 -0.684 . . . . 73.2 111.389 179.348 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 N-CA-C 106.076 -1.824 . . . . 75.43 106.076 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.36 -88.12 0.08 OUTLIER Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 105.32 -3.112 . . . . 64.34 105.32 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.6 m -128.27 143.8 51.06 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.377 -1.712 . . . . 72.25 106.377 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -124.7 -171.38 2.34 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.654 -0.498 . . . . 72.05 109.654 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.74 -40.49 88.28 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 124.329 1.052 . . . . 61.55 111.376 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.07 0.37 36.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.821 -0.627 . . . . 73.5 111.127 -176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -89.14 -14.66 35.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.915 -0.772 . . . . 74.31 108.915 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.568 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 76.44 30.52 56.54 Favored Glycine 0 C--O 1.204 -1.767 0 N-CA-C 109.502 -1.439 . . . . 63.2 109.502 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.8 176.65 6.15 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.926 -0.768 . . . . 72.53 108.926 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 157.08 34.09 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.034 0.833 . . . . 52.22 108.828 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 t -135.37 102.44 10.7 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.767 -0.457 . . . . 74.44 109.767 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.99 163.22 90.6 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 123.796 -1.335 . . . . 52.43 110.721 0.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 19.9 t -92.43 129.85 39.45 Favored Pre-proline 0 N--CA 1.41 -2.458 0 C-N-CA 120.074 -0.651 . . . . 71.25 110.187 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.29 -25.93 6.63 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.003 2.468 . . . . 65.12 113.714 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.67 -33.6 5.56 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.268 -0.968 . . . . 45.14 113.916 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.57 -118.0 1.07 Allowed Glycine 0 C--O 1.229 -0.205 0 C-N-CA 120.493 -0.861 . . . . 41.5 113.738 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -62.77 -31.89 72.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.313 0.578 . . . . 72.21 110.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.34 -12.61 66.46 Favored Glycine 0 C--O 1.254 1.398 0 CA-C-N 115.696 -0.684 . . . . 50.13 111.789 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 15.7 t -88.91 75.21 8.09 Favored 'General case' 0 N--CA 1.4 -2.939 0 C-N-CA 118.928 -1.109 . . . . 74.22 109.955 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 11.5 ptm180 -77.97 68.14 3.96 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-O 123.531 1.634 . . . . 71.51 110.274 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -120.66 -28.7 4.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 111.156 -2.747 . . . . 75.41 106.728 172.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t -95.99 -8.17 34.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.409 -0.814 . . . . 63.41 110.847 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -126.08 17.97 7.79 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.814 -0.809 . . . . 74.01 108.814 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.25 154.47 27.28 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.057 -1.09 . . . . 72.33 108.057 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -121.51 10.55 10.47 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.374 0.607 . . . . 72.32 110.37 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.9 m -104.66 154.29 20.15 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.916 -0.583 . . . . 63.31 109.506 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.77 142.37 5.35 Favored Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.467 -0.873 . . . . 31.01 112.077 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.84 50.04 3.24 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 114.125 0.41 . . . . 74.35 114.125 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.84 -84.14 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.026 1.331 . . . . 65.21 114.002 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.53 168.12 23.56 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.977 0.417 . . . . 40.44 111.376 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.31 0 N-CA-C 107.685 -2.166 . . . . 54.32 107.685 175.8 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 109.727 -0.472 . . . . 61.22 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.0 142.64 16.14 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.821 -0.627 . . . . 63.25 111.941 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.8 m -140.28 167.48 22.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 123.999 0.92 . . . . 75.45 109.027 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -144.03 -165.89 2.23 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 108.133 -1.062 . . . . 65.41 108.133 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -75.43 -17.0 60.28 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.622 0.769 . . . . 74.33 109.875 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -65.32 -23.81 67.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.367 -0.833 . . . . 54.41 110.148 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m -76.23 -50.47 14.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.075 -0.966 . . . . 63.2 111.079 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.78 2.6 39.92 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 107.822 -2.111 . . . . 65.15 107.822 -165.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.58 170.5 16.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 109.021 -0.733 . . . . 65.21 109.021 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -68.26 155.11 40.39 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.152 -1.055 . . . . 62.21 108.152 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.61 110.45 8.8 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.95 -1.13 . . . . 73.1 107.95 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.77 142.24 74.16 Favored 'Cis proline' 0 C--O 1.24 0.584 0 C-N-CA 124.065 -1.223 . . . . 43.3 111.186 0.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 41.9 t -78.33 125.46 84.81 Favored Pre-proline 0 N--CA 1.424 -1.76 0 N-CA-C 109.382 -0.599 . . . . 61.51 109.382 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.23 -16.5 22.28 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.628 2.219 . . . . 75.32 113.244 -173.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.71 -36.99 3.63 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.858 -0.687 . . . . 72.33 113.59 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.74 -110.14 0.99 Allowed Glycine 0 C--N 1.313 -0.734 0 C-N-CA 120.422 -0.894 . . . . 75.45 113.139 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -56.87 -39.96 75.28 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.57 1.148 . . . . 72.34 111.059 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.24 0.99 72.13 Favored Glycine 0 C--O 1.258 1.626 0 CA-C-N 115.763 -0.653 . . . . 74.04 113.043 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 29.8 t -89.41 96.61 10.78 Favored 'General case' 0 N--CA 1.396 -3.125 0 C-N-CA 118.219 -1.392 . . . . 73.13 110.953 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -78.02 63.0 2.91 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.317 -0.856 . . . . 70.34 108.997 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.3 m -150.92 25.3 0.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 126.629 1.972 . . . . 75.44 107.034 172.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -93.23 -9.93 37.44 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.694 -1.139 . . . . 52.1 108.781 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -130.15 22.66 5.26 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.313 -1.366 . . . . 32.43 107.313 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.38 154.26 48.93 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.727 -0.669 . . . . 34.34 109.937 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -80.83 72.1 7.79 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.414 0.626 . . . . 54.11 110.657 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.596 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 49.4 m -157.62 26.0 0.28 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.046 -1.465 . . . . 72.13 107.046 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.03 144.36 10.61 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.414 -1.474 . . . . 50.04 109.414 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.39 -61.9 1.77 Allowed Glycine 0 C--N 1.3 -1.442 0 C-N-CA 120.576 -0.821 . . . . 70.5 112.066 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.11 -13.08 31.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.96 0.409 . . . . 73.21 110.966 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.53 -174.42 0.99 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.555 -1.646 . . . . 73.13 106.555 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.32 0 C-N-CA 120.579 -0.82 . . . . 60.22 112.73 174.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 121.154 0.502 . . . . 14.41 109.65 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.92 76.17 0.04 OUTLIER Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 110.156 -1.178 . . . . 72.11 110.156 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.6 m -73.78 152.23 40.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.26 -0.47 . . . . 71.42 110.354 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -136.61 -170.17 2.62 Favored 'General case' 0 C--O 1.254 1.335 0 CA-C-N 116.07 -0.513 . . . . 74.42 109.985 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.6 -29.21 69.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.462 1.105 . . . . 60.12 112.219 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -80.31 -7.96 59.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.394 -0.522 . . . . 44.03 111.717 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.82 -25.94 29.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.235 -0.986 . . . . 63.34 111.427 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.8 8.89 69.11 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 109.396 -1.481 . . . . 73.33 109.396 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -100.68 173.31 6.59 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.333 -0.988 . . . . 70.45 108.333 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.91 158.1 31.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 123.724 0.64 . . . . 71.23 109.735 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 t -132.83 104.64 12.85 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.22 -0.659 . . . . 41.4 109.22 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.69 159.91 95.66 Favored 'Cis proline' 0 C--O 1.236 0.377 0 C-N-CA 124.031 -1.237 . . . . 63.42 109.817 -0.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 19' ' ' CYS . 42.3 t -85.97 128.45 58.1 Favored Pre-proline 0 C--N 1.289 -2.063 0 N-CA-C 108.571 -0.9 . . . . 64.12 108.571 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.49 -10.63 3.12 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.023 2.482 . . . . 73.52 114.389 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.96 -175.77 35.51 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.173 -1.171 . . . . 41.44 110.173 -176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -123.07 29.33 Favored Glycine 0 C--O 1.243 0.696 0 CA-C-N 116.853 0.326 . . . . 70.11 113.493 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 m -72.27 -21.7 61.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.432 0.634 . . . . 54.23 110.173 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.05 -14.65 78.93 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 111.286 -0.725 . . . . 71.52 111.286 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 30.0 t -90.44 91.06 8.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 C-N-CA 118.119 -1.432 . . . . 64.22 110.81 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 71.05 3.13 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.605 1.193 . . . . 64.34 108.754 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 2.0 m -157.07 15.6 0.27 Allowed 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 111.23 -2.713 . . . . 74.11 108.632 172.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 m -119.86 -42.6 2.6 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.848 -0.741 . . . . 71.42 112.495 -169.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 m -88.38 -18.87 27.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.165 0.507 . . . . 74.23 111.251 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.18 162.51 21.22 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.323 -0.621 . . . . 65.44 109.323 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 35.6 mmt180 -79.4 90.15 5.02 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.826 0.822 . . . . 72.21 111.158 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.4 m -97.05 17.26 17.43 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.4 -1.273 . . . . 71.34 109.809 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.69 -91.58 0.98 Allowed Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.669 -0.696 . . . . 75.54 112.03 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.15 123.42 1.03 Allowed Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 109.345 -1.502 . . . . 73.14 109.345 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.67 101.55 9.32 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.532 -0.544 . . . . 74.4 109.532 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.03 104.38 6.53 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.49 -0.777 . . . . 62.33 109.344 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.356 0 C-N-CA 120.549 -0.834 . . . . 75.32 111.017 -177.436 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.369 0.604 . . . . 72.44 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.83 81.0 0.46 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 111.282 -0.727 . . . . 65.51 111.282 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 76.1 m -108.55 147.84 31.16 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.997 -0.742 . . . . 73.42 108.997 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -140.76 -169.09 2.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.419 -1.697 . . . . 74.15 106.419 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.38 -18.23 63.05 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 122.281 1.038 . . . . 71.43 110.197 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -81.18 2.49 27.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.478 -1.237 . . . . 72.1 110.603 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.41 -21.97 12.93 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.795 -0.762 . . . . 65.43 112.574 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.53 16.59 68.22 Favored Glycine 0 C--O 1.212 -1.259 0 N-CA-C 109.685 -1.366 . . . . 63.32 109.685 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -106.41 179.87 4.14 Favored 'General case' 0 N--CA 1.414 -2.24 0 C-N-CA 123.283 0.633 . . . . 75.22 109.932 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.06 42.12 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.967 -1.123 . . . . 63.23 107.967 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.25 107.07 11.21 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.29 -0.633 . . . . 75.43 109.29 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.25 157.62 99.29 Favored 'Cis proline' 0 C--O 1.246 0.908 0 C-N-CA 123.79 -1.338 . . . . 54.11 110.644 0.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.9 t -89.31 132.71 36.65 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 109.192 -0.669 . . . . 45.22 109.192 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HG2' ' H ' ' A' ' 18' ' ' GLY . 69.5 Cg_endo -84.38 4.43 6.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.816 2.344 . . . . 70.11 113.065 -175.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.07 -40.21 3.09 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 115.498 0.959 . . . . 32.4 115.498 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.91 -77.11 0.66 Allowed Glycine 0 C--N 1.311 -0.855 0 C-N-CA 119.95 -1.119 . . . . 62.34 113.042 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.4 m -47.01 -41.65 16.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.626 1.57 . . . . 60.04 113.708 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 14' ' ' PRO . . . -116.03 27.36 8.25 Favored Glycine 0 C--O 1.256 1.492 0 C-N-CA 120.917 -0.659 . . . . 75.5 111.674 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.1 t -92.74 84.43 5.0 Favored 'General case' 0 N--CA 1.403 -2.81 0 C-N-CA 118.38 -1.328 . . . . 54.23 109.774 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -77.91 65.41 3.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 122.338 1.066 . . . . 75.22 108.825 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -134.31 15.35 3.79 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 112.235 -2.257 . . . . 72.41 105.518 172.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.2 t -81.0 -15.29 56.62 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.717 -1.129 . . . . 53.14 110.897 -172.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.0 m -106.96 -22.94 12.51 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.596 -0.89 . . . . 73.53 108.596 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.34 99.03 7.71 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.267 -0.879 . . . . 51.21 110.314 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -87.38 96.32 10.32 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.284 -1.006 . . . . 72.12 108.284 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.4 t -125.15 104.63 8.62 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.341 -0.985 . . . . 64.1 108.341 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.45 1.43 76.12 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.637 -0.711 . . . . 54.31 112.099 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.59 -90.88 1.99 Allowed Glycine 0 N--CA 1.425 -2.036 0 N-CA-C 111.23 -0.748 . . . . 74.01 111.23 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.35 95.53 10.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 110.455 -0.202 . . . . 65.0 110.455 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.7 145.16 0.52 Allowed 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.968 1.307 . . . . 72.14 107.802 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.696 0 C-N-CA 120.478 -0.868 . . . . 71.24 111.314 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 112.371 0.508 . . . . 42.41 112.371 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.87 122.93 30.26 Favored Glycine 0 C--O 1.242 0.613 0 O-C-N 123.583 0.552 . . . . 64.11 112.771 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m -142.06 156.91 45.42 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.33 -0.619 . . . . 74.35 109.33 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -140.22 -159.7 0.99 Allowed 'General case' 0 C--O 1.261 1.661 0 N-CA-C 107.019 -1.474 . . . . 75.51 107.019 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.03 -10.05 59.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.393 0.677 . . . . 74.04 110.765 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.75 -27.44 60.35 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.306 -0.627 . . . . 70.12 109.306 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -82.77 -37.78 24.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.699 0.629 . . . . 74.01 112.699 -175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.04 27.22 9.59 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 119.164 -1.493 . . . . 62.33 109.546 -170.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.5 -178.44 3.38 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.2 -1.407 . . . . 72.24 107.2 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.81 154.87 39.74 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.948 0.78 . . . . 62.12 109.695 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.1 t -131.04 107.18 15.04 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.644 -0.873 . . . . 71.21 108.644 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.5 155.55 89.55 Favored 'Cis proline' 0 C--O 1.247 0.938 0 C-N-CA 124.313 -1.119 . . . . 73.21 109.582 0.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.4 t -83.36 123.46 76.91 Favored Pre-proline 0 N--CA 1.412 -2.374 0 C-N-CA 119.666 -0.814 . . . . 63.44 109.668 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.7 4.5 6.57 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 123.895 3.063 . . . . 71.22 115.451 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.67 -34.13 3.97 Favored Glycine 0 C--N 1.315 -0.586 0 N-CA-C 116.196 1.238 . . . . 75.35 116.196 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.71 -101.62 2.62 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 119.678 -1.248 . . . . 73.21 113.337 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 m -61.17 -36.74 80.64 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.261 1.025 . . . . 64.02 110.22 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.22 -1.44 88.11 Favored Glycine 0 C--O 1.254 1.375 0 C-N-CA 120.468 -0.873 . . . . 75.54 112.247 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 21.5 t -96.88 97.24 9.12 Favored 'General case' 0 N--CA 1.401 -2.903 0 C-N-CA 118.518 -1.273 . . . . 63.22 110.411 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -77.46 57.55 1.56 Allowed 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.116 -0.947 . . . . 74.51 109.456 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 19.1 m -153.94 36.24 0.44 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 127.074 2.149 . . . . 71.14 107.444 175.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -81.15 -17.81 48.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.487 -0.931 . . . . 74.5 108.487 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -115.49 -40.21 3.44 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.377 -0.971 . . . . 42.22 108.377 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.58 138.29 41.36 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.458 -0.792 . . . . 53.41 109.469 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 27.4 mmt180 -102.16 -1.27 31.74 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.367 -0.533 . . . . 72.25 112.372 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.8 m -80.1 84.87 5.74 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.29 -1.004 . . . . 61.34 108.29 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 31' ' ' GLY . . . 88.31 43.65 5.52 Favored Glycine 0 C--O 1.277 2.834 0 N-CA-C 110.539 -1.024 . . . . 42.43 110.539 -176.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.539 ' HA3' ' HB3' ' A' ' 21' ' ' CYS . . . -176.96 44.21 0.1 Allowed Glycine 0 C--O 1.243 0.683 0 CA-C-N 114.841 -0.679 . . . . 75.33 111.692 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.53 -59.26 0.68 Allowed 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.608 -0.886 . . . . 63.3 108.608 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.66 -63.04 1.1 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.013 -1.106 . . . . 41.24 108.013 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' O ' ' HA2' ' A' ' 27' ' ' GLY . . . . . . . . 0 N--CA 1.436 -1.347 0 N-CA-C 109.493 -1.443 . . . . 64.01 109.493 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.284 2.9 0 CA-C-O 120.581 0.229 . . . . 75.12 111.191 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -63.56 134.49 41.64 Favored Glycine 0 CA--C 1.501 -0.784 0 O-C-N 124.676 1.235 . . . . 72.12 112.598 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 73.0 m -152.02 178.34 9.54 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.243 1.017 . . . . 73.23 108.34 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -133.93 -170.16 2.45 Favored 'General case' 0 C--O 1.258 1.508 0 N-CA-C 108.747 -0.834 . . . . 71.33 108.747 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.36 -45.35 84.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.03 1.122 . . . . 71.33 114.03 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.4 -5.61 40.95 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.359 0.503 . . . . 71.54 112.359 -172.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -81.42 -28.02 34.45 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 109.461 -0.57 . . . . 64.51 109.461 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.74 12.15 59.67 Favored Glycine 0 CA--C 1.498 -0.98 0 N-CA-C 109.501 -1.44 . . . . 74.33 109.501 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.8 m -103.51 -178.33 3.63 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.505 -0.848 . . . . 73.12 108.861 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.454 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . . . -79.75 161.78 25.54 Favored 'General case' 0 C--O 1.259 1.559 0 N-CA-C 108.261 -1.015 . . . . 74.32 108.261 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 t -137.12 107.54 8.79 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.488 -0.56 . . . . 71.02 109.488 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.88 157.12 99.07 Favored 'Cis proline' 0 C--O 1.24 0.596 0 C-N-CA 124.282 -1.133 . . . . 71.2 111.153 -0.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.8 t -86.89 129.07 53.71 Favored Pre-proline 0 N--CA 1.411 -2.385 0 N-CA-C 109.557 -0.534 . . . . 71.21 109.557 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 22.7 Cg_exo -64.38 -35.63 49.08 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.958 2.439 . . . . 64.02 113.313 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.17 -46.8 1.11 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.011 -1.09 . . . . 64.2 112.967 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.56 -95.31 2.24 Favored Glycine 0 C--O 1.25 1.153 0 N-CA-C 110.131 -1.188 . . . . 71.52 110.131 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 m -69.38 123.57 21.57 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.913 -1.514 . . . . 52.34 106.913 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.66 -22.58 21.61 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 109.54 -1.424 . . . . 60.11 109.54 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 14.8 t -96.65 91.86 5.93 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.945 -1.102 . . . . 71.12 109.677 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -54.52 -24.83 22.35 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.504 -0.771 . . . . 73.21 111.578 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 37.1 m -64.0 -27.88 69.42 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.478 -0.783 . . . . 61.53 112.01 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 t -72.15 -8.61 55.63 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.146 0.498 . . . . 61.42 111.763 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -110.76 11.45 22.57 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 120.898 0.38 . . . . 71.41 110.79 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.0 -56.97 0.42 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.299 0.571 . . . . 64.3 111.168 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -163.7 108.06 1.02 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.283 -1.377 . . . . 64.13 107.283 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 m -57.99 -52.82 63.91 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.501 0.5 . . . . 73.13 110.384 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.85 -44.5 0.75 Allowed Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.191 -0.764 . . . . 54.44 111.191 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.1 -113.59 0.72 Allowed Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.237 -1.145 . . . . 63.41 110.237 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.4 -43.99 79.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.784 0.802 . . . . 73.31 108.893 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.45 140.11 47.46 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.424 -1.324 . . . . 73.32 107.424 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.306 0 C-N-CA 119.433 -1.365 . . . . 71.32 113.08 -179.555 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 108.891 -0.781 . . . . 60.22 108.891 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.47 68.46 1.4 Allowed Glycine 0 C--N 1.301 -1.362 0 N-CA-C 109.479 -1.448 . . . . 50.5 109.479 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.7 m -117.12 169.98 9.01 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.706 -0.247 . . . . 71.31 111.334 -173.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -139.32 -171.4 3.11 Favored 'General case' 0 C--O 1.255 1.382 0 N-CA-C 107.129 -1.434 . . . . 74.23 107.129 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.99 -28.04 49.22 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.766 -0.828 . . . . 74.1 108.766 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -74.52 -10.38 59.5 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.962 -1.472 . . . . 71.34 110.198 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -34.13 49.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.94 -1.027 . . . . 75.44 108.434 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.56 56.18 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.08 -1.608 . . . . 61.45 109.08 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.1 m -97.39 173.6 7.11 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 113.773 -1.213 . . . . 62.22 109.183 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.01 163.8 27.64 Favored 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.987 0.804 . . . . 55.34 109.796 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 t -137.2 108.42 8.82 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.003 -0.74 . . . . 75.31 109.003 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.17 150.17 93.13 Favored 'Cis proline' 0 CA--C 1.514 -0.476 0 C-N-CA 123.989 -1.255 . . . . 73.41 110.476 0.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.7 t -79.86 119.04 75.43 Favored Pre-proline 0 N--CA 1.416 -2.148 0 C-N-CA 120.212 -0.595 . . . . 34.45 109.68 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -86.22 0.78 8.05 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.137 2.558 . . . . 74.21 114.296 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.45 -156.45 30.56 Favored Glycine 0 C--N 1.302 -1.33 0 N-CA-C 110.113 -1.195 . . . . 71.51 110.113 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.72 -136.42 47.44 Favored Glycine 0 C--O 1.254 1.381 0 O-C-N 123.801 0.353 . . . . 65.24 113.724 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -79.94 -23.62 41.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.238 -0.653 . . . . 71.15 109.238 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.3 -20.32 71.26 Favored Glycine 0 C--O 1.251 1.186 0 CA-C-N 115.322 -0.854 . . . . 75.42 111.187 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.3 t -86.91 99.8 12.11 Favored 'General case' 0 N--CA 1.4 -2.949 0 O-C-N 121.687 -0.89 . . . . 61.44 109.895 176.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -73.45 64.42 0.84 Allowed 'General case' 0 C--O 1.203 -1.383 0 CA-C-O 121.925 0.869 . . . . 73.21 109.094 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.891 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 1.6 m -154.56 -24.39 0.12 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.252 -1.795 . . . . 71.43 110.876 176.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -68.71 -50.05 53.96 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.265 0.555 . . . . 70.45 111.792 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -89.78 -25.78 20.93 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.951 -0.759 . . . . 75.21 108.951 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . . . -65.6 -42.85 91.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.625 -0.716 . . . . 70.01 111.108 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -90.83 103.71 16.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 108.61 -0.885 . . . . 64.3 108.61 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -88.69 120.37 30.02 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 116.301 -0.409 . . . . 73.02 110.049 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.5 45.61 0.15 Allowed Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.54 -0.838 . . . . 62.52 112.526 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.68 48.73 64.71 Favored Glycine 0 C--O 1.236 0.277 0 O-C-N 123.586 0.227 . . . . 72.51 113.503 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.29 146.59 52.09 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.628 -0.508 . . . . 74.05 109.628 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.88 -44.27 4.04 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.797 0.332 . . . . 62.13 110.937 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 21' ' ' CYS . . . . . . . . 0 C--O 1.273 2.558 0 CA-C-N 116.198 -0.455 . . . . 40.45 113.174 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 120.87 0.367 . . . . 72.51 110.505 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.03 132.04 7.24 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 111.217 -0.753 . . . . 42.11 111.217 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 93.7 m -120.42 162.65 19.16 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 110.164 -0.31 . . . . 73.53 110.164 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -131.24 -174.68 3.46 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.435 -0.95 . . . . 74.33 108.435 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.34 -32.89 70.8 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 112.279 0.474 . . . . 61.22 112.279 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -76.48 -1.66 28.33 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.788 0.804 . . . . 70.15 110.523 -177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.665 ' SG ' ' HB1' ' A' ' 29' ' ' ALA . 2.9 t -80.8 -28.57 36.26 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 114.903 -1.044 . . . . 64.42 108.404 175.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.0 8.63 58.92 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 108.875 -1.69 . . . . 63.22 108.875 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.1 m -106.87 166.18 10.78 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-N 114.347 -0.926 . . . . 75.13 110.591 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -65.42 154.58 38.04 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.629 1.205 . . . . 61.32 108.926 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.9 t -134.1 105.34 11.39 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.606 -0.887 . . . . 73.33 108.606 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.26 157.36 99.37 Favored 'Cis proline' 0 C--O 1.246 0.891 0 C-N-CA 124.066 -1.222 . . . . 63.5 112.096 -0.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 43.8 t -99.96 141.06 22.06 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 108.463 -0.94 . . . . 73.24 108.463 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.58 -41.01 34.3 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.523 2.149 . . . . 73.33 113.052 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.38 -44.41 1.31 Allowed Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.002 -1.094 . . . . 70.02 113.959 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.99 -69.73 0.26 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.774 -1.203 . . . . 64.02 113.39 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.5 m -50.43 -57.24 8.48 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.543 1.137 . . . . 53.44 112.267 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 49.97 0.83 Allowed Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 110.347 -1.101 . . . . 53.13 110.347 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.8 t -110.25 109.03 19.35 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-O 121.893 0.854 . . . . 41.24 111.574 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.71 68.59 4.72 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 123.078 1.418 . . . . 75.53 109.275 172.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 6.6 m -158.88 -36.53 0.06 Allowed 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 111.264 -2.698 . . . . 62.44 107.376 172.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 p -94.22 -37.86 11.34 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.589 0.709 . . . . 70.22 109.219 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.9 m -101.75 18.11 21.27 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.629 -0.714 . . . . 74.22 111.168 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.97 148.92 22.75 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.897 -1.149 . . . . 70.24 107.897 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -93.53 75.62 4.42 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.592 0.96 . . . . 53.55 113.592 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.1 m -97.02 136.84 37.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.899 -1.148 . . . . 52.3 107.899 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.55 -92.29 0.68 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.52 -0.847 . . . . 74.1 112.075 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.21 69.76 3.28 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 110.66 -0.976 . . . . 71.23 110.66 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.665 ' HB1' ' SG ' ' A' ' 7' ' ' CYS . . . -147.97 14.92 1.05 Allowed 'General case' 0 C--O 1.251 1.148 0 CA-C-O 121.935 0.874 . . . . 72.21 109.711 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.02 160.87 14.13 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.473 -0.785 . . . . 72.25 109.911 -177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.656 0 N-CA-C 110.321 -1.112 . . . . 50.35 110.321 -177.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.846 0 N-CA-C 107.922 -1.14 . . . . 55.3 107.922 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.41 93.24 2.21 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 108.1 -2.0 . . . . 52.24 108.1 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.1 m -79.33 153.65 29.66 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.701 0.763 . . . . 71.23 112.785 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.483 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 18.3 t70 -139.91 -171.79 3.25 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 72.14 105.821 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -82.74 -25.37 32.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.767 -1.197 . . . . 74.22 107.767 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.14 -7.81 53.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.689 -1.141 . . . . 65.15 109.449 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 5.9 t -85.82 -24.54 26.72 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.861 -1.163 . . . . 63.12 107.861 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.9 6.42 60.5 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.652 -1.379 . . . . 73.31 109.652 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 m -99.54 -178.97 4.06 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 114.18 -1.01 . . . . 64.45 109.879 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.4 159.32 21.83 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.393 -0.965 . . . . 63.53 108.393 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.5 t -137.5 109.44 8.74 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 108.925 -0.769 . . . . 55.25 108.925 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.75 149.56 94.06 Favored 'Cis proline' 0 C--O 1.25 1.106 0 C-N-CA 123.756 -1.352 . . . . 75.42 111.792 0.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -85.41 131.9 46.57 Favored Pre-proline 0 N--CA 1.427 -1.599 0 N-CA-C 108.228 -1.026 . . . . 52.31 108.228 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.09 -19.74 6.7 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.264 1.976 . . . . 73.23 115.07 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.04 -44.74 1.42 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.329 -0.939 . . . . 32.23 113.451 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.06 -117.56 1.8 Allowed Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.32 -0.943 . . . . 53.21 110.961 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 m -70.11 112.98 6.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.847 -1.168 . . . . 64.33 107.847 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.43 -21.5 4.81 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 108.274 -1.93 . . . . 62.41 108.274 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 46.1 t -92.66 93.92 8.75 Favored 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 119.879 -0.728 . . . . 65.24 110.721 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -77.5 64.11 2.77 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.035 0.922 . . . . 73.01 109.186 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 20.1 m -156.68 -24.97 0.1 Allowed 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 126.765 2.026 . . . . 55.11 109.92 175.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 p -85.65 -56.88 3.28 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.689 -0.404 . . . . 73.33 110.694 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.0 m -104.24 22.79 14.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.609 0.718 . . . . 73.44 110.006 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.4 157.17 47.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.751 -0.833 . . . . 74.01 108.751 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -88.81 122.46 32.23 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 123.437 0.46 . . . . 73.15 111.179 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.2 t -136.01 127.56 28.77 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.92 -1.511 . . . . 74.4 106.92 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.97 142.79 7.45 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 110.076 -1.21 . . . . 51.52 110.076 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.45 -43.45 1.15 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 110.678 -0.969 . . . . 32.21 110.678 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.3 154.25 49.02 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.906 -1.146 . . . . 62.35 107.906 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.16 101.65 12.01 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.905 -0.776 . . . . 63.43 108.905 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.693 0 C-N-CA 120.7 -0.762 . . . . 71.11 112.829 -177.559 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.604 0 N-CA-C 107.405 -1.332 . . . . 72.32 107.405 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.21 42.49 57.79 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 107.283 -2.327 . . . . 32.41 107.283 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.2 m -61.13 132.14 52.79 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 113.016 -1.592 . . . . 71.2 112.956 -173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 4.5 p-10 -132.42 -170.13 2.37 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.01 -1.478 . . . . 64.52 107.01 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.52 -33.01 74.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.999 0.428 . . . . 71.32 111.535 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -82.1 -0.15 43.35 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.396 0.617 . . . . 72.44 111.291 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.1 t -87.86 -16.14 34.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.034 -1.098 . . . . 42.53 108.034 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 20' ' ' ARG . . . 90.92 -4.9 81.96 Favored Glycine 0 CA--C 1.496 -1.141 0 N-CA-C 109.503 -1.439 . . . . 70.14 109.503 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 m -90.43 171.75 9.22 Favored 'General case' 0 N--CA 1.399 -3.006 0 CA-C-N 114.077 -1.061 . . . . 75.22 110.616 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.2 158.98 35.48 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.908 -1.042 . . . . 75.01 108.352 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 t -135.77 107.96 9.91 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 109.566 -0.531 . . . . 71.42 109.566 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.3 152.1 97.31 Favored 'Cis proline' 0 C--O 1.245 0.849 0 C-N-CA 123.633 -1.403 . . . . 73.34 110.489 -0.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.3 t -77.22 131.54 72.11 Favored Pre-proline 0 N--CA 1.419 -2.024 0 N-CA-C 109.812 -0.44 . . . . 74.43 109.812 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.73 -9.62 13.25 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.863 2.375 . . . . 73.33 113.774 -173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.61 -32.95 4.55 Favored Glycine 0 C--N 1.31 -0.88 0 C-N-CA 120.847 -0.692 . . . . 74.33 114.217 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.34 -127.52 0.57 Allowed Glycine 0 C--N 1.32 -0.321 0 C-N-CA 120.94 -0.648 . . . . 61.23 113.673 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -60.08 -29.26 68.46 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.889 0.875 . . . . 74.12 110.339 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.72 -3.49 63.44 Favored Glycine 0 C--O 1.256 1.507 0 CA-C-N 115.103 -0.953 . . . . 55.25 112.334 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 35.5 t -89.03 93.59 9.65 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 118.563 -1.255 . . . . 72.31 109.605 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 72.3 mtt180 -77.88 64.34 3.09 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.912 -1.04 . . . . 75.21 109.084 174.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 7.3 m -154.64 21.54 0.46 Allowed 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 126.682 1.993 . . . . 75.0 107.794 173.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 19' ' ' CYS . 11.1 t -148.5 171.77 15.56 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.18 -1.415 . . . . 60.44 107.18 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.5 m -81.43 66.79 7.12 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.026 0.917 . . . . 72.5 111.754 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.94 -54.47 2.61 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.62 -1.993 . . . . 73.11 105.62 173.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -140.34 -73.31 0.35 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.732 -1.122 . . . . 73.25 108.429 168.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 5.3 m -79.27 99.54 7.12 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.621 -0.718 . . . . 71.53 110.385 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.41 -12.48 78.38 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.918 -0.873 . . . . 65.05 110.918 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.42 101.84 1.11 Allowed Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 110.217 -1.153 . . . . 71.21 110.217 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.2 100.26 7.39 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 120.925 0.393 . . . . 32.01 111.09 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.39 -31.76 69.12 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.687 -0.857 . . . . 73.44 108.687 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.289 3.537 0 C-N-CA 119.613 -1.28 . . . . 65.14 114.763 176.865 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 108.926 -0.768 . . . . 72.35 108.926 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.9 32.75 83.68 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 124.496 1.122 . . . . 64.13 112.156 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.0 m -144.27 161.0 40.03 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 121.195 0.521 . . . . 74.42 112.382 -172.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.544 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.7 t70 -140.18 -177.68 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.108 -1.812 . . . . 72.13 106.108 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.67 -35.35 72.79 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.382 -0.97 . . . . 72.14 108.382 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -74.12 -7.17 51.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.928 -1.033 . . . . 74.44 111.068 178.211 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 4.5 t -83.32 -16.85 44.56 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 176.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.82 10.52 78.84 Favored Glycine 0 CA--C 1.485 -1.799 0 N-CA-C 109.715 -1.354 . . . . 53.31 109.715 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 m -104.26 172.17 6.94 Favored 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 113.911 -1.144 . . . . 43.22 109.625 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' CYS . . . -70.64 159.61 34.1 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.194 -0.912 . . . . 62.4 108.856 174.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.13 112.8 6.77 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.347 -0.612 . . . . 72.55 109.347 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.24 140.82 69.45 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.54 -1.442 . . . . 72.54 110.505 -0.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 35.5 t -76.64 130.24 77.13 Favored Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 120.376 -0.53 . . . . 53.45 110.192 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.18 -29.45 39.34 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.505 2.137 . . . . 75.44 112.839 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.25 -29.54 12.19 Favored Glycine 0 C--N 1.317 -0.482 0 C-N-CA 119.858 -1.163 . . . . 73.01 115.691 171.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.39 -115.84 2.24 Favored Glycine 0 C--N 1.314 -0.653 0 C-N-CA 119.791 -1.195 . . . . 71.13 112.486 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.0 p -70.19 -16.8 63.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.696 0.76 . . . . 53.11 110.814 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.5 22.26 36.34 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.903 -0.879 . . . . 63.11 110.903 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 53.5 t -115.44 115.28 26.27 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-O 121.596 0.712 . . . . 64.42 111.057 174.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -80.94 61.22 4.46 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.327 -0.99 . . . . 73.22 108.327 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 3.8 m -155.17 16.16 0.41 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.639 1.175 . . . . 63.43 111.011 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -69.75 -13.34 62.24 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.008 0.433 . . . . 54.13 110.979 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.2 t -142.78 20.46 1.99 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.647 -0.871 . . . . 75.01 108.647 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . . . -123.54 -72.4 0.68 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.024 -0.534 . . . . 64.41 110.903 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -120.8 82.96 1.99 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.984 -0.747 . . . . 74.32 108.984 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.4 m -100.01 -174.25 2.64 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.431 -0.804 . . . . 75.21 109.411 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 -104.78 3.08 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.451 -0.88 . . . . 62.5 111.598 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.52 128.31 8.13 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 111.036 -0.826 . . . . 71.2 111.036 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.02 122.59 37.72 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.905 -0.776 . . . . 72.25 108.905 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.41 99.69 1.63 Allowed 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.349 -0.612 . . . . 74.11 109.349 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 N-CA-C 108.189 -1.964 . . . . 64.21 108.189 -172.923 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.871 0 N-CA-C 107.524 -1.288 . . . . 71.44 107.524 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.7 45.78 10.43 Favored Glycine 0 CA--C 1.495 -1.162 0 N-CA-C 106.426 -2.67 . . . . 74.42 106.426 -171.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.1 m -60.23 142.41 54.57 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 113.312 -1.444 . . . . 44.41 113.623 -171.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 7' ' ' CYS . 17.0 t70 -143.37 -168.94 2.94 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 104.488 -2.412 . . . . 63.35 104.488 175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.85 -29.28 62.03 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.205 -1.405 . . . . 71.45 107.205 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.71 -11.72 39.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.265 -1.334 . . . . 72.24 110.856 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 4' ' ' ASP . 7.3 t -92.85 -19.3 21.84 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.548 -0.538 . . . . 64.41 109.548 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.03 52.71 Favored Glycine 0 C--O 1.209 -1.465 0 N-CA-C 109.665 -1.374 . . . . 72.13 109.665 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -113.95 176.51 5.01 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 122.862 0.465 . . . . 74.21 109.863 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.93 154.55 37.13 Favored 'General case' 0 C--O 1.25 1.097 0 O-C-N 124.204 0.94 . . . . 43.43 108.599 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.26 108.86 10.4 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.542 -0.54 . . . . 74.41 109.542 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.78 152.06 97.73 Favored 'Cis proline' 0 C--O 1.24 0.62 0 C-N-CA 123.549 -1.438 . . . . 70.41 110.934 -0.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 48.4 t -87.75 134.69 35.06 Favored Pre-proline 0 C--N 1.292 -1.896 0 N-CA-C 108.177 -1.046 . . . . 72.3 108.177 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 13' ' ' CYS . 9.1 Cg_exo -70.79 -37.55 6.57 Favored 'Trans proline' 0 C--O 1.24 0.6 0 C-N-CA 121.83 1.687 . . . . 75.02 112.259 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.63 124.94 5.33 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.65 -0.98 . . . . 61.41 110.65 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 -75.8 1.39 Allowed Glycine 0 C--N 1.314 -0.665 0 N-CA-C 109.858 -1.297 . . . . 43.31 109.858 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.5 m -81.51 134.64 35.55 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.682 -1.599 . . . . 74.43 106.682 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.08 6.82 80.65 Favored Glycine 0 C--O 1.243 0.701 0 CA-C-O 122.411 1.006 . . . . 74.32 110.654 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.3 t -96.73 81.76 3.21 Favored 'General case' 0 N--CA 1.384 -3.737 0 O-C-N 121.694 -0.886 . . . . 60.14 110.834 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -79.12 68.17 5.01 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 123.124 1.44 . . . . 60.32 110.152 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.2 -50.57 3.13 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 112.447 -2.16 . . . . 62.43 105.423 170.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -69.04 132.02 45.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.697 -1.138 . . . . 74.13 108.915 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.9 m 73.14 -4.71 2.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.661 1.184 . . . . 63.45 111.493 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.26 -11.35 19.55 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 115.909 -0.587 . . . . 74.14 109.89 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' A' ' 25' ' ' ARG . 7.9 tpt180 -141.09 124.04 16.28 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.834 -1.543 . . . . 74.45 106.834 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 m -89.97 119.0 29.96 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.326 0.584 . . . . 41.43 112.433 -173.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.84 -92.83 1.82 Allowed Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 115.553 -0.749 . . . . 71.33 111.33 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.32 89.32 1.61 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.582 -1.007 . . . . 73.22 110.582 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.78 81.82 8.59 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.373 0.606 . . . . 75.02 110.082 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.48 101.91 11.22 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.264 -1.013 . . . . 54.34 108.264 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.28 3.014 0 C-N-CA 120.058 -1.068 . . . . 72.15 111.965 -179.204 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_